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Abstract 
 
The aim of this study was to determine if oral mucosal lamina propria progenitor cell 
(OMLP-PC)-based therapy to the stromal beds of LASIK-like wounded corneas could 
improve wound healing.  
After epithelial and/or stromal injury, a wound healing cascade is triggered that includes 
keratocyte apoptosis and proliferation in the underlying stroma. Activation of keratocytes 
leads to their transformation into myofibroblasts, which are responsible for matrix 
remodelling. Unfortunately, LASIK-like wound healing can result in incomplete closure at 
the flap interface, reduced biomechanical strength and decreased transparency.  
The hypothesis of this study was that a therapeutic application of OMLP-PCs, known to 
facilitate non-scarring healing, to the corneal wound bed, would reduce keratocyte 
activation and consequent myofibroblastic transformation to augment matrix remodelling 
and restore transparency. To test this hypothesis, a corneal organ culture model was 
developed to monitor LASIK-like wound healing outcomes. The efficacy of a cell-based 
therapy, namely OMLP-PCs, on LASIK-like wound healing was evaluated and optimised 
over four weeks. 
The wound healing outcomes of the organ cultured porcine corneas included a significant 
reduction of percentage α-sma immunopositive cells (p<0.01) from ~45% (untreated 
wounded) to ~25% (OMLP-PC-treated) during weeks 2-3 post wounding. Peak percentage 
proliferation was 52.2% ±3.7 at 1 week in OMLP-PC treated wounds, earlier compared to 
42.2% ±3.3 at 2 weeks in untreated control corneas. OMLP-PCs did not alter stromal 
percentage apoptosis. Coherence (degree of collagen lamellae alignment) at 4 weeks after 
wound healing was significantly higher in OMLP-PC treated wounded corneas (p<0.05), 
compared to that in untreated corneas. By 4 weeks corneal transparency in OMLP-PC 
treated wounded corneas was significantly higher than in untreated corneas (p<0.01). To 
conclude, an OMLP-PC therapeutic application to LASIK-like wounds enhanced stromal 
cell proliferation and reduced myofibroblast expression, but increased collagen 
organisation with consequent improved epithelial-stromal flap wound closure and 
increased corneal transparency.
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1.1. Corneal Structure 
The cornea is the domed, clear, circular “window” at the front of the eye (figure 1.1), 
allowing the entry of light into the anterior and posterior chambers of the globe. It is 
exposed anteriorly to the outside environment covered only with a tear film, through which 
the cornea, being avascular in nature, receives its supply of oxygen. Its metabolic needs are 
met via its contact posteriorly with the aqueous humour (Oie & Nishida, 2016;  Fini, 1999). 
The outer layers of the eye carry out a number of very important roles in maintaining 
corneal homeostasis. They form the ocular surface, a complex biological continuum that, 
as a fibrous tunic, is in its most basic role a protective layer that blocks the invasion of 
foreign material such as bacteria, fungi and debris (Oie & Nishida, 2016; Delmonte & Kim, 
2011). Its smooth surface and tear film gives the eye its most anterior refractive surface.  
 
 
 
 
 
 
 
 
The only mammalian tissues that have evolved to be transparent are the cornea and the lens 
(Christens-Barry et al., 1996). This transparent nature arises from both the organisation of 
collagen fibrils in the stroma (the central layer of the cornea) and the lack of vasculature 
(Maurice, 1957; Meek et al., 2003). This provides a pathway for light to travel through to 
the back of the eye. The cornea also carries out over two-thirds of the eyes refractive 
function, with the remaining optical power produced by the lens (Krachmer et al, 2011; 
Forrester et al., 2002), equating to approximately 48 dioptres of power, to create focused 
Figure 1.1 Diagram of the 
eye (Alila Medical Images, 
Alamy Stock Photo) 
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images on the retina. The structure of the cornea provides biomechanical strength in order 
to maintain its shape, an important factor, as in order to refract light and ultimately maintain 
normal visual function it must retain not only its transparency, but also its curvature (Müller 
et al., 2001). 
 
 
 
 
  
 
 
 
The cornea is divided into five differentiated layers; the epithelium, Bowman’s layer, the 
stroma, Descemet’s Membrane and the endothelium. A sixth acellular layer has recently 
been characterised by Dua et al. in 2013. Found between the stroma and Descemet’s 
membrane, it is referred to as the pre-Descemet’s layer (or Dua’s Layer) and has a thickness 
of 15m (Dua et al., 2013). There are a number of different substances that make up these 
layers, namely epithelial and endothelial cells, collagen, water, proteoglycans and 
keratocytes, the composition of which can be seen in the following table adapted from 
Hogan et al, 1971 (table 1.1). 
 
 
 
 
Figure 1.2 Layers of the Cornea (Alila Medical Images,  
 Alamy Stock Photo) 
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1.1.1. Epithelium 
The outermost layer of the cornea, the epithelium, protects the eye as a physical barrier, to 
a certain extent, against foreign bodies, and although it can certainly be wounded it can 
heal rapidly helping to minimise scarring as best as possible and therefore maintain 
transparency and visual function. The epithelium is composed of stratified, non-stratified 
and squamous cells and is approximately 50-60m thick; 10% of the total corneal thickness 
(Forrester et al., 2001). It can be further differentiated into 3 distinct layers of cells; 
squamous, wing and basal (figure 1.3).  
 
 
 
 
 
 
Table 1.1 Substances of the cornea, adapted from 
Hogan et al, 1971 
Figure 1.3 Layers of the Epithelium 
(copied from www.writeopinions.com 
/corneal-epithelium) 
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The squamous cells (most anterior, superficial layer) are flat polygonal cells that create a 
smooth epithelial surface (Saude, 1993). These cells are joined with tight junctions (zonula 
occludens) and desmosomes that control para-intracellular movement and provide adhesion 
between the cells. They also have a layer of microvilli that keeps the tear film in place 
(Forrester et al., 2001). 
 
The wing cells occupy the middle “layer” of the epithelium and are flattened and polygonal 
in shape. There are 3 layers of these cells attached to each other with desmosomes and gap 
junctions and joined to the squamous cells (anteriorly) and basal cells (posteriorly) with 
desmosomes (Remington & McGill, 1998).  
 
The basal cells make up the posterior most layer of the epithelium, which is 1 layer thick. 
They have a cubical or cylindrical form and are attached to each other via gap junctions 
and desmosomes and via hemidesmosomes to their basement membrane. This is the layer 
in which mitosis occurs and some basal cells differentiate to become middle and superficial 
cells. The stem cells in the corneal limbus are solely responsible for epithelial cell 
replacement and tissue regeneration, making this layer the most important in corneal 
epithelial wound healing. These cells also secrete basement membrane that links to the 
Bowman’s layer by hemidesmosomes (zonula adherens), through which anchoring fibrils 
pass to plaques of extracellular matrix within the stroma (Kaufman & Alm, 2002).  
 
1.1.2.  Bowman’s Layer 
Bowman’s layer (or the anterior limiting lamina) is an acellular layer of the cornea 
consisting of randomly arranged collagen fibrils. It is only 10m thick, originating from 
the mesenchymal processes of the superficial stroma during embryogenesis and is 
incapable of regeneration (Smolin et al., 2005).  Its precise function is unknown, although 
it has been hypothesised that it may help the cornea maintain its shape, act as a barrier to 
viral infection and facilitate rapid stromal wound healing following epithelial trauma 
(Wilson & Hong, 2000; Delmonte & Kim, 2011) It is a layer that is absent in many species. 
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1.1.3.  Stroma 
The stroma (or substantia propria) is the thickest of all the corneal layers. At approximately 
500m it makes up 90% of the corneas total thickness (Patel et al., 2001) and is a highly 
transparent, organised connective tissue that gives the cornea its strength and transparency. 
It consists mainly of 200-250 lamellae (flattened collagen bundles running parallel to the 
corneal surface) surrounded by keratocytes, non-fibril forming collagens, proteoglycans, 
glycoproteins, as well as other soluble proteins and inorganic salts (Smolin et al., 2005; 
Müller et al., 1995; Forrester et al., 2002). Although this layer has the potential to heal and 
regenerate it is a complicated process and often results in opacities.  
 
1.1.4. Pre Descemet’s Membrane/ Dua’s Layer 
Pre-Descemet’s membrane is a novel layer described by Dua et al., 2013, as a strong, 
acellular layer between the posterior stroma and Descemet’s membrane. It has been 
postulated that discovery of this layer could make a significant contribution to lamellar 
corneal surgery, understanding of posterior corneal pathology and biomechanics (Al-Taan, 
2018).  
 
1.1.5.  Descemet’s Membrane 
Descemet’s membrane (or the posterior limiting lamina) is the 2 layered acellular basement 
membrane of the corneal endothelium composed of type IV and VIII collagen, laminin, 
fibronectin and proteoglycans containing heparin sulphate and dermatan sulphate. It is 
secreted by and adheres to the endothelium, providing some structural integrity and playing 
a key role in fluid regulation (Hull et al., 1984) It is capable of regeneration, with good 
antigenic properties, and increases in thickness with age from approximately 3m thick at 
birth up to 12m as an adult (Rodrigues et al., 1982).  
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1.1.6.  Endothelium 
The endothelium is the innermost monolayer of the cornea, consisting of flattened cells 
with oval nuclei and 70-80% of them have a hexagonal “honey-comb like” morphology 
(Delmonte & Kim, 2011). It is approximately 5m thick and the posterior most surface of 
the cornea, adjacent to the aqueous humour (Remington & McGill, 1998). These cells are 
joined with tight junctions with intercellular communication possible via gap junctions. 
The function of the endothelium is to maintain the hydration of the cornea, allowing the 
passage of ions, glucose and amino acids into the stroma, preventing corneal oedema and 
thus maintaining transparency. The endothelial pump actively transports water and ions 
across the cell layer from the aqueous humour into the stroma and vice versa via a Na+/K+ 
-ATPase pump system (Stiemke et al., 1991). Endothelial cell numbers are approximately 
2500/mm2 in middle age. The cells rarely divide and their number decreases with age to 
2000/mm2 in healthy corneas (Rodrigues et al., 1982).  Ultrastructural analysis of corneal 
endothelial cells has found them to have an abundant number of mitochondria, which points 
to these cells being highly metabolically active (Smolin et al., 2005). 
 
1.1.7. Species Difference 
Whilst most mammals have a similar basic ocular anatomy, there are a few interspecies 
differences due to factors such as size of the animal. In Table 1.2 the differences between 
pigs and humans have been compared alongside rats to demonstrate the effect of mammal 
size on dimensions such as corneal thickness. It can be seen that pigs and humans differ 
mainly by the absence of a Bowman’s layer, which, despite the size difference to a human, 
is present in a rat.  
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1.2.Corneal Ultrastructure 
The mechanical strength of a connective tissue relies upon the interfibrillar interactions of 
collagen molecules and the interactions of collagen with proteoglycans and water. Central 
regions of the human corneal stroma consist of approximately 200-250 stacked lamellae 
running parallel to the corneal surface and each lamella is packed with fibrils in a short-
range order (discussed in more detail later in this chapter (Kaufman & Alm, 2002). The 
axial periodicity of the corneal collagen is 65nm (slightly lower than in other collagenous 
tissues) and the fibril diameter is 31-34 nm throughout the cornea (Meek et al., 1981; Meek 
& Leonard, 1993).  
 
Proteoglycans lie between the collagen fibrils maintaining the interfibrillar spacing 
(important in transparency) and have an intermolecular Bragg spacing of approximately 
1.63nm (Meek & Leonard, 1997). Collagen spacing in the periphery of the cornea is greater 
due to the presence of chondroitin sulphate, a larger proteoglycan. Proteoglycans are 
Table 1.2. Corneal structural differences between species 
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hydrophilic and therefore have a tendency to swell, which, as they maintain interfibrillar 
spacing, can disrupt the corneal arrangement and result in a reduction in transparency.  
 
1.2.1. Collagen  
Collagen molecules have a special amino acid composition whereby one in every three 
amino acids on an  amino chain is a glycine in the polypeptide chain. These  amino 
chains form a helical structure, which, when assembled with two other collagen  chains, 
form a triple helix called tropocollagen. The tropocollagen covalently link to each other in 
a staggered array creates a rod-shaped macromolecule- a collagen molecule. These 
molecules are cross-linked to each other and this produces a collagen fibril, a structure with 
a large amount of biomechanical strength and resilience (figure 1.4) (Woodhead-Galloway, 
1980).  
 
 
 
 
 
 
 
 
 
 
Collagen types can be classified into 3 sub-families: Class I (Fibril forming collagens, types 
I, I, III, V and XI) are banded fibrillar collagens with an uninterrupted helix and are 
Figure 1.4 Corneal Collagen Hierachy 
Staggered Array 
of Tropocollagen 
Tropocollagen 
Collagen Fibrils 
Tropocollagen 
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approximately 300nm. These band together to produce fibrils and, in some tissues, fibres. 
Class II (Fibril-associated collagens with interrupted triple helix domains [FACIT], types 
IX, XII, XIV and XVI) do not form fibrils by themselves but interact with the surface of 
fibrillar collagens (Class I) (Shaw & Olsen, 1991; Koch et al., 2001). Class III (Non 
Fibrillar collagens, types VI, VI and VII) are other forms of non-fibrillar collagen forming 
basement membrane collagens, microfibrils and anchoring fibrils that form networks 
(Hirano et al., 1989; Smolin et al., 2005). 
 
The stromal collagen, consisting of type I predominantly and lesser amounts of V, VI, XII, 
XIII, XIV and XXIV (Ihanamaki & Pelliniemi, 2004), exists in the form of fibrils that have 
a uniform diameter and spacing throughout the stroma, an essential property for corneal 
transparency. Collagen type III does exist in the corneal stroma, but only in scarring, which 
will be discussed later (Smolin et al., 2005). The fibrils are arranged running parallel within 
lamellae. Lamellae are bands of corneal collagen fibrils approximately 2m thick and 9-
260m wide that run from limbus to limbus; each one running at a certain angle to each 
other and parallel to the corneal surface. They bifurcate and interweave intermittently 
throughout the cornea (figure 1.5) (Meek & Boote, 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Scanning electron micrograph, showing bifurcation 
and fusion of lamellae in the human corneal stroma. Arrows (red): 
directions of two separate interwoven lamellae. Arrowhead 
(blue): point of bifurcation of a lamella. Scale bar: 10 μm. 
(adapted from Meek and Boote, 2009. Original image from 
Radner et al., 1998),  
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Posteriorly these lamellae are arranged in preferentially orthogonal layering (running at 
right angles to one another) whereas anteriorly the lamellae are organised more obliquely 
and there is more interweaving between layers (Kaufman & Alm, 2002; Muller et al. 1995). 
It has been postulated that this increased interweaving may be so that many lamellae can 
anchor to Bowman’s layer for stability (Meek & Boote, 2009).  
 
An extracellular matrix of highly hydrophilic mucopolysaccharides (as part of the 
glycosaminoglycan side chain on proteoglycans) surrounds the lamellae essentially binding 
them together. When the endothelial pump breaks down in the cornea due to injury or 
pathology, these mucopolysaccharides, being highly hydrophilic and at a higher 
concentration in the stroma than anywhere else in the cornea, are responsible for the 
ensuing corneal oedema and disruption of the fibril organisation and spacing that ultimately 
results in loss of transparency (discussed in more detail in section 1.3) (Saude, 1993).  
 
Keratocytes make up 10% of the stroma’s volume and are differentiated mesenchymal 
corneal fibroblasts that produce components important for repair and maintenance of 
collagen, proteoglycans and keratocytes themselves (Smolin et al., 2005). Generally, 
keratocytes are flattened cells with long thin processes, however they change morphology 
throughout the stroma. Anteriorly the cells have a higher density forming an extensive 
network of branching and interconnecting cell bodies, but have poor lamellar organisation. 
Towards the centre they have the least cell density and variable organisation, then towards 
the posterior the keratocytes have a more distinctive morphology, denser population than 
centrally and are larger and connected by shorter processes. These differences of the 
keratocytes throughout the stroma have been suggested to correspond to the collagen type 
and requirements throughout the corneal stroma with regards to transparency (Poole et al., 
2003). 
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1.2.2.Keratocytes 
Keratocytes are the corneal fibroblasts and are derived from neural crest cells during 
embryogenesis (Du et al. 2005). Keratocytes produce type I and V collagen for the stroma 
during development, as well as other components for the extracellular matrix (Funderburgh 
et al., 2005; Wilson et al., 2000). These cells can be found throughout the cornea and are 
transparent, which coupled with their flattened elongated shape helps the cornea maintain 
its transparency. Keratocytes have a major role in corneal wound healing, which will be 
discussed in section 1.6.  
 
1.2.3. Proteoglycans 
Proteoglycans, the “ground substance” or extrafibrillar material of the cornea, are 
macromolecules composed of a protein core and a carbohydrate glycosaminoglycan (GAG) 
polysaccharide chain attached. They are hydrophilic, negatively charged molecules located 
at specific sites throughout the corneal stroma (Smolin et al., 2005).  The protein cores of 
proteoglycans have 7-10 leucine-rich repeats and belong to the gene family of small 
leucine-rich repeat proteoglycans. There are 3 major groups of glycosaminoglycan side 
chains, after which the proteoglycans are named.  
 
There are three different keratan sulphate proteoglycans that are abundant in the posterior 
stroma which all participate in maintaining corneal transparency alongside collagen types 
VI and XII; lumican, keratocan and mimecan. Lumican is an 11 leucine rich proteoglycan 
with a single keratan sulphate side chain, it is known to be important in maintaining corneal 
transparency by controlling the formation and diameter of collagen fibrils (Kao et al., 2006, 
Kaufman & Alm, 2002). Keratocan has 10 leucine-rich repeats and three keratin sulphate 
side chains and is exclusively an ocular proteoglycan. Finally, mimecan has 5 leucine-rich 
repeats and one keratan sulphate side chain (Kaufman & Alm, 2002). 
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Decorin, as a chondroitin/dermatan sulphate proteoglycan, has 9 leucine rich repeats and a 
single glycosaminoglycan side chain. It is more abundant in the anterior cornea than 
posteriorly and binds to type IV collagen. It is the only chondroitin/dermatan sulphate 
proteoglycan in the cornea. 
 
The keratan sulphate proteoglycans appear in other connective tissues of the human body, 
however, they are unique in the cornea as they are highly sulphated. This high sulphation 
of their glycosaminoglycan side chains increases the water retentive properties of the 
cornea and thus contributes to the regulation and corneal hydration and consequently its 
transparency (Funderburgh et al., 1993).  
 
1.3.Corneal Transparency 
Transparency of the cornea can be argued to be its most important function, and it achieves 
this transparency despite having the same composition as the sclera and skin, scattering less 
than 10% of incident light (Kaufman & Alm, 2002). This transparency becomes all the 
more impressive when it is considered how densely packed the cornea is with all manner 
of structures and cells, as discussed above. For an object to be transparent it must adhere to 
two separate requirements; it must not absorb light and it must not scatter light (Roberts et 
al., 2001; Meek et al., 2002). These two criteria are certainly met by the cornea as it contains 
no pigment or other molecules that absorb light in the visible spectrum and the prevention 
of light scatter is mostly attributable to collagen and proteoglycan organisation in the 
corneal stroma.  
 
The stromal collagen fibrils require a precise uniform diameter and spacing (controlled by 
proteoglycans), as originally proposed by Maurice in 1957. However, this hypothesis has 
since been shown to be incorrect, as modern transmission electron microscopy (TEM) 
images have revealed that neither fibril diameter nor spacing is strictly constant throughout 
the cornea (figure 1.6). 
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The control of the scattering of light (to aid transparency), aiming to produce minimal 
forward scatter relative to light transmission, can also be produced by a uniform refractive 
index. However, it is known that the components of the stroma have differing refractive 
indices, Collagen fibres have a refractive index of 1.411 compared with the extrafibrillar 
matrix’s refractive index of 1.365 (Meek & Leonard, 1997), which theoretically should 
result in light scatter. This is overcome due to the spacing and order of the collagen fibrils. 
They are arranged in short-range order, examined by Hart and Farrell (1969) who 
discovered, using a radial distribution function, that a more “liquid crystal” structure of a 
random yet regular organisation was the answer. It is this short-range order that creates the 
necessary destructive interference away from the forward direction of light resulting in all 
the constructive inference energy going only into the light transmitting through to the retina 
(Meek et al., 2003). This can be demonstrated by imagining each lamella as an individual 
diffraction grating, and applying the formula n=dsin, where  is constructive interference 
with respect to the incident light and d is the centre to centre distance of the lines on the 
grating (in this case the collagen fibrils). Where d> you will see one or more diffraction 
orders, but where d<, as is the case in the cornea, then you will only see light in the zeroth 
order, which with respect to the incident is in the forward direction (Roberts et al., 2001; 
Meek et al., 2002). Essentially, providing the spacing and the arrangement of adjacent 
Figure 1. 6 Transmission electron micrograph of 
the corneal stroma, showing parallel, small 
diameter collagen fibrils lying within lamellae. 
Four lamellae are shown, two in longitudinal 
and two in transverse section. Scale bar: 
300 nm.  (copied from Meek & Boote 2009, 
original Image by R. Young) 
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fibrils are such that there is a destructive interference of scattered light, then it is not 
necessary that the spacing and diameter of the collagen fibrils confirm to a strict 
“crystalline” structure as described by Maurice (1957) (Hart & Farrell, 1969).  
 
Through all the theories and calculations, the basic proof that corneal transparency largely 
relies upon basic organisation comes when this organisation is disrupted by either oedema 
or scarring. In these cases, the collagen fibril spacing is altered and light transmissibility 
drops, as light is scattered and absorbed, resulting in a milky appearance to the cornea and 
reduced visual acuity of the patient.  
 
A large number of keratocytes are found throughout the corneal stroma, up to 15% of the 
total stromal volume (Huang & Meek, 1999; Hahnel et al., 2000), and yet they appear not 
to scatter light. It has been postulated in the past that keratocytes produce crystalline 
molecules in their cytoplasm that change their refractive index to match the surrounding 
extracellular matrix (Jester et al., 1999; Jester, 2008; Møller-Pedersen, 2004). In 2015 
Gardner et al. showed that the refractive index of the keratocytes did indeed match that of 
the surrounding extracellular matrix, but only in their quiescent state. When activated after 
wounding the refractive index of the cells decreased, no longer matching that of the 
surrounding tissue and would therefore scatter light, reducing transparency (Gardner et al., 
2015). 
 
1.4.Refractive Surgery 
Refractive surgery is an increasingly popular and widely available elective, cosmetic 
treatment for refractive errors such as myopia, hyperopia, astigmatism and even presbyopia 
(Jester et al., 1999). Originally performed using a blade to make incisions that would flatten 
the corneal topography (in radial keratotomy) and thus reduce a myopic prescription, 
refractive surgery has evolved drastically over the last few decades through various 
permutations (some of which are still used where appropriate) to using excimer lasers 
(Jester et al., 1999). This is an “excited dimer”, popularly an argon-fluoride gas 
CHAPTER ONE  Introduction 
  
16 
 
combination that creates a high power UV light beam and is used to perform precise 
photoablation to reshape an exposed stromal bed and reduce large and varying types of 
refractive error to “plano”, with minimal thermal damage to the tissue (Waring & Seiler 
1993; Bores, 2001; Singerman & Coscas, 1998). The title of refractive surgery also 
encompasses implants such as multifocal and phakic IOLs and intacs procedure, however, 
these will not be discussed in this thesis.  
 
1.4.1. Refractive Conditions 
For clear and focussed vision to occur the three components of the eye (the cornea, the lens 
and the axial length) must interact in the correct proportions and power to bring the incident 
light beams together in focus on the retina. This state, where no refractive correction is 
required, is referred to as emmetropia (figure1.7A). When this does not happen and the 
image is not focused on the retina due to a component being too powerful or not powerful 
enough, refractive correction is required and the eye is referred to as being ametropic. 
Ametropia can present in a number of different forms; myopia, hypermetropia, astigmatism 
and the age related condition of presbyopia.  
 
 
 
 
 
 
 
C A B 
Figure 1.7 Light Diagrams of Refractive Conditions A 
Emmetropia B Hyperopia (or hypermetropia) C Myopia 
(Alila Medical Images, Alamy Stock Photo) 
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i. Myopia 
In myopia (or “short/near-sightedness”) the incident beams of light entering the cornea in 
parallel rays, from a distant object, are focussed in front of the retina rather than on it 
causing a blurred image on the retina (figure 1.7 C). This refractive state is due to an 
imbalance of the axial length of the eye (too long) and the optical power or curvature of the 
lens and the cornea (to strong) (Morgan et al., 2012; Upadhyay, 2015). This requires 
negative spectacle or contact lens correction, to reduce the refractive power of the eye and 
push the focus of the image back onto the retina, or flattening of the cornea, to reduce its 
curvature, and therefore its refractive power, using a refractive surgery procedure.  
 
ii. Hyperopia 
In hyperopia (or “long/far-sightedness”) the refraction of light entering the eye from a 
distant object is too shallow and the rays are therefore focused behind the retina resulting 
in a blurry image (figure 1.7 B). This condition is caused by imbalance of the axial length 
of the eye (too short) and the optical power or curvature of the lens and the cornea (to weak) 
(Upadhyay, 2015).  Whilst mild cases can be naturally compensated, hyperopia requires 
positively powered spectacle or contact lenses to increase the refractive power of the eye 
pulling the focused image forward onto the retina. Refractive surgery to correct this form 
of ametropia involves steepening the curvature of the cornea to increase its refractive power 
and focus the image on the retina. 
 
iii. Astigmatism 
Astigmatism is a more complex form of ametropia caused by a toric cornea or lens- one 
that is not completely round. This is where there is a larger refractive error (over-powered 
or under-powered) in one direction (or axis) across the cornea or lens compared to the other, 
Light entering the eye in this condition is refracted on different axes by differing amounts, 
resulting in an image being more in focus on one axis than another (Read et al., 2007).  
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iv. Global Incidence of Refractive Error 
The incidence of the different types of refractive error changes depending on ethnicity. 
There have been many papers reporting incindences of all ages across the world, but in 
2018 Hashemi et al., performed a systematic review of databases and studies from 1990- 
2016 and merged them using a random effect model that reported the results as an estimated 
pool prevalence (EPP) with a 95% confidence interval (CI). The global incidences of 
astigmatism, hyperopia and myopia in adults and children can be seen in Table 1.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
v. Presbyopia 
Presbyopia is an age onset refractive error (usually in middle age at around 40-50 years 
old) that occurs due to increasing stiffness of the crystalline lens. In its young and flexible 
Table 1.3 Estimated pool prevalence (EPP) of myopia, hyperopia, and astigmatism in children and 
adults by WHO regions. Table adapted from Hashemi et al., 2018.  
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state its shape can be changed by the contraction or relaxation of the ciliary muscle 
surrounding the lens to change the focus of the eye from a distance to a near object, known 
as accommodation. Once the lens stiffens there is a progressive loss of accommodative 
amplitude and the near vision is no longer clear (Mantry & Shah, 2004). In this instance 
positively powered lenses are needed purely for near work to provide the patient with clear 
near vision. This is therefore harder to correct with Laser refractive surgery, as the 
correction is not required at all times in the distance (although it can obviously occur 
alongside a longstanding refractive error that does require distance correction). It can be 
corrected by performing intraocular surgery, such as refractive lens exchange, going to the 
more obvious root of the problem, or extraocular surgery using a number of laser techniques 
(Mantry & Shah, 2004).  There are a number of differing approaches using Laser in situ 
keratomileusis (LASIK- see section 1.4.3) to create a multifocal corneal surface from the 
most commonly performed technique, central PresbyLASIK (Yin et al., 2016), to the more 
straight forward monovision LASIK technique (Vargas-Fragoso & Alió, 2017) where one 
eye (the dominant eye) is corrected for distance vision and one eye for near vision. 
 
1.4.2. PRK 
Photorefractive keratectomy (PRK) is a procedure whereby the corneal surface is re-
sculpted via excimer laser ablation. Firstly, the epithelium is removed using one of three 
methods; mechanically (using a blade or a spatula), chemically (usually using alcohol) or 
by using an excimer laser to de-epithelialise the cornea via photoablation (Bansal & 
Veenashree, 2001). The centre of the exposed cornea is then ablated using the excimer laser 
to either flatten or steepen the curvature depending on the original refractive error (figure 
1.8). The wound will re-epithelialise in a matter of days after the procedure (during which 
time a protective membrane is placed over the wound, usually a bandage contact lens), 
however, as discussed previously, stromal healing can take months and the final refractive 
result cannot be ascertained until this has happened. Each pulse of the excimer laser disrupts 
the molecular bonds in the cornea and can remove 0.25m of tissue centrally, controlled 
by a computer (Coscas & Singerman, 1999), the laser beam quality and the frequency of 
its pulses are derived by an algorithm (Fagerholm, 2000).  
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Although PRK has a long visual recovery and can be quite painful for a few days after the 
procedure and it can result in complications such as damage to the central cornea, corneal 
haze or decentred ablation causing irregular astigmatism, it does not involve the creation 
of a corneal flap and is therefore considered safer than LASIK.  
 
1.4.3. LASIK 
The first to combine the excimer laser and microkeratome technology were Buratto and 
Pallikaris in the late 1980’s, first attempting the procedure on rabbits, then blind human 
eyes in 1989 and finally sighted patient eyes in 1991 (Pallikaris et al., 1990; Pallikaris et 
al., 1991). Laser in situ keratomileusis (LASIK) involves the photoablation of the mid-
stroma of the cornea to correct refractive error, after creating a flap out of approximately 
the upper 150m of the cornea (comprising of the epithelium, Bowman’s membrane and 
the anterior stroma) using either a microkeratome or a femtosecond laser (a laser delivering 
laser pulses of infrared wavelength-1053nm- to disrupt the tissue at a specified level within 
the stroma) (Kezirian & Stonecipher, 2004; Montes-Mico et al., 2007). Once the flap has 
been created by either method it is lifted and the mid stroma undergoes reshaping by 
photoablation to correct the refractive error, much the same as with PRK. The flap is then 
repositioned and left to heal (Bansal & Veenashree, 2001) (figure 1.9).  
 
Figure 1.8. PRK Procedure- 1. Untreated 
cornea 2. Epithelium is removed 3. Laser 
ablates and reshapes corneas 4. Exposed PRK 
wound (Alila Medical Images, Alamy Stock 
Photo) 
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LASIK can be considered superior to PRK in terms of visual outcomes and patient comfort. 
In general, the patient experiences very little if any discomfort and the visual recovery is 
quick and more predictable than with PRK. However, the creation of a flap out of the 
outermost layers of the cornea creates some very serious risks of complications (see section 
1.4.5). 
 
1.4.4. LASEK 
Laser assisted sub-epithelial keratectomy (LASEK) is similar to PRK. However, instead of 
removing the epithelium and disposing of it, this procedure involves the peeling back of 
the epithelium and repositioning after the stroma has been photoablated. This is an 
improvement on PRK as it results in less central postoperative corneal haze (as the 
epithelium and Bowman’s layer are not disrupted as much) and less postoperative pain for 
the patient, yet it maintains the advantages of PRK over LASIK by not creating a flap. 
LASEK is mostly used for patients who have a thinner cornea and so would be left with an 
insufficient amount of residual stroma post operatively with LASIK. It has more discomfort 
Figure 1.9 - LASIK procedure 1. Untreated 
cornea 2. Flap creation using Microkeratome 
and lifted 3. Laser ablates and reshapes cornea 
5. Flap is repositioned 6. Post-operative eye 
(Alila Medical Images, Alamy Stock Photo) 
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than LASIK and slightly increased healing time (Ambrosio & Wilson, 2003; Taneri et al., 
2004). 
1.4.5. LASIK Post-operative Complications 
Refractive surgery procedures in general result in a number of associated post-operative 
complications. However, LASIK has the most worrying of complications due to the manner 
in which it is performed. Complications range from visual symptoms such as glare, haloes 
and reduced night time vision to the more serious recurrent epithelial erosion and corneal 
ectasias that cause, not only visual disturbances, but also discomfort and require medical 
intervention (Pallikaris et al., 2001; Perez-Santonja et al., 1998). The corneal nerves are 
also severed and their number decreases by 90% after LASIK. This number gradually 
increases, however after one year there will still be less than half the original number (Lee 
et al., 1982). This potentially reduction in sensitivity could be responsible for reduced rate 
in blinking and the dry eye problems that ensue; another common complication following 
surgery (Toda et al., 2001; Chuck et al., 2000; Rosen, 2000) 
 
As there is a flap created, which is then smoothed back down, there is great potential for 
complications with this flap. Diffuse lamellar keratitis (DLK, “sands of the sahara”) is a 
sterile inflammation that can occur under the space in the flap/stroma interface. This can 
cause a decrease in vision and in severe cases require the flap to be lifted and “washed” 
out. This complication has an incidence rate of 6% 18 months post-operatively in 
microkeratome created flaps and 10.6% in those created with a femtosecond Laser, making 
it the most common post-operative complication (Moshifar et al., 2011). This has been 
known to happen up to 12 years after LASIK (Kamiyaki et al., 2010). Other particles such 
as cellular debris and even metallic components of the microkeratome blade can be found 
in the flap interface (Kaufman et al., 1998; Dawson et al., 2005). Another disruption of 
vision involving the flap/stroma interface is the occurrence of epithelial ingrowth whereby 
the epithelium can grow under the flap edge and can induce astigmatism and encroach on 
vision if left untreated. This happens in under 1% of patients with LASIK for both 
microkeratome and femtosecond LASER created flaps (Moshifar et al., 2011). The 
treatment for this is, again, to lift the flap and wash out the cells. These both require a 
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surgical intervention that causes the patient more discomfort and requires another course 
of antibiotics and anti-inflammatory therapeutics. 
 
The most potentially damaging of the LASIK flap complications, however, is flap 
dislocation. This occurs due to an aspect of corneal wound healing, whereby the stromal 
wound healing is triggered adjacent to the epithelial wound (see section 1.6). This was 
found to happen in 2.5% of microkeratome LASIK patients and 1.1% of those created with 
a femtosecond Laser one-day post operatively by Moshifar et al. in 2011. As the flap 
created means that only a circular incision is made through the epithelium around the mid-
periphery of the cornea this is where the epithelial and stromal healing takes place, and the 
wound healing of the incision through the stroma in the middle of the cornea parallel to the 
epithelium remains potentially incomplete, leaving a hypocellular scar (Schmack et al., 
2005).  
 
This means that the flap retains only an estimated 2-28% of its original strength (Schmack 
et al., 2005; Randleman et al., 2008). The peripheral wound healing is often not enough to 
secure the flap making it vulnerable under mechanical stress and some flaps can easily, 
with trauma such as eye rubbing or car accidents, become wrinkled, folded (figure 1.10) 
or, in extreme cases entirely dislocated (Melki et al., 2000; Iskander et al., 2001; Heickell 
et al., 2004; Landau et al., 2006). Whilst in most cases this can be resolved it causes great 
discomfort and distress to the patient.  
 
 
 
 
 
 Figure 1.10. Large LASIK Flap Wrinkle 
(copied from Melki & Azar, 2001) 
CHAPTER ONE  Introduction 
  
24 
 
1.5.Wound Healing 
Wound healing is the necessary response of a mammalian body to close and clean a wound, 
preventing invasion of foreign bodies that may be harmful and returning the body to 
homeostasis as soon as possible. There are four different stages of wound healing; 
haemostasis, inflammatory stage, granulation and re-epithelialisation stage, wound 
contraction and tissue re-modelling (Falabella & Kirsner, 2005). At the end of this process 
a scar will have formed at the wound site comprising of fibrous tissue produced by activated 
fibroblasts that are activated during wound healing. This scar, once healing has finished 
and the wound is closed, remains as a tissue with a different phenotype and mechanical 
properties to that of the original tissue, giving not only a different appearance but also a 
permanently weaker tensile strength to that of the original tissue.  
 
The coagulation stage occurs immediately after injury and prevents blood loss via 
vasoconstriction. Platelets are then activated by exposure to collagen from the surrounding 
tissue (such as collagen type I) and this creates a fibrin clot at the site of injury that provides 
an initial wound matrix. The platelets are also responsible for the initial release of cytokines 
and growth factors (Falabella & Kirsner, 2005). 
 
The inflammatory stage follows the initial response to injury and can last for as long as 14 
days after wounding in normal wound healing (Falabella & Kirsner, 2005). This helps to 
minimise foreign body invasion via the migration of neutrophils and macrophages to the 
injury site.  This is followed by the granulation and re-epithelialisation stage whereby once 
the wound has been temporarily closed by the two initial stages the fibroblasts start to lay 
down and other ECM (extra cellular matrix) components creating scar tissue, further 
healing the wound.  
 
The final stage of wound healing is in the contraction of the wound and remodelling of the 
tissue. The wound is contracted, bringing the edges of the wounds together, by the final 
stages of the formation of scar tissue and this seals the injury site. This scar tissue is then 
remodelled, very slowly, as a result of the action of matrix metalloproteinases (MMP’s) 
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and various collagenases that will bring the scar tissue closer to the phenotype of the 
original tissue (Clark, 1996).  
 
1.6.Corneal Wound Healing 
No matter where the injury or what type of injury has occurred, wound healing follows the 
same basic sequence across any one organism. The cornea is no different, however, due to 
its avascular nature, some stages of the sequence do not apply. Figure 1.11 shows a flow 
diagram of the corneal wound healing cascade. 
 
 
 
 
 
 
 
 
 
Corneal wound healing can be approached by looking at each of the three major layers of 
the cornea separately (the epithelium, stroma and endothelium), as each one has its own 
characteristic sequence of events. Wound healing of both the stroma and the epithelium 
will be discussed here, as there is significant interaction between the epithelium and stroma 
during corneal wound healing and both are injured during the creation of LASIK-like 
wounds with a microkeratome. The production of metalloproteinases, collagenases and 
other enzymes that restore the damaged stromal tissue is stimulated by cytokines and 
Figure 1.11. Corneal Wound Healing Cascade- 
adapted from Eraslan & Toker, 2009 
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interleukins produced by the epithelium (see section 1.6.1) (Mohan, et al., 1999; Masur et 
al., 1996; Wilson et al., 1996). This is known as an epithelial-stromal interaction. In turn 
the myofibroblasts secrete cytokines (the receptors for which are up-regulated in the 
epithelium during injury) that aid regulation of healing of the epithelium directly above in 
aspects such as proliferation, migration and differentiation; this is referred to as a stromal-
epithelial interaction (Wilson et al., 1999).  
 
Wound healing can of course also extend to the endothelium, raising a number of 
complications as damage to the endothelium will interfere with the endothelial pump and 
therefore have an impact on corneal clarity. However, this will not be covered in the 
following paragraphs.  
 
1.6.1. Epithelial Wound Healing 
The epithelial response to injury is, as would be expected, the first in the sequence of 
corneal wound healing, whether it be for a superficial wound (such as and abrasion) or a 
penetrating wound (such as LASIK). There are three main, but continuous stages to this 
process; the latent stage, epithelial cell migration and re-epithelialisation (Zieske, 2001; 
Fini, 1999; Dua et al., 1994). 
 
Following injury in the latent phase (within 4-6 hours) (Lu et al., 2001), any necrotic or 
damaged cells are either sloughed off via the tear film or engulfed by polymorphonuclear 
cells in the tear film (Lee et al., 1982). The introduction of intracellular material into the 
extracellular space triggers apoptosis and results in the release of interleukins and growth 
factors such as transforming growth factor (TGF) α and β, Platelet derived growth factor 
(PDGF) and interleukins (IL)-1, -6 and 10 (Ljubimov & Saghizadeh, 2015; Lu et al., 2001; 
Yu et al., 2010; Netto et al., 2007). The normal mitosis of the basal cell layer (for normal 
corneal maintenance) at the wound edge ceases and the basal layer cells loosen their 
hemidesmosome attachments to the basement membrane (Kaufman & Alm, 2002). In this 
latent phase the wound edge retracts and actin filaments are generated in its vicinity. The 
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phenotype of the epithelial cells on the edge of the wound starts to change as the cells flatten 
and enlarge, causing a thinning of epithelium immediately adjacent to the wound (Lu et al., 
2001; Kaufman & Alm, 2002). Extensions from the changing epithelial cells called 
filopaedia and lamellapodia project forward onto the wound site where fibronectin is now 
present, most likely derived from the tear film, acting as a provisional matrix (very much 
like the fibrin clot in general wound healing in vascular tissue) (Gipson et al., 1993). 
 
Epithelial cell migration, begins as a sheet of epithelial cells. The cell-cell junctions (the 
desmosomes) remain intact, creating an “ameboid”-like crawling motion (Kaufman & Alm, 
2002). Cell migration is usually completed 36 hours after wounding (Dua et al., 1994), 
although this will be largely dependent on the initial size of the wound. 
 
Re-epithelialisation happens alongside cell migration. Hemidesomosomes are re-formed 
once the wound closure is complete (Steele, 1999). New epithelial cells at this juncture are 
derived from those proliferating at the limbal edge of the epithelium which migrate in a 
centripetal pattern towards the wound area. The wound is eventually covered by 1-2 layers 
of cells and a new basement membrane is developed. The release of cytokines and growth 
factors also stops (Kaufman & Alm, 2002).  
 
Complete epithelial wound healing takes approximately 48-72hrs in normal healing. Until 
it is complete the patient can experience visual fluctuations. 
 
1.6.2. Stromal Wound Healing 
Due to its varied structure and composition when compared to the epithelium, stromal 
wound healing differs significantly to epithelial wound healing. The healing process in the 
stroma, however, is “kick started” by the epithelial wound healing process. When 
cytokines, namely TGFβ 1 and 2, are produced by the apoptotic cells in the wounded 
epithelium (Masur et al., 1996; Wilson et al., 2012; Ljubimov & Saghizadeh, 2015; Mohan 
et al., 1997), they bind to receptor sites on the keratocytes almost immediately, which in 
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turn triggers keratocyte apoptosis (Wilson et al., 1999), leaving an acellular zone. This 
apoptosis can last a week or more (Gao et al., 1997; Mohan et al., 2001). The remaining 
quiescent keratocytes surrounding the void that remains after apoptosis then undergo rapid 
proliferation and their numbers increase and begin activation into keratocyte-derived 
myofibroblast phenotypes. These then migrate to the injury site where they produce 
collagen, proteoglycans and other ECM components to restore Bowman’s layer and the 
damaged stromal tissue (Wilson et al., 2012; Fini, 1999; Jain & Azar, 1994) (see section 
1.6.3).  
 
The production of metalloproteinases, collagenases and other enzymes that restore the 
damaged stromal tissue, as described above, is stimulated by cytokines and interleukins 
produced by the epithelium. This is known as an epithelial-stromal interaction. In turn the 
myofibroblasts secrete cytokines (the receptors for which are up-regulated in the epithelium 
during injury) that aid regulation of healing of the epithelium directly above in aspects such 
as proliferation, migration and differentiation. This is referred to as a stromal-epithelial 
interaction (Wilson et al., 1999). There are many interactions between the stroma and the 
epithelium during the overall corneal wound healing processes that are mediated by 
cytokines. 
 
The final phase of healing in the stroma involves remodelling of the damaged tissue in an 
attempt to bring it back as close as possible to its native state. The success of this process 
however, is dependent on the type of wound originally inflicted on the cornea. Shallow 
abrasions on the cornea (such as those inflicted during PRK and LASEK that run horizontal 
to the surface) heal over approximately a year in humans (Smolin et al., 2005). The number 
of myofibroblasts decrease through apoptosis (Kaur et al., 2009; Wilson, 2012; Gao et al., 
1997) and the basement membrane is restored leaving minimal scarring. A penetrating, 
gaping wound however (one that runs perpendicular to the corneal surface, such as surgical 
incisions and penetrating trauma), stimulate the synthesis of abnormal ECM repair 
components and collagens not habitually found in the stroma, namely collagen type III and 
abnormally large “repair type” proteoglycans by the myofibroblasts (Borcheding et al., 
1975; Wilson, 2012). This therefore results in abnormal collagen inter-fibril spacing 
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leading to a lack of the level of transparency found in the native tissue (Fini, 1999). This 
could take years to remodel and may not ever reach the optical clarity of the original un-
injured cornea (Zieske, 2001).  
 
1.6.3. Myofibroblasts and Alpha Smooth Muscle Actin (α-sma) 
Myofibroblasts are fibroblastic cells found in stromal wound healing that arise from 
quiescent keratocytes and corneal fibroblasts derived from keratocytes, activated by TGF-
β1 and TGF-β2 released by apoptotic epithelial cells after epithelial injury (Masur et al., 
1996; Wilson, 2012; Ljubimov & Saghizadeh, 2015). The activated myofibroblastic cell 
phenotype changes into an elongated morphology from a stellate one and remodel their 
actin cytoskeleton to acquire stress fibres (intracellular microfilament bundles) and express 
alpha smooth muscle actin (α-sma, associated with the contractile forces that are necessary 
for wound closure) (Ljubimov & Saghizadeh, 2015; Jester & Ho Cheng, 2003) in essence 
adopting a smooth muscle cell phenotype (Wilson, 2012). 
 
The expression of α-sma in the myofibroblast has become a reliable and widely used 
immunohistochemical marker for myofibroblasts in vitro and in vivo (Chaurasia et al., 
2009) (figure 1.12) 
 
 
 
 
 
 
 
Figure 1.12. α-Smooth muscle actin (green) staining 
in myofibroblasts cultured in RSF with 1% FBS and 
2 ng/ml TGF β1. Blue is DAPI stained nuclei. 
Magnification 200× (copied from Kaur et al., 2009) 
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Myofibroblasts produce a number of ECM components including collagen I and III and 
large proteogylcans as well as fibronectin receptor α5β1 and αvβ3 integrins that are 
involved in the assembly of fibronectin fibrils (Jester et al., 1999; Zieske, 2001; Wilson, 
2012) The myofibroblastic exertion of contractile forces and high motility (migrating to the 
wound site) are aided by the presence of this fibronectin as well as chondroitin sulphate 
that open up the stromal fibrils and promote invasion of fibroblasts to the wound site 
(Andresen et al., 2000; Taliana et al., 2000; Jester et al., 1995). The large amounts of ECM 
laid down by the myofibroblasts play an important role in wound healing by aiding with 
wound closure and the regeneration and remodelling of the stromal tissue. However, the 
activation of myofibroblasts can also have a negative impact on the outcome of the wound 
healing process by contributing to a more opaque stroma (Ishizaki et al., 1994; Wilson, 
2012) This is due to a number of myofibroblastic characteristics; the contractile forces 
altering the stromal collagen fibril organisation, the laying down of excess repair ECM and 
the diminished concentration of intracellular corneal crystallins compared to the quiescent 
(due to the dramatic increase in their size) (Jester et al., 2005; Jester et al., 2012; Ljubimov 
& Saghizadeh, 2015; Ishizaki et al., 1994; Wilson, 2012; Fini, 1999). 
 
Whilst the activation of myofibroblasts is an integral part of the wound healing process, 
elucidated by the production of TGF-β1 and TGF-β2 (Carrington et al., 2006), they are not 
generally detectable in the normal unwounded cornea and so their presence during wound 
healing is a balancing act between TGF-β1, TGF-β2 and interleukin-1 (IL-1) (Wilson, 
2012; Kaur et al., 2009). Sufficiently high enough levels of TGF-β activates the 
transformation of keratocytes into myofibroblasts, and maintain their presence by inhibiting 
IL-1 stimulated myofibroblast apoptosis (Kaur et al., 2009, Wilson, 2012). As the levels of 
TGFβ fall, the numbers of myofibroblasts decrease as IL-1 triggered apoptosis occurs. 
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1.7.Scarless Wound Healing in the Oral Mucosa 
1.7.1. Oral Mucosa 
The oral mucosa describes the mucous membrane epithelial lining of the mouth, gums and 
internal surface of the cheek. It is a multi-layered structure, consisting of the oral epithelium 
(which is either keratinized or non-keratinized depending on the location within the oral 
cavity), lamina propria and sub mucosa. The oral mucosa is multifunctional; it helps to 
regulate temperature and hydration and, like the cornea, acts as a barrier to external 
environmental damage and infection (Stephens & Davies, 2015). Due to high frequency of 
mechanical trauma from mastication and the need to close wounds rapidly (to prevent 
infection) and limit scarring (so as not to restrict the flexibility of the oral mucosa) it has 
unique preferential healing (Lee & Eun, 1999; Shannon et al., 2004; Szpaderska et al., 
2003; Enoch et al., 2007). This healing characteristic of the oral mucosa has previously 
been postulated as being a result of environmental factors such as saliva (Bodner et al., 
1992; Hutson et al., 1979) however studies have confirmed that the scarless wound healing 
properties are inherent to the oral mucosa (Szpaderska et al., 2003). 
 
1.7.2. Oral Fibroblasts 
The oral mucosal healing characteristics have been likened to that of foetal scarless wound 
healing and, focussing on the fibroblasts with respects to wound healing, it has been 
postulated that oral fibroblasts represent a subpopulation of foetal fibroblasts that have 
undergone clonal expansion (Sloan, 1991; Irwin et al., 1994; Stephens et al., 1996). 
 
The characteristic preferential wound healing of the oral mucosa includes the rapid re-
epithelialisation, an increased ability to remodel ECM (especially in the re-organisation of 
3D collagen lattices when compared to skin grafts (Shannon et al., 2005) and a short 
inflammatory phase (Stephens et al., 1996; Stephens et al., 2001; Enoch et al., 2009; Enoch 
et al., 2010). The reduced scarring potential of the mucosa may be due to the inhibition of 
hyaluronan (HA) synthesis by oral fibroblasts that modulate TGFβ1 dependent responses 
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(discussed in section 1.6.3), in essence preventing fibroblast differentiation into the 
myofibroblast which would maintain the non-scarring phenotype associated with oral 
mucosa (Meran et al., 2007; Enoch et al., 2008). This lower myofibroblastic differentiation 
would mirror the lack of myofibroblasts seen in early gestational wounds that exhibit 
scarless wound healing (Estes et al., 1994). 
 
Oral fibroblasts also express greater quantities of the cytokines hepatocyte growth factor 
(HGF or scatter factor) and keratinocyte growth factor (KGF) which both have a role in the 
regulation of wound healing in the cornea (Shannon et al., 2004; Enoch et al., 2008; 
Ljubimov & Saghizadeh, 2015). Elevated HGF is also associated with the foetal phenotype 
in wound healing (Enoch et al., 2008). 
  
1.7.3. Oral Mucosal Lamina Propria Progenitor Cells (OMLP-PCs) 
Recently a population of pluripotent stem/progenitor cells were discovered in the lamina 
propria of the oral mucosa that are thought to contribute to the foetal like scarless wound 
healing of the oral mucosa (Davies et al., 2009; Widera et al., 2009). These oral mucosal 
lamina propria progenitor cells (OMLP-PCs) are isolated from buccal mucosal biopsies by 
differential adhesion to fibronectin (Board-Davies et al., 2015; Davies et al., 2009) are 
neural crest derived and are highly multipotent with the ability to differentiate down both 
mesenchymal and neuronal lineages (Stephens & Davies, 2015; Locke et al., 2015). 
 
Furthermore, studies have demonstrated not only the immunological properties of OMLP-
PCs, showing their ability to potently suppress the proliferation of peripheral blood 
leucocytes (PBLs) in a dose and contact-independent manner (Davies et al., 2012), but also 
the potent antibacterial properties (Board-Davies, 2015). OMLP-PCs were shown to halt 
the growth of both Gram-negative, by the secretion of haptoglobin (Hp), and Gram-positive 
bacteria, via the secretion of osteoprotegerin (OPG) (Board-Davies et al., 2015).  
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OMLP-PCs are of particular interest in the field of future therapeutics as these cells are 
reliably reproducible, can differentiate down multiple distinct lineages and are easily 
accessible from a biopsy site that, by the very nature of the characteristics the cells are 
being collected for, result in minimal or no scarring for the donor (Stephen & Davies, 2015). 
The potent immunosuppressive and anti-bacterial properties of the OMLP-PCs provide the 
potential for clinical therapeutic applications. For example, the treatment of immune related 
disorders, allogeneic tissue engineering and the treatment of infectious diseases such as 
bacterial pneumonia (Board-Davies et al., 2015; Davies et al., 2012; Stephen & Davies, 
2015).  
 
1.8.Aims and Objectives 
The hypothesis of this study is that OMLP-PCs will augment corneal healing of a LASIK-
like wounded flap such that stromal remodelling and transparency is improved. 
To test this hypothesis, the overall aim of this study was to determine the effect of OMLP-
PCs as a cell based therapy on corneal wounds in an organ culture model. 
To achieve this, the following objectives were performed; 
 
1. Development of a porcine organ culture model that could be used to evaluate the 
physical properties (transparency and biomechanical strength) of the wound healing 
cornea. 
2. Optimisation of the cell therapy application to LASIK-like wounded organ cultured 
porcine corneas. 
3. Determination of the efficacy of OMLP-PCs on the cellular processes involved in 
corneal wound healing. 
4. Determination of the efficacy of OMLP-PCs on stromal matrix organisation and 
wound resolution. 
 108 
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 Source of Tissue 
2.1.1. Porcine Eyes 
Enucleated whole porcine eyes were procured from a local abattoir within 6 hours of 
sacrifice, and transported to the laboratory on ice. The eyes were examined (any with 
epithelial/corneal defects were discarded) and any excess tissue (including muscle, fat and 
optic nerve) was removed using dissection scissors, in a separate room adjacent to the 
culture room, to avoid contamination. Next the eyes were rinsed in PBS (phosphate 
buffered solution) and transferred to a beaker of sterile PBS (see Appendix for solution 
preparation details) on ice, then rinsed in new PBS, before being transferred to a sterile 
beaker containing 2.5% betadine, in which they were immersed for 5 minutes. This beaker 
was re-covered with autoclaved foil, sprayed with 70% IMS (industrial methylated spirit) 
externally and transferred to a previously cleaned and prepared class II biological safety 
cabinet. From this stage on, all solutions (see Appendix for methods and preparation 
details), instruments and containers were prepared using aseptic technique, 
autoclaved/filtered or purchased as sterile. 
 
Porcine eyes were transferred into fresh PBS and rinsed twice, before being placed into 
moist chambers (i.e. 60ml sterile pots with a few drops of PBS). Eyes were left at 4°C 
overnight. Attempts were made to measure the central thickness of the porcine cornea after 
overnight storage, however this was not possible as it exceeded the limit of the ultrasonic 
pachymeter (>1000μm). 
 
 Corneal Wounding 
A LASIK-like wound flap was created in the stromal portion of each porcine corneas of 
intact globes using a microkeratome (figure 2.1) (Hansatome Bausch & Lomb, Germany). 
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The wounding of the corneas took place in the culture cabinet to maintain sterile conditions. 
The head components of the microkeratome hand piece were autoclaved at 120°C for 40 
minutes. The hand piece (as a motor connected to an electrical supply) as well as the 
connecting wires and suction tubing were cleaned as thoroughly as possible using an 
antimicrobial reagent, Microsol, followed by 70% IMS. The operating unit and foot pedals 
remained outside of the culture cabinet. 
 
The suction ring was placed carefully over the central cornea, using the pupil as a guide 
and placing the hinge superiorly. The suction was then turned on via a foot pedal and the 
pressure in the globe was increased to approximately 26mmHg to allow safe operation of 
the blade and a more accurate incision depth. The wound flap incision was then made by 
activating the oscillating blade (mounted on a motor) to cut forward into the cornea in a 
guided arc and then reversed. Once the blade was clear of the cornea, the suction ring was 
disengaged and the microkeratome head removed from the globe. This resulted in a corneal 
flap, approximately 200μm thick (the first fifth of the corneal thickness), that remained 
attached to the peripheral cornea via a “hinge” (figure 2.2). The flap was then examined for 
quality to ensure it was properly placed and intact. 
Figure 2.1. Hansatome 
microkeratome (Bausch & 
Lomb,Germany)www.brusselsey
ecenter.be accessed 2012 
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 Organ Culture 
An organ culture method, used successfully in previous research into corneal wound 
healing (Foreman et al. 1996; Carrington et al. 2006; Kamma-Lorger et al. 2009; Dooley 
et al. 2012; Morgan, et al. 2014) in bovine and ovine eyes, was used to create an ex vivo 
model of wound healing with an air interface, representative of that in vivo. This organ 
culture protocol was based on the protocol outlined by Carrington et al., 2006. 
 
A highly important aspect of organ culture is to maintain as sterile an environment as 
possible to avoid contamination and infection by bacteria and fungi. The class II biological 
safety cabinet (BSC) and the incubator were thoroughly cleaned 24 hours in advance with 
1% Virkon solution followed immediately by Microsol, and then 70% IMS on the day of 
culture. All items introduced into the cabinet were sprayed liberally with 70% IMS. Nitrile 
gloves and a culture lab coat were worn at all times and gloved hands and arms were 
sprayed with 70% IMS before beginning, and repeated as necessary during the process.  
 
Figure 2.2. Microkeratome corneal 
wound flap. 
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2.3.1. Preparation of Solutions 
A number of solutions were prepared in advance and autoclaved before use (see Appendix 
I for full preparation methods). These included sterile phosphate buffer saline (PBS) pH 
7.4, 500ml DMEM organ culture media, agar/gelatin support matrix (Invitrogen, UK), 
300ml of 7.4% NaHCO3, pre-prepared stock antibiotic solution. Where appropriate, 
autoclaving was performed at 120°C for 40 minutes. 1L PBS was prepared by adding PBS 
pH 7.4 tablets (Sigma, UK) to double distilled water (ddH2O). A 1% agar (Sigma, UK)/1% 
gelatin (Sigma, UK) solution/gel was prepared by dissolving 2g agar and 2g gelatin in 
200ml of ddH2O, then autoclaved in a 300ml dewar bottle.  
 
A 7.4% sodium bicarbonate (NaHCO3) solution was prepared in a flask by stirring 22.2g 
of NaHCO3 in 300mls of ddH2O. Once dissolved this was then stored at room temperature 
in a 300ml dewar. Stock antibiotic solution, required for both the agar/gelatin support 
matrix and the DMEM media solution, was prepared by dissolving 500mg streptomycin 
sulphate (Sigma, UK), 500mg of kanamycin, 300mg penicillin and 730mg L-glutamine in 
50ml ddH2O. The solution was then filtered, through a 0.2μm filter, in 10ml aliquots into 
bijoux. Aliquots were stored in the freezer until needed. 
 
The agar/gelatin support solution matrix and the DMEM media for the culture were 
prepared in the culture cabinet in advance. The 200ml 1% agar/1% gelatin stock solution 
was heated in a microwave at 5 second intervals on low power until liquefied, and then, 
along with the following items, sprayed with 70% IMS, before introduction into the class 
II BSC; fungizoneTM (Invitrogen, UK), 10ml stripettes, 2ml syringes, 60ml sterile pots and 
0.2μm filters. The final support matrix was prepared by filtering 20ml of DMEM media, 
10ml of 7.4% NaHCO3 and 2ml of both the 250 μg/ml amphotericin B (Gibco™ 
Amphotericin B 15290026, Invitrogen, UK) and stock antibiotic solution into the 1% 
agar/1% gelatin solution (using the 0.2μm filters). This was then decanted into sterile 60ml 
pots and stored in the fridge until needed.  
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Organ culture DMEM (21969035, Invitrogen, UK) media was prepared by filtering 5ml of 
stock antibiotic solution and 5ml of amphotericin B into the 500ml media bottle. This was 
stored in the fridge until the day of use. 
 
2.3.2. Materials 
All required instruments and solutions, detailed in Table 2.1, were sprayed liberally with 
70% IMS and introduced into the BS cabinet. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When the workspace inside the BS cabinet was arranged and the microkeratome made 
ready to use, the 60ml pots containing the decontaminated porcine eyes (see section 2.1.1) 
were also introduced into the BS cabinet. 
 
 
Table 2.1 Materials required for organ culture 
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 Organ culture of porcine corneas 
After the LASIK-like flap wound was created in each cornea using a microkeratome 
(Hansatome, Bausch & Lomb, Germany) as previously described in section 2.2, the 
wounded corneo-scleral discs were dissected from the globes by cutting circumferentially 
3-4mm below the corneal limbus using razor blades and dissection scissors. Taking care 
not to disturb the wound, the iris and lens were peeled away using forceps and disposed 
into the waste beaker with the posterior globe. In preparation for the agar support, and to 
ensure corneas did not dry out whilst the process was repeated with 3 subsequent eyes, each 
cornea was placed inverted into the plastic lid of an autoclaved universal tube lid, rinsed 
and filled with Media.  
To avoid contamination as much as possible, the eyes were wounded in batches of 4. 
Additionally, the microkeratome blade was changed every 2 eyes and the instrument head 
cleaned with 70% IMS and rinsed with PBS between each wounding. The instrument set 
(including the disposable razor blade) was changed between each dissection with the 
unused instrument set stored in a beaker of 70% IMS in between uses (each instrument was 
rinsed in PBS before use). The 70% IMS and PBS were changed out every 8 eyeballs. 
 
 
 
 
 
 
Agar/gelatin corneal support matrix was pipetted into the corneal cavity until filled to the 
scleral rim (approximately 2ml) and allowed to set for a few minutes. Sterile petri dishes 
were labelled with the appropriate initials, date and experimental details. Once the 
agar/gelatin support matrix had set, each cornea was placed into its appropriately labelled 
sterile petri dish, with the epithelial surface uppermost, ensuring all the flaps on the LASIK-
Figure 2.3. Diagram of organ culture model showing 
the air interface. 
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like wounded corneas were in place and unwrinkled. The flap was carefully lifted using a 
disposable pipette tip and 10μl DMEM culture media was pipetted onto the stromal bed of 
the LASIK-like wound, close to the hinge to aid even distribution as the flap was carefully 
replaced using a pipette tip, with great care so as not to damage either the corneal epithelium 
or the stroma. Using a stripette, 5ml of the DMEM culture media was added to each petri 
dish (starting with a few drops to the corneal surface) (figure 2.3). The petri-dishes were 
then transferred to the incubator at 37oC, 95% O2/5% CO2.  
 
In order to keep the corneas hydrated and nourished over the culture time period of 1-4 
weeks, media was removed and replaced in the petri dishes, and a few drops of fresh organ 
culture DMEM media solution were applied to the corneal surface once every 1-2 days.  
 
For characterisation of the porcine organ culture model, 4 corneas were cultured at each of 
0, 1, 2, 3 and 4 week time points. For the 0 week time point the eyes were wounded, treated 
and processed (for transparency and/or histology) within 30 minutes of wounding. Due to 
the practicalities of organ culture and the capacity of the incubator the corneas were 
cultured in batches containing 2-3 corneas (to avoid batch bias) for each time point and 
group in a rolling culture to achieve the numbers required. 
 
 Culture and application of Oral Mucosa Lamina Propria Progenitor Cells 
(OMLP-PCs) to LASIK-like wounds 
2.5.1. Source of cells 
Oral Mucosa Lamina Propria Progenitor cells (see chapter 1) were provided by the wound 
biology group at Cardiff School of Dentistry. Normal, disease-free buccal mucosa biopsies 
were obtained from consented patients undergoing routine dental procedures. Local ethical 
committee approval had been previously obtained for the study and donors were informed 
in accordance with the Helsinki convention (Davies et al., 2010). OMLP-PCs were isolated 
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(as described by Davies et al., 2010), counted and their viability determined using trypan 
blue exclusion (1:1 dilution of cell suspension in 0.4% Trypan blue). The cell lines of 3 
different patients were transported to the School of Optometry and Vision Sciences on dry 
ice, having been previously frozen in 9:1 Fetal Calf Serum (FCS):dimethyl sulfoxide 
(DMSO) freezing media. On delivery they were placed immediately into a liquid nitrogen 
cell storage dewar. Three different cell populations acquired from different participants 
were provided. 
 
2.5.2. Cell Culture 
i. Media and solutions 
Prior to commencing the cell culture, culture media solution was prepared (see Appendix I 
for more detailed methods of solution preparation). Complete culture media was made up 
in a class II culture cabinet by adding 5ml of 200mM L-glutamine (Life Technologies, UK) 
and 5 ml 100X Antibiotic/Antimycotic mix (Life Technologies, UK) to 500ml of DMEM 
(Life Technologies, UK). This solution was stored for up to a month at 4°C. For cell 
feeding, 10% heat-inactivated fetal calf serum (FCS; Life Technologies, UK) was added to 
media to provide 10% DMEM. This complete media was stored for up to 1 week at 4°C.  
 
ii. Thawing Oral Mucosal Fibroblasts and OMLP-PC’s 
The cells were thawed rapidly by agitation in a 37°C water bath. In a culture cabinet the 
cell suspension was transferred into 5ml of complete culture media (see above) and spun 
down in a centrifuge at 1500 RPM and 4°C for 5 minutes to remove the freezing medium. 
The supernatant was discarded into a 50ml waste tube and the cell pellet was re-suspended 
in 5ml fresh media by scratching the bottom of the flask against the tip box. Complete 
media was added to the 15ml centrifuge tube to make it up to 5ml and the cells were spun 
down once more at 1500 RPM 4°C for 5 minutes and the supernatant discarded into the 
waste tube. The cell pellet was re-suspended in 1ml of complete media, and an aliquot 
removed for counting (see below). Once counted the cells were seeded at 2x103 cells cm-2 
into a T75 flask. 
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iii. Cell Counting 
To count viable cells, 10μl of 0.4% trypan blue (Sigma, UK) was pipetted into a well plate 
and, using a fresh tip, 10μl of the cell suspension was added to the trypan blue to create a 
1:1 suspension. This solution was then pipetted up and down gently to ensure mixing and 
10μl was then pipetted into a haemocytometer.  
 
To count viable cells, 10μl of 0.4% trypan blue (Sigma, UK) was pipetted into a well plate 
and, using a fresh tip, 10μl of the cell suspension was added to the trypan blue to create a 
1:1 suspension. This solution was then pipetted up and down gently to ensure mixing and 
10μl was then pipetted into a haemocytometer. The haemocytometer was then placed on 
the stage of a Leica inverted microscope (Leica IX70, Germany) and the numbers of viable 
cells (those that had not taken up the trypan blue) were counted. This has a grid of 5x5 
squares of 1/25 sq mm2 and 4 x 4 squares of 1/400mm2.  An average cell number was 
calculated and represented the cell count for 10μl. To calculate the number of cells in 1ml 
this number was multiplied by 100. 
 
iv. Passaging of the OMLP-PCs 
OMLP-PCs were seeded at a density of 2x103 cells cm-2 per cm2 i.e. 1.5 x 105 cells in a 
T75 flask. To the T75 flask, 12ml of complete media was pipetted in and the appropriate 
amount of the cell suspension required to reach the seeding density was added. Once the 
lid was replaced the T75 flask was gently swirled to ensure an even distribution and the 
flask was placed into an incubator at 37˚C and 5% CO2. The cells were monitored on the 
inverted microscope (Leica IX70, Germany) and the media replaced every 3-4 days.  
 
Once cells had reached 90% confluent, the cell culture media was removed from the flask 
and the cells were washed liberally with 10ml sterile PBS (Invitrogen, UK). The PBS was 
swirled gently around the flask to ensure washing of the complete surface area, as complete 
removal of the serum is essential before addition of trypsin. PBS was removed and 2ml of 
0.05%Trypsin/0.53mM EDTA (Life Technologies, UK) was added and swirled over the 
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cells to ensure complete coverage before being replaced into the 37˚C/5% CO2 for 5 
minutes (no longer due to the toxic effect on the cells). The side of the flask was tapped 
gently to encourage detachment of the cells, and the cells were viewed under the Leica 
Light Microscope to confirm they had rounded up and were free floating. A 2x volume of 
complete media (FCS inactivates the trypsin) was added to the flask (4ml for the T75) and 
the cell suspension trypsin/media mix was pipetted out into a centrifuge tube and spun at 
1500RPM for 5 minutes.  
 
The supernatant was then removed and the cell pellet re-suspended by scratching the 
bottom of the tube against the tip rack. This re-suspended pellet was made up to a volume 
of 1ml by the addition of complete media and the cells counted as previously described. 
Cells were re-seeded at a cell density of 1.5x105 cells/cm2. 
 
The remaining cells were frozen down by suspending the cells in 90% complete media/10% 
DMSO solution (prepared in advance in a class II culture cabinet and stored at 4°C). The 
suspension was then pipetted into a 1ml cryo-vial, which was appropriately labeled and 
placed into a Mr. FrostyTM freezing container (Thermoscientific, UK) and stored for 24hrs 
at -80°C. The vial was then transferred to a liquid nitrogen cell storage dewar until needed. 
 
iv. Application of Cells to Wounded Cornea 
10μl of OMLP-PC cell suspension at appropriate cell concentration was applied to the 
wound bed. For determination of optimal cell concentration 1.5x104, 1.5x105 and 1.5x106 
cells ml-1 were applied to wounded corneas (n=3). Next, once the optimal cell concentration 
was determined, this cell concentration was applied to n=4 corneas for each of the three 
different donor cell lines at each time point. 
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 Tissue Preparation for wax and cryoembedding 
To ensure that each section obtained would have an entire flap (consisting of flap edge, 
center and hinge) across the cornea, the hinge of the LASIK-like wound on the porcine 
corneas was visualised and the cornea cut, using a scalpel blade, straight across the middle, 
endothelium up, to bisect the flap hinge (see figure 2.4). One half was fixed in 4% PFA for 
wax embedding, the second half was snap frozen as described below. 
 
 
 
 
 
 
 
 
 
 Snap Freezing 
Foil moulds were created by forming the foil around the base of a 5ml sample pot, which 
were then labelled with date, name and sample type. These moulds were then filled with 
cryoembedding media (RA Lamb, UK). Isopentane (Fisher, UK) was placed in a beaker 
and cooled by placing the beaker into a Styrofoam box of liquid nitrogen. Each bisected 
corneal sample was then briefly immersed in isopentane to freeze, before being placed, 
cutting edge (i.e. bisect edge) down, into the mould (figure 2.5). Then the mould was held 
in the isopentane using forceps until the embedding media had frozen completely and the 
sample was then transferred to a -20°C freezer until day of cryosectioning. If long term, 
samples were stored in a -80°C freezer. 
Figure 2.4 Diagram showing bisection (red line) of 
LASIK-like wounded organ cultured porcine cornea. 
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 Wax Embedding 
The bisected corneal samples were fixed by carefully, so as not to dislodge the flap, placing 
the sample in 4% PFA within a 5ml bijou, and stored at 4°C for at least 24 hours before 
processing.  
 
The corneal samples were labelled using pencil on paper strips. Each sample was then 
immersed in 50% IMS (Fisher, UK) (vol/vol with dH20) for 30 minutes, this was then 
poured off and replaced with 70% IMS for 1 hour after which the 70% was replaced with 
90% IMS for at least 1 hour (it could also be left overnight at this juncture). The 90% IMS 
was then replaced with 100% IMS for 1 hour, followed by a final 30 minutes in fresh 100% 
IMS. The samples were transferred to glass vials and moved to a fume cupboard where the 
100% IMS was discarded and replaced with a 50% vol/vol mixture of IMS and chloroform 
(Fisher, UK) for 30 minutes followed by 100% chloroform for 30 minutes. The chloroform 
was replaced with a final 100% chloroform immersion for a further 30 minutes after all but 
a little chloroform was poured off and the vials placed on top of the wax oven to warm for 
10 minutes.  
 
The samples were blotted on filter paper and placed in fresh vials filled with molten wax 
and transferred to an oven (Thermofisher, UK) for 1 hour at 63°C. The sample was then 
transferred to a fresh glass vial full of molten wax and placed in the oven for another 30 
minutes. During this time a wax block mould was partially filled with molten wax to cover 
Figure 2.5 Diagram of embedding orientation 
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the base and placed on a refrigerated base (RA Lamb, UK) at -12°C to part solidify. The 
tissue samples were then placed onto the solidified wax with the bisected surface down, an 
embedding ring was placed on top of the wax mould, trapping the paper specimen label, 
and filled with molten wax to the top. This was then allowed to completely solidify and 
then placed in a 4°C fridge until sectioning. 
 
 Sectioning 
2.7.1. Wax Sectioning 
Using a razor blade (Fisher Scientific, UK), the wax block was trimmed around the corneal 
sample. The wax block was then clamped into the microtome chuck (after ensuring the 
blade guards were in place and the wheel locked) in an orientation such that the hinge of 
the flap in the section was inferior most. Using a Feather® s35 microtome blade (PMF 
medical, UK) the wax block was trimmed until sample to be cut was observed, then 7μm 
thick sections were cut on a microtome MICROM HM 325 (Thermo Scientific, UK). 
Ribbons of wax sections were transferred to cardboard folders. 
 
Three porcine cornea wax sections were cut from a ribbon using a razor blade and floated 
out in a cold-water bath. The sections were then picked up using a glass slide and 
transferred to a hot water bath set at 42-45°C to flatten and free of bubbles. The sections 
were floated onto a HistoBond® slide (RA Lamb, UK), and placed onto a heated platform 
for 30 minutes, then placed in a 56°C oven (GenLab, UK) overnight. 
 
2.7.2. Cryosectioning 
The cryostat chamber and sample holder was set to -20°C. The snap frozen sample was 
trimmed with a razor blade and mounted on a metal chuck using a small amount of freezing 
medium, then placed in the cryostat to set. 
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An MX35 blade (Thermo Scientific) was placed into the blade holder and the platform was 
securely fastened into the sample holder, which was moved forward as close as possible to 
the blade. The block was trimmed, by turning the handle, until the sample was visible. 
10μm sections were cut and carefully rolled out using a fine paintbrush, then picked up 
onto a Superfrost Plus Slide (Thermo Scientific, UK); placing 3 sections per slide. The 
slides were labelled and sections were air dried for 30 minutes, then transferred to a -20°C 
freezer until needed. 
 
 Histological Analysis 
2.8.1. Morphology: H&E Staining 
i. Wax sections 
Harris hematoxylin and 1% aqueous eosin were decanted into two separate staining dishes. 
The prepared porcine cornea wax sections were immersed in xylene twice, for 5 minutes 
each time. Following this the sections were taken to water, through decreasing 
concentrations of IMS; 100% for 5 minutes, 100% for 3 minutes, 90% for 2 minutes, 70% 
for 20 seconds and 50% for 20 seconds. The slides were then immersed in gently running 
tap water for 3 minutes before being immersed in Harris’ hematoxylin for 4 minutes. After 
this the slides were washed in running tap water for 2 minutes, followed by an immersion 
in the 1% aqueous eosin for 5 minutes. The slides were briefly rinsed in tap water once 
more before being taken back up through decreasing IMS concentrations, briefly dipped in 
each before a final two immersions in xylene for 2 minutes each. The slides were mounted 
in DPX (RA Lamb 03703596) and left to dry overnight. 
 
ii. Cryosections 
The prepared cryosections were brought to room temperature and subjected to three 5 
minute PBS washes. They were then placed directly into the Harris hematoxylin for 5 
minutes followed by a rinse in gently running tap water for 3 minutes. The sections were 
then placed into the eosin for 3 minutes, then washed briefly in running tap water. Sections 
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were then dipped in increasing concentrations of IMS before being mounted in DPX and 
allowed to dry overnight. 
 
2.8.2. Keratocyte Activation and transformation: -sma Immunofluorescence 
Cryosections were brought to room temperature and a water immiscible outline was drawn 
around each section using a PAP pen. PBS was applied gently to each section for three 10 
minute washes. 60µl of primary antibody solution, mouse monoclonal anti-α-smooth 
muscle actin (A2547 Clone 1A4, Sigma, UK) diluted 1 in 100 in PBS was applied to each 
section. For a negative control solution, monoclonal mouse anti-green fluorescent protein 
(GFP) antibody (Sigma, UK) was prepared at the same dilution, and applied to control 
sections (figure 2.6). 
 
 
 
 
 
 
 
 
 
 
 
These cryosections were incubated in primary antibody solutions for 2 hours in a sealed 
humidity chamber, after which time the excess antibody solution was gently poured off and 
the slides were subjected to 3 PBS washes for 10 minutes each. During the PBS washes, 
the secondary antibody solution was prepared.  
Figure 2.6 Cryosection slide for 
-sma immunofluorescence 
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Secondary antibody, donkey anti-mouse IgG (H+L) Alexa Fluor®488 (Invitrogen, UK) at 
a 1 in 1000 dilution in PBS, containing 2µl (for every ml of secondary antibody solution) 
of 1mg/ml Hoechst 33342 stock solution was added to all sections, which were then sealed 
in a humidity chamber for 2 hours.  
 
After this, three 5 minute PBS washes were applied to the slides and the samples were 
mounted in Hydromount (BDH, UK), covered in foil to maintain the signal, and stored at 
4°C until the day of imaging. 
 
The sections were imaged using a Leica DM6000 flouorescent Micropscope (Leica, 
Germany). A 100μm square was drawn onto the image in Image J software and the total 
number of cells (those exhibiting a blue Hoechst signal stain of the nucleus) were counted 
within the square. The cells that were labeled with a green fluorescent signal from the α-
sma immunolabelling, were also counted and percentage myofibroblasts was determined 
using the following equation (equation 2.1). 
 
 
  
 
 
This was performed on 3 adjacent 100 μm squares at each region of interest (flap edge, 
mid-flap and hinge) above and below the wound (18 squares per section) for each time 
point. 
 
Total Cells with Green Signal (α-Sma) 
Total Cells with Blue Signal (Hoechst Stained Nuclei) 
 
 
                 X 100 
 
 
Equation 2.1 Equation to determine percentage of 
myofibroblasts.  
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2.8.3. Cell Proliferation; PCNA immunofluorescence 
Cryosections were brought to room temperature and a water immiscible outline was drawn 
around each section using a PAP pen. PBS was applied gently to each section for three 10 
washes minutes. 60µl of primary antibody solution, rabbit polyclonal anti-PCNA 
(Proliferating Cell Nuclear Antigen) antibody (ab18197, Abcam, UK) diluted 1 in 100 in 
PBS was applied to each section. These cryosections were incubated in primary antibody 
solutions for 2 hours in a sealed humidity chamber, after which time the excess antibody 
solution was gently poured off and the slides were subjected to 3 PBS washes for 10 
minutes each. During the PBS washes the secondary antibody solution was prepared.  
 
Secondary antibody, Donkey Anti-Rabbit IgG H&L Alexa Fluor® 555 (Abcam, UK) at a 
1 in 1000 dilution in PBS, containing 2µl (for each 1ml of secondary antibody solution) of 
1mg/ml Hoechst 33342 stock solution was added to all sections, which were then sealed in 
a humidity chamber for 2 hours.  
 
After this, three 5 minute PBS washes were applied to the slides and the samples were 
mounted in Hydromount (BDH, UK), covered in foil to maintain the signal, and stored at 
4°C until day of imaging. 
 
The sections were imaged using a Leica DM6000 fluorescent Micropscope (Leica, 
Germany). A 100μm square was drawn onto the image in Image J software and the total 
number of cells (those exhibiting a blue Hoechst signal stain of the nucleus) were counted 
within the square. The cells producing a green fluorescent signal from the α-sma were also 
counted and the percentage cell proliferation was determined using the following equation 
(equation 2.2). 
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This was performed on 3 adjacent 100 μm squares at each region of interest (flap edge, 
mid-flap and hinge) above and below the wound (18 squares per section) for each time 
point. 
 
2.8.4. Cell Apoptosis; TUNEL and Caspase-3 immunofluoresence 
TUNEL 
A terminal deoxynucleotidyl transferase-dUTP nick end labeling (TUNEL) assay (Click-
iTTM Plus TUNEL Assay, C10617, Invitrogen, UK) was attempted to determine apoptosis. 
Working solutions of 1X Click-iTTM Plus TUNEL Supermix, Click-iTTM TUNEL Reaction 
Buffer Additive and 1X Proteinase K Solution were prepared in advance and stored 
appropriately (see appendix). Cryosections were brought to room temperature and PBS 
applied to each section for three 10 minute washes. The sections were then fixed in 4% 
paraformaldehyde for 15 minutes at 37°C followed by 2 applications of PBS for 5 minutes 
each.  
 
Sections were incubated in 60µl of Proteinase K solution for varying amounts of time (see 
optimisation) followed by a 5 minute wash in PBS, a further 5 minutes in 4% 
paraformaldehyde at 37°C and a final rinse in deionized water. 
 
Sufficient quantity of TdT Reaction buffer was added to each slide to allow the solution to 
spread and cover the samples completely. The slides were incubated for 10 minutes at 37°C 
whilst the TdT reaction mixture was prepared (see appendix). After removal of the TdT 
 
Total number of cells with Red Signal (PCNA) 
Total number of cells with Blue Signal (Hoechst Stained Nuclei) 
 
 
                                X 100 
 
Equation 2.2 Equation to determine percentage cell 
proliferation.  
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reaction buffer, 50µl of the prepared TdT reaction mixture was added to each section and 
incubated for 60 minutes at 37°C. Upon removal the slides were rinsed with deionized 
water and washed with 3% BSA and 0.1% TritonTM X100 in PBS for 5minutes before a 
final rinse in PBS. 
A Click-iTTM Plus TUNEL Reaction Cocktail was prepared (see appendix) and 50µl 
applied to each section before an incubation of 30 minutes at 37°C, followed by a 5 minute 
rinse in 3% BSA in PBS and a final rinse in PBS. 
 
A 50µl of 1mg/ml solution of Hoechst 33342 was added to each section for 15minutes at 
room temperature before removal and three 5 minute washes in PBS. The slides where then 
mounted in Hydromount (BDH, UK), covered in foil to maintain the signal, and stored at 
4°C until the day of imaging. 
 
TUNEL Optimisation 
The initial attempt at TUNEL assay on the samples resulted in indiscriminate 
immunolabelling of all cells in the corneal samples, therefore optimisation was attempted 
as outlined in figure 2.7. 
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The TUNEL assay on these sections failed, despite optimisation attempts, and so apoptosis 
was detected by immunolabelling for caspase-3. 
 
Figure 2.7 TUNEL Assay Optimisation images demonstrating the period of time incubated 
with proteinase K and the application of 0.1% Triton X100 of LASIK-like untreated wounded 
corneas after 1 week in organ culture. The results show Hoeschst labelling of cell nuclei (Blue) 
an indiscriminate immunolabelling of TUNEL positive cells (Green). This demonstrates a 
failure of the TUNEL protocol. Scale bars represent 100µm 
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Caspase-3 
Cryosections were brought to room temperature and a water immiscible outline was drawn 
around each section using a PAP pen. PBS was applied gently to each section for three 10 
washes minutes. The sections were incubated in 0.1% Triton-X100 for 10 minutes, 
followed by three 5 minute PBS washes. 60µl of primary antibody solution, rabbit 
polyclonal anti-active Caspase-3 (ab49822, Abcam, UK) diluted 1 in 500 in PBS was 
applied to each section. For a positive control an apoptosis positive slide of 4-day post-
weaning rat mammary gland was used (ApopTag® Positive control slide, S7115, Sigma, 
UK).   
 
These cryosections were incubated in primary antibody solutions for 2 hours in a sealed 
humidity chamber, after which time the excess antibody solution was gently poured off and 
the slides were subjected to 3 PBS washes for 10 minutes each. During the PBS washes, 
the secondary antibody solution was prepared.  
 
Secondary antibody, donkey anti-rabbit IgG H&L Alexa Fluor® 555 (Abcam, UK) at a 1 
in 1000 dilution in PBS, containing 2µl (for every ml of secondary antibody solution) of 
1mg/ml Hoechst 33342 stock solution was added to all sections, which were then sealed in 
a humidity chamber for 2 hours.  
 
After this, three 5 minute PBS washes were applied to the slides and the samples were 
mounted in Hydromount (BDH, UK), covered in foil to maintain the signal, and stored at 
4°C until the day of imaging. 
 
The sections were imaged using a Leica DM6000 flouorescent Micropscope (Leica, 
Germany). A 100μm square was drawn onto the image in Image J software and the total 
number of cells (those exhibiting a blue Hoechst signal stain of the nucleus) were counted 
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within the square. The cells that were labeled with a red fluorescent signal from the 
Caspase-3 immunolabelling, were also counted and percentage of apoptotic cells was 
determined using the following equation (equation 2.3). 
 
 
 
  
 
This was performed on 3 adjacent 100 μm squares at each region of interest (flap edge, 
mid-flap and hinge) above and below the wound (18 squares per section) for each time 
point. 
 
 Transmission Electron Microscopy 
Transmission electron microscopy (TEM) was used to observe the corneal ultrastructure 
up to x100 000 magnification. Corneas were removed from organ culture and fixed in a 
2.5% glutaraldehyde solution overnight. They were then rinsed twice in 0.1M cacodylate 
buffer pH7.4 at room temperature for 10 minutes each, before storing at 4°C until needed 
(see appendix for solution preparation). 
 
The samples were dissected under a light microscope with a razor into tissue blocks, 
isolating the wound edges of the trephine and LASIK-like wounded corneas, keeping the 
flap intact and on the stromal bed. These tissue blocks were placed into glass vials 
appropriately labelled and then placed into 1% osmium tetroxide in 0.1M cacodylate buffer 
for 1 hour, after which they were rinsed in distilled water (dH2O) three times for five 
minutes each. After the last rinse, 0.5% aqueous uranyl acetate was decanted into the glass 
vials and the tissue blocks were stored in this for one hour.  
 
 
 
Total Cells with Red Signal (Caspase-3) 
Total Cells with Blue Signal (Hoechst Stained Nuclei) 
 
                 X 100 
 
 
Equation 2.3 Equation to determine percentage of apoptotic 
cells.  
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The samples were then dehydrated through increasing concentrations of ethanol solution 
(70%, 90% and 100% twice) for 15 minutes each. After the last ethanol change, the samples 
were immersed in propylene oxide for 15 minutes twice. Finally, the vials were drained 
and samples immersed in 1:1 mixture of propylene oxide and araldite resin for 1 hour.  
 
The tissue blocks were infiltrated with araldite resin in glass vials placed in a rotator within 
a fume cupboard. This resin was changed thrice, approximately every 2 hours before being 
left to infiltrate. A further three changes of resin were repeated again, every 2hours. The 
samples were placed into moulds, filled with fresh araldite resin and placed in a 60°C oven 
for 24hrs, thus creating resin blocks for sectioning. Each sample was labelled appropriately 
and great care was taken to orientate the samples correctly so that when they were sectioned 
and placed on the electron microscope the desired location was imaged. 
 
A Leica UC6 ultramicrotome (Leica, Germany) was used to cut ultrathin sections (~90nm 
thick) using a glass knife made using a Leica EMKMR2 knifemaker (Leica, Germany) 
(figure 2.8). Once the sections were lifted and placed on grids, they were examined and 
imaged using a Jeol 1010 transmission electron microscope (Jeol, USA). 
 
 
 
 
 
 
 
 
Figure 2.8. TEM Sectioning - A- Polished resin block sample prior to sectioning. B- 
Sectioning with glass knife. C- Ribbon of ultrathin sections 
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 Extensometry 
The corneas were loaded into the Barons Artificial chamber (figure 2.9). This chamber 
allowed a pressure to be introduced into the system via injection of PBS into a valve, to 
mimic intraocular pressure, as well as a support to orientate the cornea in a vertical position.  
 
 
 
 
 
 
The PBS was injected into the chamber with care, until the cornea adopted the normal 
domed shape and the valve was clipped shut. The chamber was then attached to a vertical 
support, fixed to the bottom chuck of the extensometer (figure 2.10), ensuring that the hinge 
of the LASIK-like flap was in the superior position. Attached to the vertical chuck, a clamp, 
lined in sandpaper to provide grip and friction, held a stiff strip of card, the end of which 
had an area of 5x5mm that was glued (with a thin layer of superglue) to the centre of the 
corneal flap (figure 2.11). 
 
 
 
 
 
 
 
 
Figure 2.9. Barons Artificial Anterior 
Chamber. (www.bpic.com accessed 
2013) 
 
Figure 2.10. Diagram of extensometer set up to measure vertical 
shear. 
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The extensometer slowly pulled the cardboard strip upwards at a set rate and force, creating 
a direct shear effect. The programme was set to the following parameters (table 2.2);  
 
 
 
 
 
 
  
 
 
 
 
The stress and strain forces on the corneal flap were recorded by the extensometer, 
controlled by the Nexygen 4.1 user interface software (Lloyd Instruments, Bognor Regis, 
UK). A graph of force versus time was automatically produced by the software. The 
dehiscence/break point of the LASIK-like wound can be determined by a sharp drop in 
force (seen on the realtime data plotted on the graph by Nexygen software), but was also 
monitored by eye. Time to flap detachment was recorded and compared to the data 
collected by the software.  
 
 
 
 
 
 
Table 2.2. Nexygen 4.1 programme 
parameters for pull to break testing  
 
Nexygen Parameters 
Preload 0.20N 
Speed 1.50mm/min 
Gauge Length N/A 
Area 5mm x 5mm 
Break Load Drops to 10% 
 Figure 2.11. Image of cornea loaded 
into Barons Artificial Chamber 
before pull to break cycle is started.  
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 Transparency Measurements 
2.11.1. Spectrophotometry  
Spectrophotometry quantitatively measures the ability of a material to transmit light as a 
function of wavelength. The spectrophotometer, in this study, generated a 1mm beam of 
light at a given wavelength that passed through a sample and the amount of light transmitted 
through the sample was measured via a detector. 
 
An SP8-100 UV/VIS spectrophotometer (PYE Unicam ltd) was switched on at least one 
hour before use, to warm up. Ensuring no sample or cuvette was in its path, the transmission 
was measured at 100% (by altering the zero dial). A cuvette was filled with silicon oil (Dow 
Corning, UK) and placed in the beam path (figure 2.12). Starting at 400nm the transmission 
% was recorded at 10nm intervals up to 700nm. This provided a “blank” measurement used 
to normalise the data. 
 
 
 
 
 
 
 
 
A porcine corneal sample was placed in the custom-made sample holder (figure 2.13 A). 
Syringing through valves, containing 5 mm stoppers (SGE Analytical Science, Australia), 
silicon oil was added to both the anterior and posterior chamber of the sample holder to 
Figure 2.12 Silicone oil filled cuvette 
placed in beam line 
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reduce the scattering of light. The prepared sample holder with the porcine cornea sample 
was then placed into the spectrophotometer (figure 2.13 B) and the % transmission was 
recorded at 10nm intervals from 400 to 700nm. These measurements were repeated 3 times 
for each corneal sample and the blank measurement of silicon oil was performed between 
each sample to ensure stability in the reading. 
 
 
 
 
 
 
 
 
 
 
The data, once collected, was normalised against the blank reading of the silicon oil and 
statistical analysis was performed. 
 
2.11.2. Visual Transparency Assessment 
The use of spectrophotometry, although useful in the provision of detailed data on the 
transmission of different wavelengths through the wounded organ cultured cornea, destroys 
the sample as it becomes irreversibly coated in silicon oil and damaged by the sample 
holder. In order for transparency and cellular/collagen to be analysed in the same sample, 
an alternative measure of transparency was required.  
 
Figure 2.13 A Custom-made corneal sample holder. Yellow arrow indicates 
passage of light beam. B Sample holder placed in beam line. 
 
B 
 
A 
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Once removed from organ culture, but before fixation or cryoembedding, each cornea was 
photographed, epithelium down, at a fixed distance and illumination, over a page of graph 
paper. The same sample was then moved to a dissecting microscope (Leica, UK) and 
imaged.  
 
These images were arranged in random tiled order and presented to 10 different individuals, 
who were shown the grading scale as a guide, and then assigned a level of clarity to each 
image (figure 2.14). This method was successfully employed in previous research by 
Kamma-Lorger et al. (2009) and Dooley et al. (2012). 
 
 
 
 
 
 
 
 
 
 
 
Data were collected for n=3 corneas at each time point for each treatment and each level of 
clarity was assigned a numerical value (3= Clear, 2= Moderately Clear 1= Cloudy) to allow 
graphical representation of the transparency and statistical analysis. 
 
 
Figure 2.14 Demonstration of visual grading of cornea 
transparency 
 
Clear Cloudy Moderately Clear 
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 SHG Imaging 
2.12.1. Non Linear Microscopy 
The imaging of the 3D architecture of tissues such as the cornea has been possible using 
non-invasive methods since the advent of non-linear microscopy techniques. This non-
linear optical microscopy technique was employed to examine the fibre organisation of the 
corneal sections, using second harmonic generation (SHG) (λex/em=800nm/ 400nm).  
 
10µm cryosections were brought to room temperature and subjected to three 5 minute PBS 
washes. Then sections were mounted in VECTASHIELD® with propidium iodide (PI) 
(Vector Labs, UK), as PI excites at about 535nm and emits at about 615 nm when bound 
to DNA, producing a red fluorescence, this provided a nuclear stain. The sections were then 
allowed to air dry (in the dark) for 1 hour and sealed with clear nail varnish before being 
wrapped in foil and stored at 4°C.  
 
The laser scanning microscope (LSM) 880 NLO on Axio Examiner fixed stage upright 
microscope (Carl Zeiss Ltd., Cambridge, UK) was turned on, being careful to adhere to 
instructions and ensure that the coolant temperature was 25°C. The Zen software was 
initialized and the microscope configured as below (figure 2.15A). Once set up as such, the 
ocular tab in Zen was chosen to enable safe viewing of the slide so that the appropriate area 
of interest could be located. Once located and brought into focus, the “acquisition” tab was 
selected and “live scan” selected, ensuring that the Channel panel was set up as follows 
(figure 2.15B). 
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The desired pseudocolouring for forward scattered SHG and PI fluorescence were also 
selected for the image (Green- SHG, Red- PI) (see figure 2.16). A focus step of 1m for 
corneal sections was also selected. The wounds in the corneal sections were tracked by 
finding an initial reference point, such as the flap edge, setting that point to zero and 
tracking along the wound until the hinge was identified. Once these two points were 
determined the distance moved in the X and Y directions, calculated from the x,y co-
ordinates of each position, were used to estimate the location of the mid-flap region (figure 
2.17). Images were collected with Plan-Apochromat 20x/0.8NA objective lens (Zeiss). 
Configuration of the scans is covered in Chapter 6.  
 
Figure 2.15 A Saved configuration ‘SHG PI’ to be used when viewing samples mounted 
with VECTASHIELD® with PI B Drop down menus showing setting for channels used 
viewing samples mounted 
 
A 
 
B 
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These images were saved as .lsm files and the fibrillar collagen bundle coherence and 
distribution of orientation at each region of interest were determined using Image J 
Orientation J Analysis software (version 1.52a, National Institutes of Health, USA) as 
previously described by Rezakhanih et al. (2011). Detailed methods of application of 
Orientation J image analysis will be provided in Chapter 6. 
 
Figure 2.16 SHG (Green Arrows) and PI fluorescence (Red 
Arrows) image of LASIK-like Wounded porcine cornea 
cryosection mounted in VECTASHIELD® with PI (Vector 
Labs, UK) 
 
Figure 2.18 Diagram of LASIK-like wounded porcine cornea. 
Red boxes demonstrate ROI’s; Flap Edge, mid-flap and 
hinge.Figure 2.17 SHG (Green Arrows) and PI fluorescence 
(Red Arrows) image of LASIK-like Wounded porcine cornea 
cryosection mounted in VECTASHIELD® with PI (Vector 
Labs, UK) 
Figure 2.17 Diagram of LASIK-like wounded porcine 
cornea. Red boxes demonstrate ROI’s; Flap Edge, mid-
flap and hinge. 
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2.13.  Statistical Analysis 
In the analysis of data compiled in the experiments it was necessary to compare the results 
of a particular test such as percentage α-sma immunopositivity for each group of samples 
against each other and each time point. For this a 2-way ANOVA (analysis of variance) 
was used to compare the mean differences between groups split on two independent 
variables, to understand if there was an interaction (significant difference) between the 
independent variables on the dependant variable.  
Multiple comparisons were run on a single data set and so a post-hoc test to adjust for this 
and reduce error rates, such as Bonferroni, Scheffes’s or Tukey HSD (Honest Significant 
Difference), was needed. With these results multiple pairwise comparisons were required 
and so a Tukey HSD test was used as a post-hoc test. The 2-way ANOVA tells of 
significance but can’t tell you where the significance lies, so the Tukey HSD was used to 
run comparisons between all possible pairs of groups to find out which specific groups are 
significantly different to one another.  
The lack of statistical power to these analyses from the low sample numbers throughout 
these experiments was something to bear in mind during the evaluation of the results. 
 
 108 
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3.1 Introduction  
Refractive corneal surgery has become an increasingly popular method of vision correction 
over the years. However, due to the incomplete healing of LASIK-treated corneas they 
maintain only 2-28% of the tensile strength of the native cornea (Schmack et al., 2005; 
Randleman et al., 2008). This limited wound healing is of significant clinical importance 
and can ultimately result in dehiscence of the flap created during the LASIK procedure 
(figure 3.1).  Although this dehiscence can be treated with mostly positive results, it can be 
extremely painful and traumatic for the patient and can result in a significant reduction in 
functional vision. 
 
 
 
 
                       
 
 
 
 
 
 
 
 
Researchers have tried to resolve this issue by improving flap adhesion using “biologic 
tissue glues” and attempting to modify the stromal healing process. The properties of 
quiescent keratocytes at the wound edge alter in the early stages of wound healing; the cells 
become activated fibroblasts and migrate towards the wound bed. These fibroblasts then 
transform into myofibroblasts on reaching the wound bed and begin expressing α-smooth 
muscle actin (sma), as well as desmin and an increased amount of vimentin (Chauraisia et 
al., 2009). The α-sma expression directly correlates with the contractile forces exerted by 
the myofibroblasts, thus closing the wound gap (Jester et al., 1995). Concurrently, 
fibroblast expression of corneal crystallins are downregulated and the transparency of the 
 
 
 
Figure 3.1. Corneal Flap Dehiscence Following 
Screwdriver Trauma 10 Years After Lasik (Rodriguez 
& Ascaso, 2013) Reproduced with permission from 
Rodriguez & Ascaso, 2013, Copyright Massachusetts 
Medical Society. 
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cornea is reduced through the contractile forces and deposition of opaque ECM (Jester et 
al., 1999; Fini, 1999; Jester et al., 2005). The expression of α-sma then ceases on 
completion of the wound healing process and the disappearance of myofibroblasts (Fini, 
1999). The activation of keratocytes into the myofibroblast phenotype, and the presence of 
α-sma, can therefore be associated with the corneal haze that accompanies corneal wound 
healing.  
 
Dooley et al. (2012) used an organ culture model of LASIK-like wounded ovine corneas to 
investigate the effect of cell applications, and evaluated the activation of keratocytes to 
fibroblasts and myofibroblasts using alpha smooth muscle actin (α-sma) in treated and 
control corneas to investigate the role of these cells in producing scarless wound healing 
and a subsequently clear cornea. The potentially improved wound healing was tested by 
assessing the strength of the flap adhesion at various time points during the culture. An 
extensometer was used to subject the flap to a known vertical force and the time to 
dehiscence (or break) was recorded (figure 3.2A). However, a vertical force is not 
representative of the naturally occurring shear force that is the cause of most cases of post-
LASIK flap dehiscence (e.g. eye rubbing and other abrasive forces) and was performed in 
the absence of any other natural forces acting on the cornea, such as intraocular pressure. 
 
Littlechild et al. (2012) constructed a rig to apply a shear force to corneal tissue. Various 
combinations of fibrinogen “glue” and riboflavin/UVA crosslinking were used to adhere 
corneal strips from rabbit or shark corneas together. Their adhesion was measured by 
pulling apart the corneal strips via scleral tags using a motorised horizontal test stand and 
measuring time to break and the force required (see figure 3.2B). 
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This method was found to markedly increase the biomechanical adhesion strength of the 
wound after 30 minutes. Finally, Randelman and Dawson (2008) evaluated the 
biomechanical strength of a LASIK-like wounded cornea by applying a force along their 
axis and measuring the elasticity based on Young’s Modulus. As Randelman and Dawson 
stated themselves, this method does not reflect an in vivo trauma. The force they used to 
measure Young’s Modulus exerted over the X or Y axis, was one that would be very 
unlikely to cause flap dehiscence and that, in reality, a compressive or shear force with a 
degree of torque would be the more natural event to result in this specific trauma. A vertical 
shear extensometry rig was constructed to measure the shear force that also incorporated a 
Baron’s Artificial Chamber to introduce the more natural intraocular pressure and shape of 
an eye (figure 3.2C). 
 
 
 
A 
 
C 
B 
 
Figure 3.2. A Dooley’s 2012 Extensometer design- Reproduced with authors permission 
(Dooley et al., 2012) B Littlechild’s method of measuring flap adhesion (Littlechild et al. 
2012) C Final vertical shear extensometry design.  
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3.2 Aim 
Porcine organ culture was carried out to ascertain whether the fibrinogen glue had any 
effect on the corneal wound healing of LASIK-like wounded corneas as a function of time 
in organ culture.  
The objectives of this chapter were to: 
 Evaluate porcine cornea wound healing of LASIK-like flaps in an organ culture model 
 Use fibrinogen as an example of a therapeutic agent to determine the efficacy of the 
model in evaluating change in healing outcome measures as a function of treatment. 
 
3.3 Experimental design 
The following investigations used the application of fibrinogen solution as outlined by 
Littlechild et al. (2012) as a model to develop a porcine corneal wound organ culture model 
that could later be used to test the efficacy of potential therapeutics. Outcome measures for 
evaluation of change were: morphological and structural assessment (Haematoxylin and 
Eosin staining and electron microscopy), α-sma immunopositivity (i.e. myofibroblastic 
transformation), cell number (cell proliferation/movement), transparency 
(spectrophotometric analysis) and mechanical properties (shear force) of the treated and 
untreated cornea.  
 
To characterise the wound healing of LASIK-like wounded corneas during organ culture, 
and to assess the effects of fibrinogen treatment, porcine corneas were procured and 
wounded and treated before being placed into organ culture (see section 2.1-3). Corneas 
were wounded with the microkeratome to create a LASIK-like wound. Wounded, but not 
cultured, corneas provided 0 time point samples.  
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Half of the corneas were left as controls, the other half were treated by adding 10µl of a 
180mg/ml fibrinogen solution (see Appendix) to the stromal bed under the epithelial-
stromal flap of the LASIK-like wound. Corneas were examined using spectrophotometry 
immediately after treatment to assess the effect of the addition of fibrinogen on corneal 
light transmission, unwounded controls. 
 
After 4 weeks in culture, corneas were examined using spectrophotometry (see section 
2.11.1), extensometry (see section 2.10), electron microscopy (see section 2.9), α-sma 
immunofluorescence (see section 2.8.2) and H&E (see section 2.8.1). The number of 
corneas used is outlined in Table 3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1 Table demonstrating porcine cornea number. 
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An additional organ culture was carried out with LASIK-like wounded porcine corneas for 
1, 2, 3 and 4 week time points to further refine the immunofluorescence protocol. The 
number of corneas used is outlined in Table 3.2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2 Table demonstrating the number of porcine corneas used in αsma 
immunofluorescence protocol refinement.  
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Results 
3.4 Morphology: 
3.4.1.  H&E staining 
Haematoxylin and eosin stained images of fibrinogen-treated and untreated wounded 
corneas, captured using a Leica AF6000 microscope (Leica, UK) and analysed using the 
LF software (Leica, UK), can be seen in figure 3.3.  Higher cellularity was observed above 
and below the wound in the untreated LASIK-like wound (figure 3.3A,B), compared to the 
fibrinogen treated LASIK-like wound (figure 3.3C,D). The stroma-flap interface of the 
wound can be clearly seen. In figure 3.3D the wound appeared to have been stained more 
heavily with blue, unlike image B where the wound has not been stained a significantly 
different colour to the rest of the sample.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Haematoxlin and eosin stained organ cultured porcine corneal 
wound. A untreated LASIK-like wounded cornea after 4 weeks in organ culture. 
Region of interest (ROI) outlined in red is magnified in B to show the wound 
interface (W) between the flap (F) and the stromal wound bed (ST) Epithelium 
(EP). C fibrinogen treated LASIK-like wounded cornea after 4 weeks in organ 
culture, with D magnified ROI. Scale bars represent 100µm for A and C, and 
25µm for B and D. 
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Cell counts were performed in 100µm2 squares at 3 adjacent sites above and below the 
wound in figure A and C and recorded in Table 3.3.  
 
  
Position 
of 
Counts 
Cell Count Total Average 
Total 
Average 
Untreated 
LASIK-like 
Wounded 
Cornea 
Above 
the 
Wound 
6 6 7 19 6.3 
5.7 
Below 
the 
Wound 
5 3 7 15 5 
Fibrinogen 
treated LASIK-
like Wounded 
Cornea 
Above 
the 
Wound 
5 4 4 13 4.3 
3.8 
Below 
the 
Wound 
4 4 2 10 3.3 
 
 
 
 
Figure 3.4 demonstrates a lower overall cellularity (p<0.05) in the untreated LASIK-like 
wounded cornea after a culture period of 4 weeks when compared to the fibrinogen treated 
LASIK-like wounded cornea, cultured for the same period. 
 
 
 
 
 
 
 
 
 
Table 3.3 H&E Cell counts for Fibrinogen treated and untreated LASIK-like wounded 
corneas.  
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3.4.2. Corneal Ultrastructure 
Specific areas of the LASIK-like wounds were unable to be identified in the electron 
micrographs, however, other features were determined. The images obtained were not 
directly comparable due to the differing magnifications, however some general 
observations were possible. Figure 3.5A, the 4 week organ cultured untreated wounded 
cornea, demonstrated collagen disarray and areas without collagen fibrils in the matrix. In 
figure 3.5C, although swollen by the culture incubation, this part of the untreated cornea 
has aligned, undamaged collagen fibrils. As well as a degree of warping, alignment was 
also visible in figure 3.5E. The fibrinogen treated corneas also demonstrated aligned, albeit, 
swollen collagen fibrils (figure 3.5F). However, disarrayed and damaged collagen can be 
seen in the micrographs shown in figures 3.5B and D. In these micrographs, there were 
patches of intense amorphous background staining suggesting the presence of non-
collagenous material, possibly fibrinogen. 
 
 
 
Figure 3.4 Comparison of Average Cell Counts for Fibrinogen 
Treated and Untreated LASIK-like wounded porcine corneas after 
4 weeks in organ culture. Fibrinogen treated corneas had 
significantly lower cell count than untreated (p<0.05 t-test) 
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Figure 3.5. Electron micrographs of 4wk organ cultured porcine corneas. A-Untreated wounded 
cornea- showing spaces in matrix (red arrow) and collagen disarray (blue arrow). B-Fibrinogen 
treated cornea- showing collagen disarray and presence of non-collagenous substance (red arrow). 
C-Untreated cornea- demonstrating swollen extracellular matrix but with aligned collagen (red 
arrow). D-Fibrinogen treated cornea- shows damaged cornea with collagen in disarray (red arrow). 
E-Untreated cornea- demonstrates warping of collagen in stroma. F-Fibrinogen treated cornea- 
area of organised collagen structure.  
 
Untreated Fibrinogen treated 
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3.5 Corneal Stromal Cellularity 
3.5.1. Keratocyte Activation: α-sma immunofluorescence 
The activation and transformation of keratocytes into myofibroblasts can be detected by 
the presence of alpha smooth muscle actin (α-sma). The number of myofibroblast was 
ascertained using ex/em λ =494nm/520nm, which has a maximum emission of 520nm 
(bright green). Therefore, a myofibroblast had the combination of the Hoescht nuclei 
labelling in blue and α-sma in green, resulting in a blue-green cell. Figure 3.5 shows α-sma 
immunolabelling in wax sections for the treated and untreated 4 week organ cultured 
LASIK-like wounded corneas.  
 
A small number of myofibroblasts were observed above the wound in the untreated cornea 
after 4 weeks in organ culture (figure 3.6A). The number of myofibroblasts in the untreated 
LASIK-like wounded cornea (figure 3.6A) was higher than that in the Fibrinogen treated 
LASIK-like wounded cornea (figure 3.6B) as recorded in Table 3.4.  
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The percentage activation of keratocytes denoted by the α-sma positive cells was 
significantly higher (p>0.01) in the untreated LASIK-like wounded cornea than the 
fibrinogen treated LASIK-like wounded cornea (table 3.4) that had no activation of α-sma, 
with only the blue Hoescht labelled nuclei being visible (figure 3.6B). Again, 
the flap-stroma interface of the wound was seen (indicated by the red arrow), but not as 
clearly as in figure 3.5A of the untreated LASIK-like wounded cornea. There was a large 
amount of background fluorescence in this sample, but the flap-stroma interface of the 
LASIK-like wound was clearly demarcated (indicated by the red arrow). 
 
A 
 
B 
 
B 
Figure 3.6 Immunolocalisation of α-sma in wax sections. A-LASIK-like 
wounded cornea after 4 weeks in organ culture. B- Fibrinogen treated LASIK-
like wounded cornea after 4 weeks in organ culture. Blue arrows indicate α-
sma immunopositive cells. Red arrows indicate the wound. White arrows 
indicate hoescht labelled cell nuclei. Scale bars represent 100µm 
 
Figure 3.5 Immunolocalisation of α-sma in wax sections. A) LASIK-like 
wounded cornea after 4 weeks in organ culture. B) Fibrinogen treated LASIK-
like wounded cornea after 4 weeks in organ culture. Blue arrows indicate α-
sma immunopositive cells. Red arrows indicate the wound. White arrows 
indicate hoescht labelled cell nuclei. Scale bars represent 100µm 
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Area of 
Counts 
Total Cell 
Count 
α-sma 
Positive 
Cells 
Percentage 
Activation/% 
Mean 
Percentage 
/% 
Untreated 
LASIK-like 
Wounded 
Cornea 
Above 
the 
Wound 
6 6 5 1 2 1 17 33 20 
21 
Below 
the 
Wound 
4 5 3 1 1 0 25 20 0 
Fibrinogen 
treated 
LASIK-like 
Wounded 
Cornea 
Above 
the 
Wound 
3 3 2 0 0 0 0 0 0 
0 
Below 
the 
Wound 
3 4 2 0 0 0 0 0 0 
 
 
 
3.5.2. Immunofluorescence Protocol Refinement 
For optimisation of α-sma immunolabelling for future investigations, the quality of the 
immunolabelling when using wax sections was compared to that of samples prepared using 
cryosections (see section 2.7) to determine the most appropriate tissue preparation method 
using LASIK-like wounded porcine corneas organ cultured for 4 weeks (figure 3.7). 
 
It was determined that cryosectioned corneal tissue produced a better immunolabelling of 
cells (figure 3.7 B,D,F), with less background signal, with retention of the corneal 
epithelium, when compared to images produced from wax sections (figure 3.7A, C, E) 
immunolabelled using the same protocol. 
 
 
Table 3.4 Myofibroblast (α-sma-positive cell) counts for Fibrinogen treated and 
untreated LASIK-like wounded corneas.  
 
 
Table 3.2 Myofibroblast (asma-positive cell) counts for Fibrinogen treated and 
untreated LASIK-like wounded corneas.  
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The necessity of using a block during the immunolabelling process (see section 2.8) was 
determined when comparing the use of 5% goat serum (Sigma, UK) to block the signal on 
cryosectioned LASIK-like wounded 2 week organ cultured porcine corneas with no 
blocking (figure 3.8).  It was determined that no block was required in future 
immunolabelling as the signal from 5% blocking was too weak (figure 3.8B and D) and no 
block resulted in good signal and easy detection of immunopositive α-sma cells with a low 
level of background signal in corneal cryosections (figure 3.8A & C). 
Figure 3.7 Comparison of Wax sections (A, C & E) and Cryo-sections 
(B, D & F) in immunofluorescence. Images show immunolabelled with 
1 in 100 primary antibody concentration and goat anti-mouse IgG 
(H+L) Alexa Fluor 488 secondary antibody, cryosectioned porcine 
cornea after 2 weeks in organ culture. Blue arrows indicate α-sma 
immunopositive cells. Red arrows indicate the wound. White arrows 
indicate hoechst labelled cell nuclei. Scale bars represent 100µm 
Wax Section 
 
 
Cryosection 
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The type of secondary antibody was determined on cryosectioned 2week organ cultured 
LASIK-like wounded porcine corneas, using a 1 in 100 concentration of primary antibody 
with no block. The immunolabelled images were examined for signal strength and presence 
of background (figure 3.9). 3 different secondary antibodies were considered; “Goat” goat 
anti-mouse IgG Alexa Fluor 488 (figure 3.9C & F) and 2 separate batches of Donkey anti-
mouse IgG Alexa Fluor 488, “Donkey 1” (figure 3.9A & D) and “Donkey 2” (figure 3.9B 
& E).  
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Figure 3.8. Determination of necessity of blocking with goat serum 
during immunolabelling. Images A, B, C & D show 
immunolabelled with 1 in 100 primary antibody concentration and 
goat anti-mouse IgG (H+L) Alexa Fluor 488 secondary antibody, 
cryosectioned porcine cornea after 2 weeks in organ culture. White 
arrows indicate α-sma immunopositive cells, Red arrows indicate 
Limbal Blood Vessels and Blue arrows indicate hoescht labelled 
cell nuclei. Scale bars represent 100µm  
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The donkey anti-mouse IgG Alexa Fluor 488 secondary antibody produced a good signal 
allowing for easy identification of α-sma immunopositive cells with low background signal 
(figure 3.9B and E) and would therefore be used going forward.    
Finally, the concentration required of the primary antibody, mouse monoclonal anti-α-
smooth muscle actin (sigma UK), during immunolabelling was refined using cryosectioned 
2 week organ cultured LASIK-like wounded porcine corneas with no block and the chosen 
secondary antibody. The images were compared for signal strength and background 
fluorescence (figure 3.10). 
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Figure 3.9 Determination of Secondary antibody type. Images show 
immunolabelling with 1 in 100 primary antibody concentration and 
cryosectioned porcine cornea after 2 weeks in organ culture. White arrows 
indicate α-sma immunopositive cells. Red arrows indicate the wound. Blue 
arrows indicate Hoescht labelled cell nuclei. Scale bars represent 100µm.  
 
Figure 3.8 Determination of Secondary antibody type. Images show 
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The 1 in 100 concentration of the primary antibody was determined to produce the clearest 
cell signal to identify the α-sma immunopositive cells with the lowest background signal 
(figure 3.10B & F).  
Following these protocol refinements snap frozen porcine corneal cryosections would be 
immunolabelled with 1 in 100 dilution of the primary antibody mouse monoclonal anti-α-
smooth muscle actin, and donkey anti-mouse IgG (H+L) Alexa fluor 488 with hoescht, and 
no blocking step. 
 
The following images in figure 3.11 show the first panel of this refined protocol imaging 
the 3 separate regions of interest (ROI’s) the flap edge, flap centre and flap hinge 
Figure 3.10 Determination of Primary Antibody Concentration. Images show alpha sma 
immunofluorescence following incubation of organ cultured corneal cryosections in primary 
antibody dilutions at 1in50 (A,E), 1in100 (B,F), 1in 400 (C,G) and 1in1000 (D,H) . Blue arrows 
indicate α-sma immunopositive cells. Red arrows indicate the wound. White arrows indicate 
Hoechst labelled cell nuclei. Scale bars represent 100µm 
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(demonstrated in chapter 2 section 2.12) at the uncultured 0 time point and following 1, 2, 
3 and 4 week time points. The appearance of two layers pf epithelium seen at flap edge at 
0 week time point (figure 3.11) is due to the disruption of the morphology of the flap when 
placed into the moulds with no wound healing. The flap edge can misalign causing the 
observed appearance. 
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Figure 3.11: Myofibroblast expression during wound 
healing in organ culture.-sma (green).   Hoechst 
(blue) labelled nuclei. Red arrows indicate wound site. 
Blue arrows indicate activated cells. Positive control 
(+ve) = limbal vessels. Negative control (-ve) = anti-
GFP. Scale bar represents 100μm. 
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3.6  Corneal Transparency 
Spectrophotometry was used to assess the transparency of the wounded corneas at 0 time 
point after wounding and after 4 weeks in organ culture for both the LASIK-like wounded 
and the trephine wounded corneas. Figure 3.12 shows the spectrophotometry results for all 
wounded organ-cultured corneas. 
 
The unwounded controls showed a significant (p<0.01) reduction in transparency after 4 
weeks in culture (figure 3.12A), dropping by about 45% at 550nm. The creation of the 
LASIK-like flap also causes a significant (p<0.01) reduction in transparency (figure 3.12C) 
when compared to the unwounded cornea at 0 time point. This reduction in transparency 
was maintained during the culture incubation such that after 4 weeks there was no 
significant change (figure 3.12B) and the transmission was similar to that of the unwounded 
(p>0.01) cornea at this time point (figure 3.12D). 
 
Figures 3.12E and 3.12F show that fibrinogen treatment has very little effect on the LASIK-
like corneal transmission either after wounding (figure 3.12E) or after 4 weeks in culture 
(figure 3.12F) with no significant difference found between the transmission curves 
(p>0.05).  
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Figure 3.12 Normalised data showing the percentage transmission of light through a 
wounded, treated and untreated corneas plotted as a function of the wavelength of light. A: 
Unwounded corneas at 0 and 4 weeks in culture. B: LASIK-like wounded corneas 0 and 4 
weeks in culture. C: Comparison of LASIK-like wounded and unwounded corneas at 0 
weeks. D: Comparison between LASIK-like wounded and unwounded corneas at 4 weeks in 
culture.  E: Effect of fibrinogen treatment at 0 weeks. F: Effect of fibrinogen treatment at 4 
weeks. 
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Some corneas were examined at 0 and 4 weeks using a visual transparency assessment as 
described in section 2.11.2 (figure 3.13) and the assigned numerical value was used to 
facilitate graphical representation (figure 3.14A)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The LASIK-like wounded corneas appear less transparent than the unwounded corneas at 
0 time point (figure 3.13A-F) before being placed in organ culture, although there is no 
significant difference (p<0.01), but appear to be similarly cloudy after 4 weeks in organ 
culture (figure 3.13G-L). This is demonstrated graphically in figure 3.14A.  
 
 
 
Figure 3.13 Visual Grading Images. Images of LASIK-like 
wounded (n=6) (D-F,J-L) and unwounded (n=6) (A-C,G-I) porcine 
corneas at 0 time point (A-F) and after 4 weeks in organ culture (G-
L), used to determine the transparency of corneas (as described in 
chapter 2 section 2.9). 
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The decision was made to continue with the visual grading as the process of 
spectrophotometry destroyed the cornea, and so no further analysis of a particular sample 
would be able to take place. Using the visual grading technique would enable the same 
cornea to be subjected to snap freezing, cryosectioning and analysis of α-sma 
immunolabelling. This would enable a correlation between transparency and myofibroblast 
expression to be determined in the same cornea.  
 
 
 
3.7 Mechanical Properties 
After 4 weeks in culture the wounded control and treated corneas were placed into an 
extensometer and tested, as outlined in section 2.10. The results produced by the Nexygen 
4.1 software are shown in figure 3.15A-F 
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Figure 3.14 Visual Grading Vs. Spectrophotometry. Averaged data comparing 
the results of visually graded transparency (A) and spectrophotometry 
determined transparency at 550nm (B) for both wounded and unwounded 
porcine corneas at 0 time point and organ cultured for 4 weeks.  
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The figures demonstrated the time taken in seconds for the flap edge of the wound in the 
corneas to become detached from the surrounding cornea against the force required for 
dehiscence to occur. Notably, each graph had a different line profile and an observed time 
of detachment was necessary to interpret the graphs. The following table (table 3.5) 
demonstrates both the observed and recorded data. 
Figure 3.15 Extensometry: Force and time required to detach flap from wound bed in 
LASIK-like wounded untreated (A-C) and Fibrinogen treated (D-F) porcine corneas. 
Red arrows indicate the time of observed break. 
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Specimen 
No 
Treatment 
Force (N) 
at Break 
Observed 
Time of Break 
Observed Factors 
Effecting Outcome 
A Control 0.050N 56s None 
B Control 0.030N 28s None 
C Control 0.030N 15s 
Flap possibly pre-
detached by high IOP 
D Fibrinogen 0.300N 35s 
Graph shows pull to 
complete detachment 
E Fibrinogen 0.030N 87s 
Flap possibly pre-
detached by high IOP 
F Fibrinogen 0.145N 106s None 
 
 
The control corneas (LASIK-like wounded, without treatment) required, on average, a 
lower force and shorter time (figure 3.16) to detach the flap from the wound bed than the 
fibrinogen treated corneas, although the differences were not significant with the sample 
numbers used in this study.  
 
 
 
 
 
 
 
 
 
 
 
Table 3.5 Force required to detach corneal flaps in treated and untreated corneas: 
observed break time and any factors observed effecting the outcome 
 
Table 3.3 Force required to detach corneal flaps in treated and untreated corneas: 
observed break time and any factors observed effecting the outcome 
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Figure 3.16 A Average Time Required to break for Control (untreated LASIK-
like wounded corneas) vs. Fibrinogen (treated LASIK-like wounded corneas)     
B Average force required to break for control (untreated LASIK-like wounded 
corneas) vs. fibrinogen treated LASIK-like wounded corneas.  
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3.8 Discussion 
The aim of the preliminary experiments described in this Chapter was to assess the optical, 
histological and biomechanical effects of LASIK-like flap creation in the porcine cornea, 
and to establish effective protocols using fibrinogen as a model treatment for stabilising the 
flaps.  
 
The electron micrographs produced from the TEM processing of the samples showed areas 
of organised and disorganised stroma in all samples after wounding and following a period 
of organ culture. This is as would be expected. The regions of disarray and lamella warping 
are almost certainly due to damage to the cornea from the wounding itself, as collagen 
synthesis during wound healing is minimal at the flap/bed interface. Some disruption will 
also be caused by tissue swelling in the culture medium.  Interestingly, the presence of 
additional background staining in the fibrinogen-treated samples probably reflects the 
penetration of fibrinogen into the ECM. Although the possibility of the fibrinogen solution 
filling the interface would appear to solve the dehiscence problem by acting as a “biologic 
glue” increasing the adhesion strength of the flap, this presents its own potential problems. 
Fibrinogen is an extra substance of a different refractive index, 1.347 compared to the 
corneas 1.376) that has been introduced into the corneal structure. In vivo this would most 
certainly interfere with the visual acuity of the cornea by changing the overall refractive 
index (Meek & Leonard, 1997) and therefore altering the refraction of the cornea, resulting 
in a different focus for the eye. The presence of fibrinogen within the ECM would also be 
expected to cause an interruption in the collagen fibril organisation that is partially 
responsible for maintaining the transparency of the cornea (Meek et al., 2003; Meek, 2002). 
Therefore, a topical treatment that would not just simply glue the flap down, but enhance 
the wound healing of the stroma, as well as maintaining the transparency needs to be found. 
 
As the wound was by its nature easily detached, in order to preserve the morphology of the 
wound during processing, the size of each sample needed to be unusually large for TEM. 
This larger size resulted in poorer quality embedding, and the resultant inability to locate 
any wound landmarks. The morphology of the wound and the identification of the activated 
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cells during wound healing can be investigated by utilising H&E staining and 
immunolabelling instead.   
 
The images of the H&E staining of the fibrinogen treated and untreated LASIK-like 
wounded corneas showed an increased cellularity in the untreated corneas and the presence 
of the fibrinogen filling the wound in the treated corneas.  The wax sections of the samples 
provided good morphology of the corneal wound for H&E staining and can therefore be 
used to evaluate the wound healing process throughout the organ culture period.  
 
Keratocyte activation occurs in the wound healing process of the cornea and can be 
identified using immuno-labelling to detect the presence of α-sma (an indicator of 
keratocyte activation). A higher cell number and presence of α-sma activated cells were 
observed in the immunolabelled samples of the untreated LASIK-like wounded organ 
cultured corneas as opposed to the fibrinogen treated samples (table 3.2). This may indicate 
a difference between the natural wound healing process of the untreated cornea and the 
possibly altered healing process of the fibrinogen treated cornea.  
 
Use of this method to perform cell counts at all time points to follow cell number and 
percentage activation, as well as utilising Caspase-3 active immunolabelling to assess cell 
apoptosis and confirm the fate of the cells, would allow a more in depth analysis of corneal 
wound healing over the culture period. Both images obtained from the samples subjected 
to immunofluorescence showed a large amount of background staining which is not optimal 
for analysis and signal identification. The use of wax sections to evaluate keratocyte 
transformation into myofibroblasts using immunolabelling did not result in a good quality 
of image. A refinement of the protocol found that cryosectioned samples provided more 
distinct labelling with improved immunoreactivity resulting in stronger signals of the α-
sma immunopositive cells and a reduced background signal.  
  
The transparency of unwounded corneas reduced significantly after 4 weeks in organ 
culture (figure 3.12A). Whilst the Foreman air-interface method (Foreman et al., 1996) of 
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organ culture was an improvement over earlier methods where the tissue was immersed, it 
is impossible to entirely eliminate tissue swelling, which is responsible for the loss of 
transparency observed. The transparency of the unwounded corneas at 0 time point was 
higher than the microkeratome wounded corneas at 0 time point (figure 3.12C). This would 
most likely be due to the creation of the flap interface (with accompanying wrinkling) 
within the body of the stroma. When the wounded cornea was incubated for 4 weeks there 
was no further loss of transparency (figure 3.12B). This could be because the flap interface 
wrinkling had smoothed out, but the cornea had swollen during the 4 week incubation, 
resulting in a lower drop in transparency than would have been expected. Due to this 
swelling, the transparency had dropped to the same level as the unwounded cornea (figure 
3.12D). There was no difference in the transparency between the fibrinogen treated and un-
treated LASIK-like wounded corneas for either time point (figures 3.12E & F).  
 
Spectrophotometry of the corneal samples provides numerical data relating to their 
transparency as a function of wavelength before and after organ culture, however it destroys 
the sample. Comparative analysis against visual transparency measurements using graph 
paper, as used in previous studies by Dooley et al. (2012) and Kamma-Lorger et al. (2010), 
provided a good comparative assessment method by which data could be collected for 
samples which would then be processed for histological analysis to maintain a narrative.   
 
The data profiles of the graphs from the biomechanical testing in this study using the 
extensometer were not significant. Additionally, data profiles were inconsistent and 
showed that the time of detachment, and therefore the force required to do so, could not be 
reliably ascertained from the graph alone and required visual confirmation. The 
inconsistency of the profiles also suggested that other factors relating to the biomechanical 
testing of the corneas, such as the intraocular pressure (IOP) of the corneal sample, would 
need much tighter regulation. The testing also completely destroyed the corneal sample and 
rendered any further processing impossible. For these reasons, it was decided that a custom-
built shear rig or rheometer would be a more appropriate method, so this line of 
investigation was discontinued for this current study.  
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4.1.  Introduction 
Oral Mucosa Lamina Propria Progenitor cells (OMLP-PCs) are multipotent neural crest- 
derived progenitor cells found in the oral mucosa lamina propria that have been shown to 
demonstrate potent immunosuppressive qualities (Davies, et al., 2012). Their presence in 
the buccal mucosa is thought to promote preferential wound healing and accounts for the 
low rate of recurrent infections in the oral cavity despite the exposure to repeated 
mechanical trauma and the presence of diverse microflora and potentially harmful bacteria 
(Board-Davies et al., 2015). 
 
In corneal wound healing, due to the optical necessity of maintaining the transparent nature 
of the tissue, the aim is to improve wound healing by increasing the biomechanical strength 
of the wound area in the healed cornea and reducing the formation of scar tissue and corneal 
haze. Research in recent years has explored the possibility of using topical applications of 
cells from varying sources as a potential stem cell-based therapy to realise this aim. 
Proposed cell-based therapies have included stem cells isolated from adult human corneal 
stroma with the potential for treatment of corneal opacity (Dua et al., 2009). This direction 
of research was continued by Morgan et al. (2014), using human corneal stromal stem cells 
to heal LASIK-like wounds i.e. penetrating wounds in ovine corneas, whilst Dooley et al 
(2012) investigated the use of oral mucosal fibroblasts as a potential therapeutic agent for 
corneal wound healing in similarly wounded ovine corneas.  
 
Both of these studies used an organ culture model to test efficacy of these cell therapies on 
wound biomechanical strength, stromal cell number, keratocyte to myofibroblast 
transformation and percentage transparency over a 3-week period. Both experiments had 
positive outcomes (i.e. an increased transparency in treated corneas, an increase in 
biomechanical strength and a reduced myofibroblast expression). However, the source of 
cells for these cell-based therapies would require the ex vivo culturing of cells harvested 
from the patient (an autologous donation), over a period of weeks before the treatment 
could be applied to the wound without risk of rejection or infection. This may not be 
appropriate in all situations such as a traumatic injury where the therapy may be required 
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in a short time frame. Therefore, a non-autologous source of cells, in plentiful supply, that 
could aid the wound healing process of the cornea needs to be identified.  
Such a potential source of non-autologous cells could be the previously mentioned oral 
mucosa lamina propria progenitor cells due to their possible preferential wound healing 
properties and potent immunosuppressive qualities (Davies et. al., 2012; Board Davies et 
al., 2015). A supply of OMLP-PCs as a cell-based therapy could potentially be ready to 
apply in an emergent situation.  
 
Both ovine and bovine eyes have been used by previous researchers (Kamma-Lorger et al., 
2010, Dooley et. al., 2012; Morgan et al., 2014) in their investigations into corneal wound 
healing using organ culture models. Bovine corneas used by Kamma-Lorger et al. (2010) 
in a manually induced flap wound were determined too large and inappropriate for creating 
semi-automatic LASIK-like flaps using a microkeratome. The ovine corneas used by 
Morgan et al. (2014) and Dooley et al. (2012) were an excellent substitute for human eyes, 
however during the early stages of protocol optimisation (Chapter 2), a high proportion of 
ovine eyes, in batches procured from local abattoirs, were found to have significant corneal 
scars and traumatic injuries (approximately 30%) which rendered them unviable for this 
research project. Pigs have been shown to be one of the best animals to be used in both in 
vivo and ex vivo organ culture models due to the similarity to the anatomy and physiology 
of humans (Jian Fei Wang et al., 2000) and have already been used in investigations into 
the promotion of scarless wound healing using oral mucosal fibroblasts in skin (Mak et al., 
2009). The porcine cornea itself, although lacking a Bowmans layer, is similar in structure 
to the human cornea with both stromas containing a large amount of Type I collagen 
(Delmonte & Kim, 2011; Sanchez et al., 2011). The porcine central corneal thickness has 
been measured as approximately 666 µm in vivo and 1013 µm ex vivo (Faber et al., 2008), 
whilst a human cornea is approximately 500-550 µm in vivo (Delmonte & Kim, 2011). 
During the protocol optimisation of organ culture, it was found that the batches of porcine 
eyes procured had significantly lower percentage of scarred and injured corneas when 
compared to ovine eyes (Chapter 2). Therefore, the choice was made to use porcine eyes 
in this research. 
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Corneal injury usually results in altered collagenous structure within the extra-cellular 
matrix (ECM) (Jester et al., 1999; Piatigorsky, 2000) which can have a detrimental effect 
on the transparency of the cornea and subsequently the vision of the patient (Girgis et. al., 
2007). During corneal healing of a penetrating wound, the damage to the epithelium 
initiates a wound healing cascade that results in keratocyte apoptosis and the activation of 
corneal keratocytes (Wilson et al., 2001). These activated cells have significantly reduced 
levels of crystallin proteins, ALDH1A1 and ALDH3A1 (Jester et. al., 2012) and a lowered 
refractive index compared to that of the quiescent keratocyte that no longer matches that of 
the surrounding tissue and therefore scatters light, reducing transparency (Gardner et al., 
2015). They also produce ECM materials that have been shown to reduce corneal 
transparency and increase light scattering or ‘corneal haze’ (Jester et al., 1999; Pei et al., 
2006, Jester et al., 2012).  The success of the application of the OMLP-PC to a corneal 
wound could be measured by a reduction in activation of keratocytes, indicated by reduced 
expression of α-sma (Jester et al., 1999), and in turn, the subsequent maintenance or even 
improvement of corneal transparency.  
 
4.2.  Aim 
The aim of this chapter was to optimise conditions, including finding the optimal cell 
concentration, for application of OMLP-PCs to a corneal wound bed (using a LASIK-like 
penetrating injury) in porcine corneas in an organ culture model for future experiments.  
 
Towards this aim, the efficacy of three different concentrations of OMLP-PCs on 
cellularity, transparency and myofibroblast activation in the wounded porcine corneas was 
assessed at five different time points during LASIK-like corneal wound healing in the organ 
culture period.  
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4.3. Experimental Design 
The concentration of the cell-based therapies applied to the stromal wound bed has varied 
in previous research and the reasoning for the selection of these concentrations has seemed 
arbitrary and unsupported by any evidence as to how they were chosen. Therefore, a 
determination of the optimal concentration of OMLP-PC solution to be applied to the 
wound bed was deemed necessary. The experimental design of this investigation also 
enabled the comparison of efficacy of OMLP-PCs to that of other previous cell-based 
therapies on corneal wound healing.  
 
Fresh porcine eyes were procured from a local abattoir, disinfected, dissected and wounded 
as outlined in section 2.1.1. Three different cell lines of frozen human OMLP-PCs were 
obtained by Cardiff School of Dentistry and passaged as outlined in section 2.5.2. The cells 
were made up into concentrations of 1.5x104, 1.5x105 or 1.5x106 OMLP-PCs ml-1 and a 
control solution of culture medium without cells, was also prepared. These three cell 
concentrations were selected based on previous successful cell-based applications to 
wounded corneas in a similar organ culture model. For instance, Dooley et al. (2012) 
applied 1.5x105 cells ml-1 of oral mucosa fibroblasts and Morgan et al. (2014) applied 
6.5x104 cells/ml of corneal stromal stem cells in ovine organ culture models. 
 
A 10 µl volume containing 1.5x104, 1.5x105 or 1.5x106 OMLP-PCs ml-1 was applied to the 
wound bed of corneas in triplicate, and cultured in organ culture for 0, 1, 2, 3 and 4 weeks 
(see Table 4.1). At each time point, triplicate wounded corneas, treated with a 10 µl volume 
of media without cells were cultured as control corneas. At each appropriate time point, 
treated and control corneas were removed from culture and assessed for transparency, 
cellularity and α-sma expression. Transparency was assessed in triplicate corneas as 
outlined in section 2.11.2. These same corneas were then snap frozen and cryosectioned as 
described in sections 2.6.1, and 2.7.2. Myofibroblast transformation was assessed in these 
cryosections as a measure of percentage α-sma positivity. In brief, sections were incubated 
in primary antibody, mouse monoclonal anti-α-smooth muscle actin (A2547 Sigma, UK, 1 
in 100 dilution) for 2 hours, rinsed and then incubated in donkey anti-mouse IgG (H+L) 
CHAPTER FOUR  Optimisation 
 
 
100 
 
Alexa Fluor®488 (Invitrogen, UK, at a 1 in 1000 dilution), with 2µl of 1mg ml-1 Hoechst 
33342 solution (see section 2.8.2) added to each millilitre of secondary antibody solution. 
 
Images of each section were acquired using a Leica DM6000 fluorescent microscope 
(Leica, Germany), α-sma positive cells and Hoechst labelled cell nuclei were counted above 
and below the wound edges at 3 sites (flap edge, centre and hinge region) across the wound. 
Percentage myofibroblast transformation was calculated as a measure of α-sma positivity 
i.e. the number of α-sma cells divided by the number of Hoechst labelled cells in a given 
area, multiplied by 100. 
The number of corneas used is outlined in Table 4.1. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.1 Table demonstrating porcine cornea number.  
 
1.5x104 
1.5x105 
1.5x106 
ml-1 
ml-1 
ml-1 
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Statistical analyses 
Statistical analysis, using 2-way ANOVA and Tukey HSD, was carried out to compare the 
results of transparency, cellularity and percentage α-sma positivity of differing 
concentrations of OMLP-PCs at each time point and wound site for treated and control 
corneas. 
Although the 2-way ANOVA was used as a statistical analysis for transparency, the results 
for transparency were in the form of ordinal data and so a Kruskhal Wallis was run, and the 
resulting statistics were the same.  
Results 
4.4. Effect of OMLP-PC therapy on keratocyte activation 
Percentage activation of keratocytes, identified by α-sma-immunopositive cells (labelled 
with green fluorescence, figure 4.1), was ascertained at 3 adjacent sites in 3 different 
regions of interest (ROIs; flap edge, flap centre, flap hinge) in the epithelial-stromal flap 
(above the wound site) and the stromal wound bed (below the wound site). This was 
repeated for 1.5x104, 1.5x105 and 1.5x106 OMLP-PC ml-1 applications and the wounded 
untreated control corneas at each organ culture time point.  
 
Percentage α-sma immunopositivity was significantly increased (p<0.001) in all ROIs in 
both treated and control corneas (figure 4.2) at weeks 1, 2 and 3, compared to week 0 
corneas. This was followed by a significant decrease at 4 weeks in the percentage of α-sma 
immunopositivity (p<0.001) in all treated corneas for each cell concentration. An apparent 
decrease in untreated control corneas was not statistically significant (p>0.05). Notably, the 
percentage α-sma immunopositivity was significantly lower at 1,2,3 and 4 week time points 
in cell treated corneas (figure 4.2), compared to control corneas at the same time points 
(p<0.001). There was no significant difference in α-sma immunopositivity in corneas 
treated with 1.5x104, 1.5x105 or 1.5x106 OMLP-PCs ml-1 at any time points during the 
organ culture period.  
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Figure 4.1 α-sma 
immunolabelling in central 
flap during wound healing in 
organ culture of corneas 
treated with 1.5x105 ml-1 
concentration of OMLP-PCs 
(Left) and control wounded 
untreated corneas (Right). 
Images shown are 
immunolabelled with donkey 
anti-mouse IgG (H+L) Alexa 
Fluor 488 secondary 
antibody, cryosectioned 
porcine corneas after 0,1,2,3 
& 4 weeks in organ culture. 
Blue arrows indicate α-sma 
immunopositive cells. Red 
arrows indicate the wound, 
White arrows indicate 
Hoechst labelled cell nuclei. 
Scale Bars = 100µm. A 
negative control; primary 
antibody replaced with anti-
Green Fluorescent Protein 
(GFP) antibody. B Positive 
control; corneal limbal blood 
vessels Immunolabelled with 
primary antibody mouse 
monoclonal anti-α-smooth 
muscle actin.  
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The percentage activation of keratocytes in the epithelial flap wound (above the wound) 
across all ROIs (figure 4.3) followed the same trend as was seen in figure 4.2 across the 
entire corneal sample. Increased keratocyte activation at 1, 2, and 3 weeks for cell treated 
and control corneas was observed, when compared to 0 time point (p<0.05). At 4 weeks 
there was a significant reduction in keratocyte activation for cell-treated samples (p<0.05), 
and once more a noticeable decrease for untreated control corneas not statistically 
significant (p>0.05) (figure 4.3). In the epithelial-stromal flap wound the percentage of 
keratocyte activation for corneas treated with OMLP-PCs was significantly higher that 
untreated control corneas at weeks 1, 2, 3 and 4 (figure 4.3). 
 
Keratocyte activation of the stromal wound bed across all ROIs, whilst showing a visible 
increase after 0 time point for weeks 1, 2 and 3, had no statistically significant difference 
between all OMLP-PC treated corneas at all time points (figure 4.3). There was a 
significantly lower percentage of keratocytes in the OMLP-PC treated corneas when 
compared to untreated control corneas (p<0.001) during the organ culture period for weeks 
1, 2, 3 and 4 (figure 4.3).  
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Figure 4.2 Total percentage α-sma immunopositive cells at wound site (above 
and below wound) in all three ROIs during 4 weeks organ culture. OMLP-PC 
treated corneas, for all cell concentrations, had a significantly lower percentage 
of α-sma immunopositive cells (**p<001) compared to untreated control 
corneas at 1, 2, 3 and 4 week time points. 
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The 3 different concentrations of the cell solution all showed that the keratocyte activation 
above the wound was statistically higher when compared to below the wound at weeks 1, 
2 and 3 (p<0.05), whereas the keratocyte activation above and below the wound in the 
control corneas showed no significant difference throughout the organ culture period 
(figure 4.3).  
 
Whilst the percentage of α-sma immunofluorescent cells was significantly different 
depending on whether it was observed above or below the wound in the cell-treated 
corneas, the regional site of the cell count i.e. flap edge, flap centre or flap hinge, revealed 
no statistically significant effect on the α-sma expression at any time points for both cell 
treated or control samples (p>0.05).  
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Figure 4.3 Percentage Activation of Keratocytes (Percentage α-sma immunopositive cells) above and 
below the wound Site A Percentage α-sma immunopositivity in epithelial flap (above) and B stromal 
(below) wound bed (averaged data across all 3 ROI sites for controls and cell treated corneas) as a 
function of culture time. All concentrations showed a significantly higher activation above the wound 
than below for weeks 1, 2, 3 and 4 (p<0.01, marked on the graph for only 1.5x105 cells ml-1). 
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4.5. Keratocyte cellularity 
Keratocyte cellularity during organ culture refers to the number of cells counted as a 
measure of Hoechst-labelled nuclei (labelled blue in figure 4.1). Figure 4.4 shows that the 
cellularity at the wound site was significantly higher in corneas treated with 1.5x105 cells 
ml-1 at 2 and 4 weeks, than in the respective controls (p<0.05). Interestingly, corneas treated 
with 1.5x104 and 1.5x106 cells ml-1 had significantly higher cellularity at 3weeks, when 
compared to the control corneas (p<0.05, figure 4.4).  
 
 
 
 
 
 
 
 
 
 
 
 
When treated with different cell concentrations, appart from the differences in cellularity 
seen in figure 4.4 between the control corneas and the corneas with cell solutions applied 
to the LASIK-like wound bed, there were no significant differences between the cellularity 
above (figure 4.5A) and below (figure 4.5B) the wound for cell treated or control and no 
significant difference between each ROI (figures 4.5 C, D & E). 
 
 
 
 
Figure 4.4 Total Cell Count in corneal wound area calculated as the total number 
of Hoechst labelled cell nuclei in all 3 ROIs above and below the wound (average 
of n=3 for each time point) over a 4 week organ culture period.  
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Figure 4.5 A Cell Count above wound. B Cell Number Below Flap below wound (A & B show 
Number of Hoechst labelled cells at all 3 ROI’s for above the LASIK-like wound for an n=3 
over a 4 week organ culture period). C Cell Count at Flap Edge. D Cell Count at Flap Centre 
E Cell Count at flap Hinge (C, D & E show number of Hoechst labelled cells above and below 
the LASIK-like wound at each ROI for an n=3 over a 4 week organ culture period 
 
 
Figure 4.5 A Cell Count above wound. B Cell Number Below Flap below wound (A & B show 
Number of Hoechst labelled cells at all 3 ROI’s for above the LASIK-like wound for an n=3 
over a 4 week organ culture period). C Cell Count at Flap Edge. D Cell Count at Flap Centre 
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4.6. Transparency Measurements 
Figure 4.6 demonstrates representative images of corneas used for transparency grading; 
acquired immediately following removal from organ culture. The corneas (n=3 for each 
cell concentration and control at each time point) were imaged using a Leica MZ10F 
dissecting microscope (Leica, UK) while overlying scaled graph paper (as described in 
section 2.11.2).  
 
Images were masked and placed in random order. Ten people, masked to organ culture time 
and treatment, were asked to determine whether the corneas appeared “clear”, moderately 
cloudy” or “cloudy”. Arbitrary numerical values, 1 to 3, were then applied to these ‘grades’ 
to allow for statistical analysis (figure 4.7).  
 
The data for the transparency is shown in Figure 4.7, the higher the value on the y axis the 
higher the transparency. The transparency for all samples decreased similarly after the 
initial time point and the remained constant with no significant difference between the 
control corneas and those treated with OMLP-PCs at all concentrations. 
 
The transparency of the corneas was found to be significantly higher (p <0.001) in all 0 
time point corneas compared to those subjected to organ culture (figure 4.7).  
 
During the organ culture period, no significant difference in corneal transparency was 
observed between corneas treated with OMLP-PCs and control corneas at weeks 0, 1, 2 
and 3. However, at week 4, the porcine corneas treated with a 1.5x105 OMLP-PCs ml-1 had 
a significantly higher visually graded transparency than, not only the control corneas, but 
also the other OMLP-PC treated corneas (p<0.001, see figure 4.7)). 
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Figure 4.6 Images of LASIK-like wounded corneas; control and treated (cell concentrations of 1.5x104 1.5x105 or 1.5x106 OMLP-PCs ml-1 
used to grade corneal transparency at 0 time point (A), 1 (B), 2 (C), 3 (D) and 4 (E) weeks in organ culture. 
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4.7. Discussion 
In this experiment, the organ culture model based on Foreman et al. (1996), and refined 
over subsequent investigations into corneal wound healing by Carrington et al. (2001), 
Kamma-Lorger et al. (2009), Mi et al. (2011), Dooley et al. (2012) and Morgan et al. (2013) 
was used to assess the wound healing of LASIK-like wounds in porcine corneas over a 4 
week culture period. Three concentrations of the OMLP-PCs from a single donor source, 
were applied to the wound bed under the LASIK-like flap, which was then relayed back, 
prior to being placed in organ culture. These were varied by a factor of ten (1.5x104, 1.5x105 
and 1.5 x106 cells ml-1, to include cell numbers used in previous cell therapy investigations) 
and cultured alongside un treated control corneas. 
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Figure 4.7 Corneal Transparency. Visually graded transparency of LASIK-like 
wounded corneas with an application of either a control solution or a cell solution 
of OMLP-PCs at 3 different concentrations at 5 time points over an organ culture 
period. Treated corneas at 1.5x105 OMLP PC ml-1 concentration were 
significantly more transparent at 4week time point than untreated controls 
(***p<0.001) 
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The main question under investigation in this chapter was the determination of the optimum 
concentration of OMLP-PC solution for application to the stromal wound bed of LASIK-
like wounds in porcine corneas. In order to determine the optimum cell concentration to be 
applied to the wound bed in future experiments, three different OMLP-PC concentrations 
were examined with regards to α-sma expression (an indication of keratocyte activation 
and transformation in myofibroblast phenotype (Jester et al., 1999), cellularity, and 
transparency, over an organ culture period of 4 weeks. 
 
However, another important question in these initial experiments was the viability of the 
protocols in general and whether the results of the application of OMLP-PCs to the LASIK-
like wound, regardless of concentration, would yield comparable results to those 
therapeutic cell solutions used in previous research (Dooley et al., 2012; Morgan et al., 
2013) and therefore allow us to proceed with this line of investigation.  
 
During normal corneal wound healing, myofibroblastic transformation of keratocytes plays 
a major role in ECM deposition, collagen fibril organisation and wound contraction (Petroll 
et al., 1993; Jester et al., 1999). These myofibroblasts can be detected by the intracellular 
appearance of α-sma (Jester et al., 1987 & 1995). Therefore, in this study percentage 
activation of keratocytes in the wounded corneas was determined following cell counts of 
Hoescht labelled cell nuclei and α-sma immunopositive cells in organ cultured porcine 
corneas over the organ culture period. This was compared to previous research by Dooley 
(2012) and Morgan (2014). Dooley applied a solution of oral mucosal fibroblasts to 
LASIK-like wounded ovine corneas which were then placed in organ culture alongside 
controls for 3 weeks. The results showed that the percentage activation for the keratocytes 
was significantly reduced by approximately 20-30% for the corneas treated with oral 
mucosa cells, when compared to the control corneas after weeks 1, 2 and 3 in organ culture 
(Dooley, 2012). Similarly, Morgan et al. (2014) found that the percentage keratocyte 
activation for wounded corneas treated with a solution of corneal stromal stem cells 
(CSSCs) was significantly reduced compared to the control corneas at 1, 2 and 3 weeks in 
organ culture, by approximately 20%. The results observed in this experiment were 
favourably comparable to the outcomes of these previous studies; the averaged percentage 
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activation of all the different cell concentrations and the average results of the control 
corneas showed an overall reduction of approximately 20-30% in activation of keratocytes 
over the same 3 weeks in organ culture as Dooley and Morgan (table 4.2), indicating a 
successful experimental design.  
 
  % Activation 
  1 week 2 week 3 week 
Dooley (2012)    
Oral Mucosal 26.63% 17.10% 21.62% 
Control 49.84% 49.11% 41.65% 
Morgan (2014)    
CSSC 19% 30% 29% 
Control 24% 48% 44% 
 Current Study    
OMLP-PC 20.8% 18.2% 20.2% 
Control  44.5% 46.1% 43.2% 
 
 
 
The percentage activation of keratocytes across the entire cornea for the differing cell 
concentrations applied (figure 4.5) was not statistically significantly different from one 
another throughout all time points during the organ culture period. Whilst the cell-treated 
corneas exhibited a significant difference between the keratocyte activation in relation to 
the LASIK-like wound (higher activation above the wound when compared to below), the 
difference between the varying concentrations was not significant. 
 
Following penetrating corneal injury and subsequent scarring, the decrease in transparency 
has been shown to be associated with disorganised collagen fibril structure compared to the 
native tissue in the unwounded cornea (Cintron et al., 1981; Rawe et al., 1994). As 
previously mentioned, these changes are largely brought about by the activation of 
keratocytes into myofibroblasts, characterised by the expression of α-sma and have 
Table 4.2 Comparison of % Keratocyte Activation to Previous 
Research.   
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significantly reduced corneal crystallin expression (Pei et al., 2006; Jester et al., 1999), 
which in turn, also has a negative impact on corneal transparency. The transparency of the 
corneas over the organ culture period was significantly reduced from the initial 
measurements at 0 week for both the control and the cell solution-treated corneas, to the 1 
week time point, and this level of transparency was then maintained throughout the 
remainder of the organ culture. This would be partly due to corneal swelling caused by time 
in organ culture which increases the thickness of corneal tissue, which, in turn has a 
negative impact on the propagation of light through the cornea (Hart and Farrell, 1969; 
Freund et al., 1991; Farrell & McCally, 2000; Meek et al., 2003; Doutch et al., 2008).  
 
Therapies reducing the appearance of myofibroblasts by suppressing the release of TGFβ 
(Shii et al., 2009) and neutralising antibodies to TGFβ (Møller-Pedersen et al., 1998) have 
been shown to reduce the appearance of corneal haze, thus improving the transparency, in 
the healed cornea. Cell based therapies used by Dooley (2012) and Morgan (2013) showed 
that the transparency for those corneas subjected to an application of a therapeutic cell 
solution was significantly increased by approximately 10% in both cases when compared 
to the control corneas. The outcomes of this experiment, whilst not improving the 
transparency of the cornea during wound healing, did not significantly reduce it. At week 
4, the end of the organ culture period, the transparency of those corneas treated with a 
1.5x105 cells per ml concentration OMLP-PC solution significantly increased when 
compared to the control corneas, and those treated with the other 2 cell concentrations. This 
indicated that a concentration of OMLP-PC at 1.5x105 cells per ml had a statistically 
significant positive effect on corneal transparency towards the end of organ culture period. 
 
The cellularity of the corneas treated with 1.5x105 OMLP-PC ml-1 was significantly higher 
at 0 week, 2 weeks and 4 weeks when compared to the other treated and control corneas. 
The increased number of Hoechst labelled cells counted at the 2 week time point in 
the1.5x105 OMLP-PC ml-1-treated LASIK-like wounded corneas could be indicative of 
increased proliferation during the cell replenishment that follows apoptosis during initial 
wound healing (Wilson, 2002). Oral mucosal fibroblasts have been shown to proliferate 
faster than dermal fibroblasts (Lee & Eun, 1999) and so could account for the significantly 
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increased cellularity of those corneas treated with a 1.5x105 OMLP-PC ml-1 solution 
compared to the controls. The other concentrations did not show a similarly significant 
difference in cellularity, indicating that perhaps the lower and higher concentrations of 
OMLP-PCs had a negative effect on the efficacy of the OMLP-PCs due to under-population 
and over-population, respectively.  
 
During the course of this study to determine the optimal concentration of OMLP-PCs for 
application to the wound bed, the results showed significant differences between the cell- 
treated and the control corneas in line with previous research by others, especially with 
respect to the keratocyte activation. When compared to each other, however, the 3 
concentrations of OMLP-PCs were not statistically different to one another throughout the 
organ culture time points when investigating keratocyte activation. However, there was a 
positive result of the increasing transparency of those corneas treated with 1.5x105 cells per 
ml of OMLP-PC solution at the end of the organ culture period when compared to other 
concentrations and the controls. Also the significantly higher cellularity of the corneas 
treated with 1.5x105 cells ml-1 of OMLP-PC solution at the 2 week time point could indicate 
an increased rate of proliferation of the OMLP-PCs at this concentration. There were 
statistically significant results in this chapter, however the low number of samples used in 
this determination may have elicited unreliable results and so the concentration 1.5x105 
cells ml-1 of OMLP-PC would be logical to use as it was similar to concentrations used in 
previous research and the middle concentration. Therefore, the decision was made to 
proceed in all subsequent experiments with the application of a cell concentration of 
1.5x105 OMLP-PCs ml-1 prepared as outlined in section 2.5.2.  
 
 
  
 
108 
 
Chapter 5 
  Application of OMLP-PCs to 
Penetrating Corneal 
Wounds: Effect on Stromal 
Healing and Transparency 
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5.1 Introduction 
The inflammatory and proliferative stages in the complex biological process of corneal 
wound healing (as described previously in section 1.5) often leads to significant changes in 
the organisation of the stromal collagen which, in turn, negatively effects the corneal 
transparency and biomechanical properties that rely on the highly ordered nature and 
precise spacing of the native tissue (Meek, 2009). Transparency in the wounded cornea can 
be negatively affected by the natural need to rapidly close the wound in order to provide 
protection to the underlying structures and avoid potential infection. The laying down of 
disorganised stromal collagen that reduces the efficacy of light transmission, increasing 
light scatter results in an opaque cornea. Also contributing to corneal haze are the 
fibroblastic changes following activation with cytokines and inflammatory growth factors 
(Jester et al., 1999; Piatigorsky, 2000) These include a reduction in crystallin protein 
concentration that alters the refractive properties of myofibroblasts and fibroblasts (Jester 
et al., 2012) causing light scatter.  
 
Whilst, following the initial wound healing response, the cornea can continue to remodel 
over many months, a return to the exact original organised nature of the native tissue never 
occurs and significant scarring can be the result (Lee et al., 1982; Cintron et al., 1990). If 
this scarring is unfortunately located on the visual axis this can be permanently detrimental 
to the patient’s vision potentially requiring surgical treatment such as keratoplasty (corneal 
transplant). Research into novel cell-based therapies to improve the biomechanical strength 
and ameliorate the formation of corneal haze and scarring is, therefore, clinically important.  
 
Recent research has looked into the application of fibronectin based glues and the use of 
corneal cross linking (Littlechild et al., 2012, Mi et al., 2011), as well as application of 
corneal stromal stem cells, activated corneal fibroblasts and various signal inhibitors and 
growth factors (Kamma-Lorger 2007; Müller et al., 2005; Morgan, 2015) with varying 
results. More recently, attention has been brought to the oral mucosa as a potential future 
source for non-autologous cell based therapies, with Dooley, 2012, successfully applying 
oral mucosal fibroblasts cells to the wound bed of LASIK-like wounded corneas.  
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There is a history of autologous oral tissue transplantation to repair ocular conditions, 
including OOKP (osteo-odonto-keratoprosthesis) (Liu et al., 2005) and tissue engineered 
oral mucosal epithelial cell sheets (Nishida et al., 2004) with good reason. The oral mucosa 
undergoes mechanical trauma on a regular basis due to mastication and so requires a rapid 
cell turnover and benefits from privileged wound repair. Whilst early studies involving de-
salivated animal models suggested that saliva was the origin of the oral mucosa’s enhanced 
wound resolution (Bodner et al., 1992; Hutson et al., 1979), more recently it has been 
determined that, rather than being due to environmental factors such as saliva and 
temperature, this is related to the intrinsic characteristics of the oral mucosa (Szpaderska et 
al., 2003).  Oral mucosa fibroblasts have been shown to exhibit both adult and foetal-like 
properties (Sloan, 1991), resulting in the preferential wound healing observed in the oral 
mucosa, with rapid re-epithelialisation, remodelling with minimal scarring and very rare 
formation of keloid or hypertrophic scarring that is comparable to foetal wound repair 
(Stephens et al 1996; Mak et al., 2009). The intra-oral mucosal fibroblasts differ from the 
superficial extra-oral epithelium due to their ability to synthesise collagen and ECM 
components without expressing excessive amounts of alpha-smooth muscle actin (α-sma), 
associated with a myofibroblast phenotype. Therefore, it is thought that these cells produce 
factors that are possible inhibitors of fibroblast cells returning to homeostasis (Wilson et 
al., 2000).  Due to these properties, cells and tissues from the oral mucosa have been widely 
utilised successfully in attempts to enhance wound healing properties of other organs (Ohki 
et al., 2006) including the cornea (Nishida et al., 2004; Nakamura et al., 2004). 
  
A population of multipotent neural crest-derived progenitor cells within the lamina propria 
of the oral mucosa (figure 5.1), oral mucosa lamina propria progenitor cells (OMLP-PCs), 
have demonstrated not only potent immunological properties but also innate broad 
spectrum antibacterial properties. OMLP-PCs, therefore, are an ideal source for non-
autologous cell-based therapies (Davies et al., 2012; Board-Davies et al., 2015).  
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It is well established that alpha smooth muscle actin (α-sma) is expressed in activated 
myofibroblasts during the contraction phase of a wound (Jester et al., 1987 & 1995). Their 
presence, as previously discussed, not only reduces the production of crystalline proteins 
in the cells, increasing light scatter, but also increases the deposition of opaque ECM and 
contractile forces, therefore diminishing transparency in the cornea. Whilst OMLP-PCs 
have been found to have the ability to differentiate into tissue lineages removed from their 
origin (Davies et al., 2012), and can differentiate into myofibroblasts, they have also been 
shown to express significantly lower levels of α-sma (Shannon et al., 2006). Interestingly, 
Tsai et al. (1995) and Lee and Eun (1999) found oral fibroblasts to have the smaller 
contractile potential compared to dermal fibroblasts during wound healing. These 
differences in phenotype between the native myofibroblast and the potentially 
differentiated OMLP-PCs as a therapy to apply to corneal wounds, could have a positive 
effect on the wound resolution resulting in improved transparency and a tissue closer to 
that of the native unwounded cornea.  
 
 
Figure 5.1 Histology section through the Oral Mucosa. The 
location of the Oral Mucosa Lamina Propria Progenitor 
cells (OMLP-PCs) within the Lamina Propria (Adapted 
from Fleisch et al., 1978). 
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5.2.    Aim 
Following determination that OMLP-PCs, at an optimal concentration, can affect corneal 
transparency and α-sma expression following application to a penetrating corneal wound 
(Chapter 4), in this chapter the optimised OMLP PC concentration from different donor 
sources will be applied to corneal wounds.  
 
The aim of this chapter was to determine whether or not the wound healing of LASIK-like 
wounded porcine corneas could be improved by the application of OMLP-PCs to the wound 
bed over a course of 4 weeks. This would be assessed by measuring the cell proliferation 
and cellularity, monitoring and quantifying the transparency of the wound healing cornea, 
determining the level of apoptosis and calculating the percentage α-sma expression.  
 
5.3.    Experimental Design 
Fresh porcine eyes were procured, dissected and wounded as outlined in sections 2.1 and 
2.2. OMLP-PCs were obtained from Cardiff School of Dentistry from 3 different human 
donors and passaged as outlined in section 2.5.1.  
 
10 µl aliquots, containing 1.5x105 OMLP-PCs/ml in culture media or control media (i.e. 
the same media without cells) were applied to the wound bed of quadruplicate corneas, and 
subjected to organ culture as previously described (see section 4.7). Quadruplicate corneas 
were removed from corneal organ culture at each time-point, namely 0 (not cultured), 1, 2, 
3 or 4 weeks. Additionally, to determine corneal changes as a function of organ culture, 4 
unwounded, untreated corneas were also cultured for each time point. On removal from 
culture, transparency was assessed immediately in quadruplicate corneas as outlined in 
section 2.11.2. These same corneas were then snap frozen and cryosectioned as described 
in sections 2.6.1, and 2.7.2 for subsequent labelling. 
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Myofibroblast transformation was assessed in these cryosections as a measure of 
percentage α-sma positivity. In brief, sections were incubated in primary antibody, mouse 
monoclonal anti-α-smooth muscle actin (A2547 Sigma, UK, 1 in 100 dilution) for 2 hours, 
rinsed and then incubated in donkey anti-mouse IgG (H+L) Alexa Fluor®488 (Invitrogen, 
UK, at a 1 in 1000 dilution) with 2µl 1mg/ml Hoescht 33342 added to each millilitre 
secondary antibody solution (see section 2.8.2). 
 
Cell proliferation was assessed as a measure of percentage proliferation, and followed the 
same immunolabelling procedure described for α-sma immunolocalisation, except that the 
primary antibody used was a rabbit anti-PCNA antibody (ab18197 Abcam, UK), at a 1 in 
100 dilution and the secondary antibody was a donkey anti-rabbit IgG (H&L) Alexa 
Fluor®555 (ab150062 Abcam, UK at 1in 1000 dilution). 
 
To determine cell apoptosis at the wound site immunolocalisation of anti-active caspase-3 
antibody (ab49822, Abcam, UK) was performed on cryosections as detailed in section 
2.8.3. 
 
Images of each corneal section were acquired using a Leica DM6000 fluorescent 
microscope (Leica, Germany), from three wound sites (flap edge, centre and hinge region), 
and labelled cells were counted above and below the wound edges and expressed as a 
percentage of total cells (i.e. number of Hoechst labelled cell nuclei). For the unwounded 
corneas, as the regions of interest could not be dictated by an inflicted wound, surrogate 
areas at similar corneal depths and regions were imaged and analysed. 
 
The number of porcine corneas used for each cell line and control group for LASIK-like 
wounded corneas and for unwounded corneas at each time point is outlined in Table 5.1 
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Statistical Analysis 
Statistical analysis, following determination of a normal data distribution a 2-way 
ANOVAs and Tukey HSD were performed to determine the effect of OMLP-PC 
application on corneal transparency, total stromal cellularity, percentage α-sma positivity, 
percentage stromal cell proliferation and apoptosis as a function of culture duration. 
Additionally, inter-donor cell line application of 3 differing OMLP-PCs cell lines was also 
analysed.  
 
 
Table 5.1 Table demonstrating porcine cornea number.  
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Results 
5.4. Keratocyte activation and myofibroblast activation: α-sma immunopositivity  
The green fluorescently labelled α-sma immunopositive cells were identified amongst non-
activated keratocytes (Hoechst-blue labelled nuclei) in treated and control wounded 
corneas at all time points in organ culture (figure 5.2). Overall, there was a significant 
increase (p<0.01) in percentage α-sma immunopositive cells from the 0 time point to the 1 
week time point in all wounded corneas, those treated with three different cell lines of 
OMLP-PCs and untreated controls (figure 5.3). This increase was maintained across the 
organ culture weeks 1, 2 and 3; then at week 4, percentage α-sma immunopositivity 
significantly decreased in both treated and untreated wounded corneas (p<0.01, figure 5.3). 
The unwounded control corneas maintained a low percentage α-sma immunopositivity 
throughout organ culture week (p<0.05, figure 5.3).  
 
The wounded OMLP-PC treated corneas (all three cell lines) had a significantly lower 
percentage keratocyte activation at weeks 1, 2, 3 and 4 when compared to the untreated 
wounded control corneas (p<0.001, figure 5.3), and significantly higher percentage α-sma 
expression than the unwounded control corneas at all time points (p<0.001, figure 5.3). 
There was no significant difference in the percentage α-sma immunopositivity between cell 
lines at all points during the organ culture (p>0.05). 
 
No significant difference was found with regards to α-sma expression, whether above or 
below the wound, in both the OMLP-PC treated controls and the untreated wounded control 
samples (p>0.05) during the organ culture in the differing regions of interest of the wound 
site (flap edge, flap centre, flap hinge). 
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Figure 5.2: α-sma 
immunolabelling in central 
flap during wound healing in 
organ culture of corneas 
treated with Cell Line 2 of 
OMLP-PCs (Left) and 
Control wounded untreated 
corneas (Right). Images 
show immunolabelled with 
donkey anti-mouse IgG 
(H+L) Alexa Fluor 488 
secondary antibody, 
cryosectioned porcine 
cornea after 0, 1, 2, 3 & 4 
weeks in organ culture. Blue 
arrows indicate α-sma 
immunopositive cells. Red 
arrows indicate the wound. 
White arrows indicate 
hoescht labelled cell nuclei. 
Scale bars represent 100µm. 
Negative controls (A); 
Corneal limbal blood vessels 
immunolabelled with Green 
Fluorescent Protein (GFP). 
Positive Control (B); corneal 
limbal blood vessels 
immunolabelled with 
primary antibody mouse 
monoclonal anti-α-smooth 
muscle actin. 
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However, across all time points during the organ culture in all OMLP-PC treated wounded 
corneas (with all three cell lines), the percentage α-sma immunopositivity was significantly 
higher when measured above the wound in the epithelial stromal flap compared to in the 
stromal wound bed below the wound, (p<0.001, figure 5.4). This significant higher α-sma 
immunopositivity above the wound compared to below (p<0.001) was also observed in the 
control wounded corneas at all 5 time points during the organ culture period (figure 5.4).  
 
 
 
 
Figure 5.3 Total percentage α-sma immunopositive cells across wound site (above 
and below wound in all 3 ROIs.) during 4 weeks organ culture. OMLP-PC treated 
corneas, for all cell concentrations, had a significantly lower percentage of α-sma 
immunopositive cells (**p<001) compared to untreated control corneas at 1, 2, 3 and 
4week time points and a significantly higher percentage keratocyte activation 
compared to unwounded control cornea at all time points. Error bars represent SD.  
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5.5. Keratocyte cellularity 
A steady reduction of the number of blue Hoechst-labelled nuclei (figure 5.2) during the 
organ culture period was seen in all treated corneas and controls (figure 5.5). There was no 
significant difference between the cellularity of the OMLP-PC treated corneas and the 
untreated wounded controls for 0 time point and weeks 1, 2 and 4, however the treated 
corneas had a significantly higher cell number at week 3 when compared to the wounded 
controls (p<0.01, figure 5.5).   
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Figure 5.4 Percentage α-sma immunopositive cells above and below the wound site. All 
cell lines showed a significantly higher α-sma concentration in the epithelial-stromal 
flap (above the wound) than the stromal wound bed (below the wound) for weeks 1,2,3 
and 4 (p>0.01, marked on the graph for cell line 2 only for clarity). Wounded untreated 
control corneas also demonstrated higher percentage activation above the wound 
compared to below for weeks 1, 2, 3 and 4 (p>0.05). 
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The cellularity, although showing no difference at 0 and 4 weeks in organ culture, was 
significantly lower in wounded corneas, treated and untreated corneas, at weeks 1, 2 and 3 
(p<0.001, figure 5.5), compared to unwounded corneas. 
 
When assessed separately, the same overall trends were noted above and below the wound 
site and at all three ROI’s (flap edge, flap centre and flap hinge) for all treated and untreated 
wounded corneas and unwounded cornea. However, there was no significant difference 
above and below the wound or at any of the ROIs (p>0.05).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 Total Cell Count in corneal wound area calculated as the total 
number of Hoechst labelled cell nuclei in all 3 ROI’s above and below 
the wound (average of n=4) over a 4 week organ culture period. Cell number 
for cell line 1 and 3 treated wounded corneas was significantly higher at 0 time 
point compared to control treated corneas (**p<0.01). Error bars represent SD.  
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5.6. The Effect of OMLP-PC Therapy on Stromal Cell Proliferation 
Percentage stromal cell proliferation, calculated as a proliferating cell nuclear antigen 
imunopositive cells (PCNA, labelled red, figure 5.6) percentage of total cell number in 
same region, for both treated and control wounded porcine corneas significantly increased 
from 0 time point to 1 week (p<0.001, figure 5.7). For those corneas treated with cell line 
1 OMLP-PCs the peak percentage of proliferating cells was 52.20% ±3.73 at 1 week and 
was significantly higher than 35.89% ±5.89 the untreated wounded controls (p<0.05). At 
subsequent time points the percentage cell proliferation decreased at a steady rate (figure 
5.7). 
 
The untreated wounded controls, reached a peak proliferation 42.17% ±3.38 at 2 weeks, 
albeit at a lower percentage proliferation than the cell-treated wounded corneas, in 
particular cell line 1 (p<0.05, figure 5.7). After this 2 week time point the cell proliferation 
in the untreated wounded corneas decreased steadily up until week 4. 
 
At weeks 1, 2, 3 and 4, wounded corneas, treated with OMLP-PCs and untreated, had a 
higher percentage proliferation than the unwounded control corneas (p<0.001). The 
unwounded controls maintained a low rate of proliferation throughout the organ culture 
period from 0 to 4 weeks (figure5.7).   
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Figure 5.6: Representative 
images of PCNA 
immunolabelling in the 
central wound area during 
wound healing in organ 
culture of corneas treated 
with OMLP-PC Cell Line 2 
(Left) and Control 
untreated wounded corneas 
(Right). Images show 
immunopositive cells (red 
fluorescence) indicated by 
Blue arrows, whilst Red 
arrows point to the wound 
site White arrows indicate 
Hoechst labelled cell 
nuclei. Scale bars represent 
100µm.  
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There was no significant difference in percentage cell proliferation between ROIs (flap 
edge, flap centre and flap hinge) for all wounded and unwounded corneas at all time points 
during the organ culture. 
  
However, there was no statistically significant difference between the percentage of 
proliferating cells for the OMLP-PC treated and control treated LASIK-like wounded 
corneas and the unwounded corneas when comparing above and below the wound (p>0.05), 
although there was a consistent trend of higher proliferation above the wound in the 
epithelial-stromal flap (figure 5.8 A, B, C and D).  
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Figure 5.7 Mean percentage cell proliferation throughout wound area (i.e. 
above and below wound in all 3 ROIs.) as a function of organ culture time. 
OMLP-PC treated corneas, for cell line 1, had a significantly higher 
proliferation percentage than untreated wounded controls at 1 week (*p<0.05). 
All untreated and OMLP-PC treated corneas had a significantly higher 
proliferation at weeks 1, 2, 3 and 4 weeks compared to the unwounded controls 
(p<0.001). Error bars represent SD.  
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5.7. Keratocyte apoptosis during organ culture:  
Percentage stromal cell apoptosis, calculated as caspase 3 imunopositive cell (labelled red, 
figure 5.9) percentage of total cell number in same region, for both treated and control 
wounded porcine corneas significantly increased from 0 time point to 1 week (p<0.001, 
figure 5.10). 
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Figure 5.8 Percentage Proliferation Above and Below Wound Site (at all 3 ROIs.) during 4 weeks 
organ culture. Despite proliferation being consistently higher above the wound than below in all 
wounded porcine corneas (control and treated) there was no significant difference (p=>0.05). Error 
bars represent SD.  
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 From week 1 to week 3 the percentage of apoptosing stromal cells showed a very slight 
decrease for both treated and untreated wounded corneas (figure 5.10), however, this was 
not significant (p>0.05).  
 
At week 4 the percentage Caspase-3 immunolabelled cells decreased significantly (p<0.01, 
figure 5.10). There was no significant difference between the OMLP-PC treated LASIK-
like wounded corneas and wounded corneas left untreated throughout the organ culture 
period (p>0.05). 
 
The unwounded corneas showed caspase-3 immunopositive cells at 0 time point and a very 
low percentage in subsequent weeks (figure 5.10). 
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Figure 5.9: Representative 
images of Caspase 3 
immunolabelling in the 
central wound area during 
wound healing in organ 
culture of corneas treated 
with OMLP-PC Cell Line 2 
(Left) and Control 
untreated wounded corneas 
(Right). Images show 
immunopositive cells (red 
fluorescence) indicated by 
Blue arrows, whilst Red 
arrows point to the wound 
site White arrows indicate 
Hoechst labelled cell 
nuclei. Scale bars represent 
100µm.  
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5.8. Transparency Measurements 
The transparency of the corneas during the organ culture period, shown in figure 5.11, was 
visually graded as previously outlined in sections 2.11.2 and 4.6.  
 
The cell-treated and untreated wounded corneas, and the unwounded corneas all underwent 
a significant decrease in transparency between 0 time point and week 1 (p<0.001, figure 
5.12). In weeks 1 to 3 there was a slight, albeit not statistically significant, decrease in 
transparency although there was no difference between any of the samples (p>0.05).  
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Figure 5.10 Mean percentage cell apoptosis throughout wound area (i.e. above and 
below wound in all 3 ROIs.) as a function of organ culture time. There was no 
significant difference between the wounded treated and untreated corneas throughout 
the organ culture (p>0.05). All wounded corneas had a significant increase 
(**p<0.001) in apoptosis from 0 time point to 1 week. The percentage of apoptosis 
was maintained from weeks 2-3, followed by a significant decrease at week 4 
(**p<0.001) (significance shown on controls only for clarity). The unwounded 
corneas showed very little apoptosis during the organ culture period. Error bars 
represent SD 
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At week 4 there was no significant increase in transparency, however those wounded 
corneas treated with a solution of OMLP-PCs had a significantly higher transparency when 
compared to the untreated wounded controls (p<0.01). Representative corneal images 
demonstrate this in figure 5.11. Most notably, the wounded corneas treated with OMLP-
PCs showed no statistically significant difference in transparency when compared to the 
unwounded control corneas (p<0.01, figure 5.12). 
  
Figure 5.11 Visual Transparency Grading Images. Used to assess corneal 
transparency for LASIK-like wounded corneas with applications of 1.5x105 cells per 
ml concentration of OMLP PC solution from 3 cell lines, untreated LASIK-like 
wounded corneas and unwounded corneas at 0 time point and after 1,2,3 and 4weeks 
in organ culture. 
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5.9. Discussion 
On wounding of the cornea the complex cascade of cellular responses begins with epithelial 
loss mediating the apoptosis of keratocytes immediately below the epithelial wound by 
release of cytokines such as IL-1 and TGFα (Wilson et al., 1996; Masur et al., 1996; Mohan 
et al., 1997). The site of this apoptosis is dependent on the original injury; an abrasion or 
epithelial scrape will elicit keratocyte apoptosis immediately below the initial wound in the 
superficial stroma, whereas a penetrating lamellar cut (such as those inflicted by 
microkeratomes in LASIK) produce keratocyte apoptosis in the stroma anterior and 
posterior to the lamellar interface of the wound as well as below the original injury site of 
the epithelium (Wilson et al., 2001). This apoptosis is the first observable sign of wound 
healing to take place after epithelial wounding and can occur for several days at a minimum, 
after initial injury (Gao et al., 1997). 
 
Figure 5.12 Corneal Transparency. Visually graded transparency of unwounded 
porcine corneas and LASIK-like wounded corneas with an application of either a 
control solution or a 1.5x105 cells per ml cell solution of OMLP-PCs from 3 
different patients at 5 time points over an organ culture period. Cell Lines 1, 2 and 
3 were significantly more transparent at week 4 than untreated wounded controls 
(**p<0.01, shown only on Cell Line 2. Error Bars represent SD 
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Following this, in the first 24 hours, the keratocytes remaining after apoptosis begin 
proliferation and keratocyte numbers increase rapidly (Zieske et al., 2001). However, with 
the increasing number of keratocytes, apoptosis of the new cells occurs cause a rolling 
simultaneous occurrence of apoptosis and proliferation over a number of days (Mohan et 
al., 2001). The activation of these keratocytes and transformation into myofibroblasts takes 
place and they begin to acquire temporary expression markers of smooth muscle 
differentiation, α-sma, in the microfilaments of myofibroblasts. This α-sma expression is 
regarded as a reliable indicator of the presence of myofibroblastic cells (Darby et al., 1990; 
Gabbiani, 2003). Whilst the appearance of α-sma is necessary and contributes to the 
contractile forces of myofibroblasts (Gabbiani, 2003) this has a negative impact on 
transparency of the cornea through a markedly diluted concentration of intracellular corneal 
crystallins due to a dramatic increase in the cell size of activated keratocytes (Jester et al., 
2005; Jester et al., 2012). 
 
The repair of the stroma ensues as collagen and other ECM components, such as 
glycoproteins and proteoglycans, are synthesised by the activated fibroblasts. A lack in 
organisation compared to the native cornea results and therefore contributes to the reduced 
transparency of the wound healing cornea. Remodeling of this newly laid down ECM, 
controlled by matrix metalloproteinases (MMPs) such as collagenase and gelatinases, 
potentially continues for years and can result in tissue that does not closely resemble the 
organisation or strength of the native corneal tissue (Lee et al., 1982; Cintron et al., 1990; 
Steele et al., 1999).  
 
In this study, the activation of keratocytes into myofibroblasts was ascertained by 
determining the percentage of cells expressing α-sma at different time points during the 
organ culture period following creation of a penetrating wound, similar to that created in a 
LASIK-like flap, in porcine corneas, using a microkeratome.  
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In order to determine the effect of OMLP-PCs on wound healing, they were inserted into 
the wound bed under the epithelial-stromal flap. The cell response, in terms of cell 
apoptosis and proliferation, cell number and presence of myofibroblasts, within the wound 
area, was then compared to untreated wounded corneas and unwounded porcine corneas 
cultured for up to four weeks. Whilst the unwounded corneas showed a significantly low 
activation of keratocytes across the organ culture, this has not been seen in in vivo studies 
of the unwounded cornea. In 2003 Mohan et al. observed no α-sma in the unwounded 
cornea of an in vivo rabbit model. The low level of activation shown in the organ cultured 
unwounded porcine corneas could be a result of epithelial damage during the organ culture, 
leading to an initiation of the wound healing cascade.  
 
As was also shown in chapter 4 (sections 4.4 and 4.7), the OMLP-PC treated corneas once 
more, had a significantly lower percentage of cells with α-sma expression, and therefore 
number of myofibroblasts, than the untreated wounded corneas from week 1 in organ 
culture. This was consistent to that observed in previous studies of cell-based therapies 
applied to corneal wounds in an organ culture model; oral mucosal fibroblasts and corneal 
stromal stem cells (CSSCs) (Dooley et al., 2012; Morgan et al., 2014).  
 
The lowering of the percentage of myofibroblastic transformation in the organ cultured 
wounded porcine corneas should have positive ramifications for corneal transparency 
during wound healing as it has less of a negative effect on the expression of corneal 
crystallins and reduced production of disorganised ECM products. The significant lowering 
of keratocyte activation when compared to the untreated wounded corneas also indicates 
that the OMLP-PC treatment is having an effect on the wound healing of the cornea, 
potentially introducing some of the characteristics of oral mucosa wound healing into that 
of the wounded cornea.  
 
The privileged repair of the oral mucosa has been well documented as having rapid re-
epithelialisation and remodeling (Stephens et al., 1996) and the intra-oral mucosal 
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fibroblasts have been shown to exhibit foetal-like phenotypes that are consistent with the 
scarless wound healing associated with the foetal-like behaviours of the oral mucosal 
(Sloan, 1991). Oral mucosal fibroblasts have demonstrated they have the ability to 
accelerate collagen gel contraction whilst lowering the expression of α-sma (Shannon et 
al., 2006), a faster proliferation than dermal fibroblasts (Glim et al., 2014; Lee & Eun, 1999) 
and a significantly increased ability to reorganise ECM (Stephens et al., 1995). The foetal 
like wound healing of the oral mucosa led researchers to hypothesise that a progenitor cell 
population was yet to be discovered in the lamina propria that was contributing to the 
preferential wound healing. This hypothesis was proved correct in 2010 by Davies et al., 
when OMLP-PCs were discovered and shown to be multipotent with the ability to 
differentiate down different lineages, potently immunosuppressive and possessing anti-
microbial properties (Davies et al., 2010 & 2012; Board-Davies et al., 2015). 
 
The apoptosis of keratocytes in corneal wound healing, triggered by cytokine release from 
the epithelium, occurs almost immediately after wounding (Wilson et al, 2001), which can 
be seen in this study. Apoptosis was seen in the wounded corneas at 0 time point (detected 
by caspase-3 immunolabelling), compared to no apoptosis in the unwounded corneas. A 
significant increase in apoptosis occurred at 1 week and continued until a significant 
reduction at 4 weeks. There was a low amount of apoptosis in the unwounded corneas from 
1 week onwards, potentially triggered by low level damage to the epithelium as a 
consequence of organ culture. Interestingly there was no difference in apoptosis between 
the wounded and unwounded corneas at any time point during the organ culture, indicating 
that the application of OMLP-PCs had no effect on the apoptotic stages of wound healing 
in the LASIK-like wounded cornea.    
 
In this study attempts were made to follow the fate of the OMLP-PCs within the porcine 
cornea throughout the organ culture by labelling with a human antigen Anti-Histone H2B 
antibody - N-terminal (Abcam, UK,). However, the antibody indiscriminately labelled all 
cells (results not shown), and it was later found that porcine and human proteins have a 
high homology (Franek & Sorm, 1970). Despite numerous protocol optimisations, it is 
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likely that cross reaction between porcine and human antigen is high and, therefore the 
OMLP-PCs could not be tracked. 
 
The proliferation within the organ cultured porcine corneal stroma, in the wound area, 
showed an earlier and higher peak at 1 week post wounding, when treated with OMLP-
PCs. This peak appeared at a lower level, and at 2 weeks in the untreated wounded corneas, 
indicating the cell proliferation progressed at a faster rate in treated corneal wounds. The 
comparatively faster cell proliferation in the OMLP-PC treated corneas suggests that 
potentially the OMLP-PCs produce growth factors that trigger stromal cell proliferation 
within the porcine cornea as they have been shown to proliferate faster than other 
fibroblasts (Lee & Eun, 1999; Glim et al., 2014). The peak in proliferation for the untreated 
wounded porcine corneas may be indicative of the keratocyte replenishment that takes 
place following apoptosis in the corneal stromal wound healing process (Wilson, 2002).  
 
The cellularity of the corneas throughout the wound healing process followed an overall 
trend of reduction over the organ culture period. The number of stromal cells in the corneas 
treated with OMLP-PCs decreased from 0 time point to 1 week significantly (p<0.001), 
whereas the consequent weeks, although showing a decreasing trend, did not show a 
consistently significant reduction in cell number. At 0 time point there was a significantly 
higher number of cells in the wounded corneas treated with OMLP-PCs compared to the 
untreated corneas, but once again no consistently significant reduction in numbers between 
the untreated corneas and when compared to the cell treated corneas. However, the trend 
for the unwounded corneas is interesting as it shows a smooth non-linear decrease in cell 
number, from 0 to 4 weeks in organ culture. During organ culture the porcine corneas have 
a tendency to swell (Van Horn et al., 1975; Summerlin et al., 1973) resulting in an 
increasing thickness over the organ cultured period. This would lower the number of cells 
per area in the assessment of cellularity and result in a steady decrease over the organ 
culture period.  
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This increased thickness of the cornea can also have a negative impact on the transparency 
of all corneas over the 4 week organ culture period (Hart & Farrell, 1969; Cox et al., 1970, 
Meek et al., 2003; Doutch et al., 2008). During the wound healing of the untreated wounded 
corneas a number of factors, as previously discussed can have a negative impact on the 
transparency. The activation of myofibroblasts is a major determinant as, due to the 
increase in size of the keratocytes, the intracellular corneal crystalline concentration is 
effectively diluted, thus reducing the transparency (Jester et al., 2005 & 2012), as well as 
the laying down of new disorganised ECM components by the newly activated keraocytes 
causing opacification. In the wounded corneas treated with OMLP-PCs, there was a similar 
reduction in transparency over the organ culture period, as in the unwounded corneas. 
However, at the 4 week time point the transparency of the OMLP-PC treated corneas and 
the unwounded corneas were not only similar, but significantly more transparent than the 
untreated corneas. As the increase in thickness due to the corneal oedema caused by the 
organ culture was a common factor between the untreated and treated wounded corneas 
and the unwounded corneas, the low percentage of myofibroblasts present in the wound 
area must have a positive effect on the transparency of the cornea, as previously discussed.  
 
The success of previous researchers using cell based therapies to improve the wound 
healing capabilities of the organ cultured corneas (Dooley et al 2012; Morgan et al., 2014) 
have led the way to utilising the OMLP-PCs as possible source of cell based therapy that 
could provide immunosuppressive, anti-microbial, and self-renewing properties from an 
easily accessible biopsy site. Due to the very nature of cells, these could be collected easily, 
induce rapid healing with minimal scar formation, similar to the foetal like characteristics 
of oral mucosal wound healing (Sloan, 1990; Davies et al., 2010 & 2012; Board Davies et 
al., 2015).  
 
These cells appear to have been successful in improving the wound healing properties of 
the wounded porcine cornea; their application increased the rate of cell proliferation, 
lowered the number of keratocytes transformed into myofibroblasts, and significantly 
improving corneal transparency to the level of an unwounded cornea by 4 weeks in organ 
culture. 
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6.1. Introduction 
The stroma makes up the bulk of the human cornea, accounting for 90% of its thickness 
(500µm) (Rodrigues et al., 1982) and has a unique homogeneity of cell types, consisting of 
keratocytes, proteoglycans and collagen (Hogan et al., 1971; Fini, 1999). The organisation 
of the collagenous stroma is highly specialised; collagen fibrils of narrow and uniform 
diameter and spacing are aligned in parallel within stromal lamellae and surrounded by 
proteoglycans (Maurice, 1957). Lamellae, numbering approximately 300 in the central 
corneal to 500 in the periphery (Radner et al., 1998), are orthogonally stacked with respect 
to each other (Fini, 1999) and run from limbus to limbus.  
 
The transparency of the cornea, which is crucial for functional vision, is reliant, not only 
on its avascular nature, but also on the uniquely organised ultrastructure, as described in 
brief above. Disruption of this specific arrangement results in the loss of corneal 
transparency (Meek et al., 2003). There are a number of potential causes for the loss of 
transparency with respect to wound healing, the stromal collagen arrangement is disrupted 
during the wound healing process due to swelling, laying down of repair ECM components 
and eventual remodelling (Zieske, 2001; Fini, 1999).  
 
The initial damage to the epithelium releases cytokines such as TGFβ and IL-1 (see section 
1.6) that mediate apoptosis in the adjacent keratocytes via the fas-fas ligand system 
(Toricelli & Wilson, 2014), resulting in an acellular zone (Zieske, 2001). Proliferation of 
remaining nearby keratocytes ensues and fibroblast activation and transformation into 
myofibroblasts begins; with a fibroblastic phenotype (Jester et al., 1999; Funderburgh et 
al., 2003). As previously discussed in Chapters 4 and 5, appearance of myofibroblasts 
negatively impacts on transparency due to the decreased concentration of corneal 
crystallins compared to keratocytes (Jester et al., 2005 & 2012), but also due to their 
excessive deposition of repair ECM products (Masur et al., 1996; Moller-pedersen et al., 
1997; Jester et al., 1999; Mohan et al., 2003) and contractile forces (Ishizaki et al., 1994).  
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The concurrent apoptosis, proliferation and activation of keratocytes and transformation 
into myofibroblasts continues for days or weeks and stromal remodelling begins. Over 
many months, the ECM is remodelled with continuous collagen (and other component) 
synthesis, degradation and re-synthesis (Fini, 1999). The parallel lamellar layers are 
gradually reformed across the wound site as deposited collagen lamellae in the repair tissue 
interleaves with the cut collagen (Davison & Galbavy, 1986). The collagen fibrils return to 
a more uniform size and become more organised (Cintron et al., 1978).  This stromal 
remodelling is dependent on the wound type of the initial injury; wounds that run parallel 
to the corneal surface such as PRK, heal with minimal scarring and may take up to a year 
or more to heal. Incisional wounds, where the cut occurs perpendicular to the surface (e.g. 
gaping wounds) require the deposition of collagens and abnormally large proteoglycans 
which may take many years of healing to return to its native opacity, if at all (Zieske et al, 
2001; Funderburgh et al., 1998). The deposition of these proteoglycans has a significant 
effect on corneal transparency as, due to their hydrophilic nature, they play a major role 
(along with the corneal endothelial pump, as previously discussed in chapter 1) in 
regulating the collagen fibril spacing (Hassell et al., 1983). The presence of these larger 
proteoglycans can therefore not only increase the fibril spacing due to their size, but also 
increase corneal hydration, thereby disrupting the specific corneal collagen organisation 
required for normal visual function (Funderburgh et al., 1998; Saika, 1998; Ishizaki et al., 
1994). 
 
The collagen ultrastructure of the cornea is traditionally imaged using transmission electron 
microscopy (TEM). However, second harmonic generation (SHG) microscopy can be used 
to investigate fibrillar collagen (Han et al., 2005). In this non-linear microscopy technique, 
two photons with the same frequency can interact with a structure that has non-
centrosymmetric molecular organisation, with consequent scatter in a non-random phase 
(Zipfel et al., 2003). Two near infrared incident photons are converted into one photon with 
twice the energy of the incident laser beam; twice the frequency and half the wavelength 
(figure 6.1) (Mohler et al., 2003; Strupler et al., 2007).  SHG conserves the energy and the 
coherence of laser light, as it does not involve an excited state (Campagnola & Loew, 2003) 
The near infrared wavelengths used allow excellent depth penetration without the need for 
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confocal optics (Cox et al., 2003; Campagnola & Loew, 2003).  Without the need for dyes 
such as fluorophores, SHG is non-invasive and can image samples without degrading or 
destroying them, specifically targeting fibrillar collagen I and has had a significant impact 
on biomedical research (Mohler et al., 2003; Brown et al., 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The activation and transformation of keratocytes into myofibroblasts in the process of 
corneal wound healing results in many processes that decrease the corneal transparency 
including altered collagen organisation within the cornea. Additionally, a decrease in 
corneal crystallins, production of contractile forces and the excessive deposition of repair 
ECM occurs. The presence of myofibroblasts was shown to be significantly reduced by the 
application of OMLP-PCs to the wound bed of LASIK-like wounded porcine corneas over 
a 4 week organ culture, when compared to the wounded untreated control corneas (Chapter 
5).  The structure of collagen is non-centrosymmetric, being made up of repeating units of 
parallel cross-linked triple helical molecules (tropocollagen) (Thomas et al., 2007). As has 
been reported on numerous occasions, collagen is a very effective “upconverter” of light 
by SHG and so is ideal for this non-linear imaging method (Georgiou et al., 2000; Cox et 
al., 2002). Therefore, in this study SHG imaging was used to assess the collagen fibril 
organisation within the stromal cornea as a function of wound healing to assess whether 
Virtual State 
 
 
Ground State 
 
Ground State 
ω
i
 
 
 
ω
i
 
 
ω
i
 
Figure 6.1 Diagram showing Second Harmonic Generation (or 
frequency doubling). Two incident photons with the same 
frequency (ωi) interact with non-centrosymmetric molecules and a 
photon with twice the frequency and half the wavelength (2ωi) is 
produced and energy is conserved. 
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the application of OMLP-PCs to the LASIK-like wounded cornea improved the 
remodelling of corneal ECM back to, or as near as possible to, the native unwounded state. 
 
6.2. Aim 
The aim of this chapter was to determine the effect of OMLP-PCs on the stromal collagen 
organisation in corneal wound healing.   
 
The results were used to assess the efficacy of OMLP-PCs in remodelling stromal collagen 
to improve healing and consequent corneal transparency after LASIK-like wounding. 
 
6.3. Experimental Design 
Corneal cryosections obtained from the organ cultured LASIK-like wounded porcine 
corneas from section 5.3 were used in this experiment (Sections 2.1- 2.7.2.).  
 
The morphology of the stromal wound area was assessed using Haematoxylin and Eosin 
staining (H&E). In brief, triplicate corneal cryosections from unwounded, treated (1.5x105 
OMLP-PCs ml-1, Cell line 2) LASIK-like wounded and untreated wounded corneas were 
immersed in Harris haematoxylin followed by 1% aqueous Eosin and then mounted in DPX 
(03703596, RA Lamb, UK). Images of these sections were acquired using a Leica DMRA2 
Microscope (Leica, Germany) and Zen image capture software (Zeiss, Germany). The 
images were assessed for differences in the corneal stroma morphology during wound 
healing, between the treated and untreated corneas, over an organ culture period of 4 weeks. 
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Triplicate 10µl cryosections from OMLP-PC treated (at 1.5x105 cells ml-1) LASIK-like 
wounded corneas and similarly wounded (media without cells) and unwounded control 
corneas were mounted in Vectorshield® with propidium iodide (PI) (Vector Labs, UK) 
(section 2.12.1) and imaged using a Laser scanning microscope (LSM) 880 NLO on Axio 
Examiner fixed stage upright microscope (Carl Zeiss Ltd., Cambridge, UK). A tuneable 
ultrafast (< 140fs) titanium-sapphire laser (Cameleon, Coherent, Inc., UK) operating at 800 
nm. Second harmonic emission was collected in the forward propagating direction through 
a 400 +/-3nm near infrared (NIR) blocking band pass filter. Serial optical sections at 
1024x1024 resolution were collected at 3μm z-focus intervals. The resulting image datasets 
were analysed using the OrientationJ plugin to ImageJ version 1.52a (National Institutes of 
Health, USA). All images were equally adjusted for brightness and contrast and 
despeckled. 
 
A maximum intensity profile image was created from the z stack and an orientation colour 
overlay applied (figure 6.2), the settings in figure 6.3 were applied. The coherence of 
orientation (a measure of the degree of the number of fibres aligned in a preferred 
orientation) and the distribution of the orientation across the sample were analysed at 
adjacent triplicate points for each sample above and below the wound in the flap centre.  
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2 Circular colour survey map 
coding, Original image courtesy of 
Urszula Zajaczkowska.  
 
 
Figure 6.3 OrientationJ plugin (ImageJ 
version 1.52a National Institutes of 
Health, USA) settings for OrientationJ 
Analysis tool.  
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For the unwounded corneas, as the regions of interest could not be dictated by an inflicted 
wound, surrogate areas at similar corneal depths and regions were imaged and analysed.   
 
The number of unwounded and LASIK-like wounded porcine corneas (treated with cell 
line 2 OMLP-PC solution and those treated with a control solution) used is outlined in 
Table 6.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Statistical Analysis 
Following determination of a normal data distribution a 2-way ANOVAs and Tukey HSD 
were performed to determine the effect of OMLP-PC application on corneal collagen 
orientation coherency and distribution as a function of culture duration.  
 
 
Table 6.1 Table demonstrating porcine cornea number.  
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Results 
6.4. H&E 
Morphological traits of the wound healing stroma (Haematoxylin labelled blue cell nuclei 
with pink eosinophilic background) were assessed at 3 different regions of interest (ROIs); 
namely flap edge, flap centre and flap hinge within the stroma. Wounded corneas treated 
with a 1.5x105 cells ml-1 OMLP-PCs (cell line 2), untreated and unwounded corneas were 
compared at each organ culture point.  
 
At 0 time point the stroma of all corneas appeared dense with a regular distribution of cells. 
The corneas that were wounded had an easily observable gaping epithelial wound at the 
point of entry of the microkeratome blade (the flap edge), and a defined lateral incision 
running parallel to the epithelium (flap centre) culminating in the end of the incision within 
the stroma (flap hinge) (figure 6.4). 
Through weeks 1, 2 and 3 after wounding an epithelial plug had formed at the incision 
wound site (the flap edge) in the treated and untreated wounded corneas. The stromal 
lamellae in all corneas became less compact, with a less organised appearance and the 
spacing of the nuclei and matrix had increased. The wounded corneas, treated with the 
OMLP-PCs, showed better wound closure in the central cornea compared to those 
untreated wounded corneas, which appeared closed at 4 weeks (Fig 6.6). Untreated 
wounded corneas had larger central areas where the epithelial-stromal flap had not fully 
adhered to the stromal wound bed (figures 6.5 & 6.6).  
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By week 4, whilst the epithelial wound at the flap edge showed a varying degree of wound 
closure (complete healed epithelium, epithelial ingrowth and markedly thinned 
epithelium), the central stroma, particularly at the flap-wound bed interface, demonstrated 
a degree of stromal organisation that more closely resembled the unwounded organ cultured 
cornea than the untreated wounded cornea (figure 6.6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 H&E stained cryosections of LASIK-like 
wounded porcine treated with a 1.5x10
5
cells ml
-1
 
solution of OMLP-PCs, LASIK-like wounded control 
corneas with no treatment and unwounded porcine 
corneas at 0 time point. Arrows indicate the wound site. 
Scale bars represent 100µm.  
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Figure 6.5 H&E stained cryosections of LASIK-like 
wounded porcine treated with a 1.5x10
5
cells ml
-1
 
solution of OMLP-PCs, LASIK-like wounded control 
corneas with no treatment and unwounded porcine 
corneas after 1 and 2 weeks in organ culture. Arrows 
indicate the wound site. Scale bars represent 100µm. 
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Figure 6.6 H&E stained cryosections of LASIK-like 
wounded porcine treated with a 1.5x10
5
cells ml
-1
 
solution of OMLP-PCs, LASIK-like wounded control 
corneas with no treatment and unwounded porcine 
corneas after weeks 3 and 4 in organ culture. Arrows 
indicate the wound site. Scale bars represent 100µm. 
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6.5. Non-Linear Imaging 
Figure 6.7 demonstrates SHG signals generated in a full thickness corneal section of an 
untreated LASIK-like wounded porcine cornea at 0 time point, with propidium iodide 
labelling the cell nuclei (red fluorescence). The collagen organisation within stromal 
lamellae are clearly seen, with LASIK-like wound running parallel to the epithelium clearly 
defined.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.7 Non-linear Second Harmonic Generation 
(SHG) image of corneal collagen (green) with 
propidium iodide (PI) fluorescence of labelled cell 
nuclei (red) within the central cornea (from 
epithelium to endothelium) of a 0 time point LASIK-
like wounded porcine cornea. Arrow indicates wound 
site. Scale bar represents 200µm 
 
 
CHAPTER SIX  Matrix Organisation 
 
 
 
152 
 
6.6. Orientation Analysis 
Triplicate corneas for each time point (0, 1, 2, 3 and 4 weeks) for OMLP-PC treated, 
untreated wounded and unwounded corneas were subjected to SHG imaging at the flap 
centre. Images were then assessed using OrientationJ analysis (ImageJ version 1.52a 
(National Institutes of Health, USA) where a colour survey map overlay image was 
generated and data collected with regards to preferred fibre orientation, coherence of 
orientation and distribution. 
 
At 0 week (figure 6.8), the stromal collagen lamellae appeared to be mostly horizontally 
aligned, parallel to the epithelium in wounded and unwounded corneas and collagen 
lamellae appeared condensed and tightly pack within the stroma. Analysis of coherence 
showed a significantly higher coherence in unwounded corneas compared to treated and 
untreated corneas (p<0.001), but no significant difference between treated and untreated 
wounded corneas (p>0.05) (figure 6.11). The stromal incision inflicted by the 
microkeratome was clearly seen in both of the images of LASIK-like wounded corneas. 
 
At 1 week in organ culture, the alignment of the collagen lamellae in all samples appeared 
to decrease (figure 6.8), however analysis of the coherence indicated an increase in the 
coherence in unwounded corneas, compared to 0 time point. The spacing of the collagen 
lamellae appeared to have increased from 0 time point for both the wounded samples and, 
to a lesser degree, in the unwounded samples. The stromal wound was still evident in both 
the cell treated and untreated wounded corneas, with a clear gap at the interface, however, 
there appeared to be evidence of small areas of intermittent wound closure. Coherence of 
the cell-treated and control corneas decreased from 0 time point to 1 week, but there was 
no distinct observable differences between them (figure 6.11). The gaping at the stromal 
flap interface in the OMLP-PC treated cornea appears greater at 1 week than for the control 
untreated corneas at the same time point. However, although not significantly different, the 
coherence of the OMLP-PC treated corneas does appear to be slightly greater than the 
untreated controls at this time point.  
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At weeks 2 and 3 in organ culture the stromal wound appeared to have closed more in the 
OMLP-PC treated corneas compared to the untreated wounded corneas (figure 6.9). There 
was a large amount of disorganised collagenous stroma seen in all samples, but, once again, 
to a lesser extent in the unwounded cornea. Analysis of coherence showed significantly 
higher coherence in the unwounded corneas compared to the wounded at 2 weeks 
(p<0.001), however there was no significant difference between wounded and unwounded 
at 3 weeks (p>0.05). Once more there was no significant difference between the treated and 
untreated wounded corneas at either 2 or 3 weeks (p>0.05) (figure 6.11). 
 
By week 4 the stromal wound was mostly closed in the OMLP-PC treated LASIK-like 
wounded corneas, whilst the similarly wounded untreated control corneas showed more 
open gaping wounds at the flap interface (figure 6.10). The LASIK-like wounded corneas 
treated with OMLP-PCs showed a small, but significant increase in collagen coherence 
when compared to the similarly wounded untreated corneas (p<0.05). Notably, there was 
no significant difference between the coherency of the unwounded and OMLP-PC treated 
wounded corneas at this point (p>0.05) (figure 6.11).  
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Figure 6.8 SHG imaging of the collagenous stroma (green) in treated and untreated 
LASIK-like wounded and unwounded corneas at 0 week and after 1 week in organ 
culture. Aligned and organised collagen stromal lamellae at 0 time point becomes 
more disorganised 1 week after wounding. Collagen lamellae orientation 
coherence is represented by the colour map overlay generated by OrientationJ 
plugin for Image J version 1.52a (National Institutes of Health, USA). Arrows 
indicate wound site. Scale bars represents 100µm.   
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Figure 6.9 SHG imaging of the collagenous stroma (green) of treated and untreated 
LASIK-like wounded and unwounded corneas at 2 and 3 weeks in organ culture. 
Collagen lamellae appear increasingly disorganised in all corneas. Colour map 
overlay orientation generated by OrientationJ plugin for Image J version 1.52a 
(National Institutes of Health, USA). Arrows indicate wound site. Scale bar 
represents 100µm.   
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Figure 6.11 Coherence of collagen lamellae orientation in the flap centre of LASIK-
like wounded corneas treated with1.5x105 cells ml-1 solution of OMLP-PC Cell line 2 
and untreated and unwounded corneas at 5 time points during organ culture. 
Unwounded corneas showed a significantly higher coherence (**p<0.001) than 
wounded corneas at 0, 1, and 2 weeks. Cell treated corneas and unwounded corneas 
showed no significant difference in collagen coherency (p> 0.05) until week 4 where 
OMLP-PC treated corneas showed a significantly higher coherency than untreated 
wounded corneas (*p<0.05) and no significant difference when compared to 
unwounded corneas.  
 
** 
** 
** 
* 
Figure 6.10 SHG imaging of the collagenous stroma (green) of treated and 
untreated LASIK-like wounded and unwounded corneas after 4 weeks in organ 
culture. Collagen lamellae appear more disorganised in the wounded corneas 
compared to the unwounded corneas. Colour map overlay orientation generated by 
OrientationJ plugin for Image J version 1.52a (National Institutes of Health, USA). 
Arrows indicate wound site. Scale bar represents 100µm.   
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Distribution of collagen orientation was analysed using OrientationJ plugin (ImageJ, 
version 1.52a National Institutes of Health, USA). The wounded corneas showed a lack of 
any distinct peaks in distribution of stromal collagen lamellae orientation throughout the 
organ culture period (figure 6.12).  
 
 
At 0-time point wounded corneas showed peaks in distribution at approximately 0º 
(horizontally), (figure 6.12A). At weeks 1, 2 and 3, definition of any peaks were less 
prominent in the LASIK-like wounded corneas and the treated and untreated samples 
appeared indistinguishable from one another (figure 6.12 B, C & D). 
 
At the end of the organ culture period the LASIK-like wounded corneas showed a more 
defined peak distribution of approximately horizontal collagen lamellae orientation 
compared to the untreated control corneas that showed a lesser distribution peak off the 
horizontal axis (figure 6.12 E).  
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Figure 6.12 Weekly Time Points of Distribution of Collagen Lamellae Orientations over an 
organ culture period of LASIK-like wounded corneas treated with a control solution (Control) 
and similarly wounded corneas treated with OMLP-PCs (OMLP-PC). Distinction of peaks in 
collagen lamellae orientation distribution decreases from time point 0 over weeks 1, 2 and 3 
before increasing at week 4 for both treated and untreated LASIK-like wounded corneas.  
 
Figure 6.12 Weekly Time Points of Distribution of Collagen Lamellae Orientations over an 
organ culture period of LASIK-like wounded corneas treated with a control solution (Control) 
and similarly wounded corneas treated with OMLP-PCs (OMLP-PC). Distinction of peaks in 
collagen lamellae orientation distribution decreases from time point 0 over weeks 1, 2 and 3 
before increasing at week 4 for both treated and untreated LASIK-like wounded corneas.  
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6.7. Discussion 
The stromal collagen lamellae organisation of the cornea can potentially undergo dramatic 
changes during corneal wound healing, largely due to the deposition of repair extracellular 
matrix ECM and abnormally large proteoglycans produced by activated myofibroblasts 
during the granulation and remodelling stages of wound healing (Kamma Lorger et al., 
2009; Zieske, 2001; Fini, 1999; Funderburgh et al., 1998). Whilst this study of collagen 
organisation during wound healing after LASIK-like incision in an organ culture model can 
be used to assess the efficacy of OMLP-PCs in improving the wound healing outcomes in 
the porcine model, the effects on orientation of the stromal lamellae can only derive a 
general comparison as the lamellar orientation of humans and pigs is different. 
 
 A diffraction study by Meek et al., in 1987 determined that the orthogonal preferential 
orientation of stromal collagen appears unique to humans and in recognition of the fact that 
research in this area would be heavily reliant on specimens obtained from abattoirs, a need 
for a comparative study was suggested. This was later confirmed by Hayes et al., (2007) 
who ran a comparative study of fibrillar collagen arrangement in the corneas of primates 
and other mammals using X-ray scattering patterns, and included porcine corneas. The 
corneal collagen arrangement of pigs was found to be circumferential compared to 
orthogonal in humans.  
 
In this study the crucial organisation of collagen fibres was assessed in the central section 
of the stroma (flap centre) of LASIK-like wounded porcine corneas treated with 1.5x105 
cells ml-1, similarly wounded control porcine corneas treated with a control solution and 
unwounded porcine corneas over a 4 week organ culture period. An overview of the 
structural changes within the wound healing organ cultured porcine corneas was performed 
by looking at stromal wound morphology using H&E staining. A more in-depth 
investigation into the microstructural changes in the collagenous stroma over the same time 
period was carried out using SHG imaging, taking advantage of the non-centrosymmetric 
nature of corneal collagen. The stromal collagen organisation was quantitatively analysed 
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from these images using OrientationJ plugin (ImageJ, version 1.52a (National Institutes of 
Health, USA), whereby the coherency of orientation was determined and the distribution 
of orientation over the entire image was determined. 
 
All corneas treated, wounded or unwounded, exhibited signs of stromal swelling during 
organ culture. Consequently, the collagen appeared more disorganised and the cell density 
reduced over the 4 week period. The corneas treated with the OMLP-PCs demonstrated a 
faster, more comprehensive closure of the stromal wound inflicted, compared to the gaping 
between the epithelial-stromal flap and the wound bed still evident in the control untreated 
wounded corneas, seen at equivalent time points. The cell-treated corneas also 
demonstrated a close resemblance to the unwounded control corneas in the central flap 
region by week 4. The central wound area of the OMLP-PC treated wounded corneas at 4 
weeks was relatively acellular with warped and stretched appearance to the ECM. 
However, the ECM collagen had been laid down sufficiently at the wound site to effectively 
close the wound, compared to the remaining space and gaping viewed in untreated control 
corneas at the same time point.  
 
The results of the orientation analysis of coherence and distribution of corneal collagen 
lamellae orientation showed that both the treated and untreated wounded porcine corneas 
exhibited a significantly reduced coherence of collagen lamellae orientation compared to 
the unwounded porcine corneas in the first 3 time points during organ culture (p<0.001). 
Although at different amplitudes, the dominant orientation for wounded corneas at 0 time 
point appeared to be horizontal. The coherency of the collagen lamellae orientation of the 
wounded corneas was significantly lower than the unwounded controls immediately after 
wounding at 0 time point. This is possibly a result of the incision severing lamellae that run 
from limbus to limbus (Radner et al., 1998) and so releasing the mechanical tension that 
would be present in the collagen fibres running through the lamellae resulting in an instant 
reduction in orientation coherency at the time of wounding.  
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At week one the coherency of the collagen lamellae orientation had significantly dropped 
in both the wounded treated and untreated corneal samples, this would reflect the activation 
of keratocytes and their transformation into myofibroblasts, which begin to lay down 
disorganised repair extracellular matrix (Masur et al., 1996; Møller-Pedersen et al., 1997; 
Jester et al., 1999; Mohan et al., 2003). Likewise, the distinction of any preferential 
orientation distribution decreased in the wounded samples. The remodelling that takes 
place during wound healing occurs concurrently with apoptosis and proliferation in a 
rolling wound healing cascade (Mohan et al., 2001; Fini et al., 1999) and ECM can continue 
to remodel for weeks. Over weeks 2 and 3 of organ culture wound healing in this study, the 
coherence of orientation in the wounded, untreated and treated corneas gradually increases 
from the low point at 1 week, whilst peaks in orientation distribution show gradually 
increasing definition in the wounded corneas. The OMLP-PC treated LASIK-like wounded 
porcine corneas demonstrated no significant difference to the control untreated wounded 
corneas during this organ culture up until and including the 3 week time point (p>0.05). 
Interestingly, over the same period the coherence of orientation in the unwounded corneas, 
whilst remaining significantly higher than that of the wounded corneas (p<0.001), gradually 
decreases and at 3 weeks shows no significant difference in orientation coherency 
compared to both wounded corneas (p>0.05).  
 
Certainly, this study is limited by the fact that the analysis was only undertaken in a 2D 
plane, not allowing full appreciation and analysis of the 3D structural organisation of the 
stromal collagen. Future works should be aimed at analysis of collagen nanostructure using 
WAXS (wide angle x-ray scattering) in serial sections through the cornea, looking at 3D 
analysis of fibril orientation to gain further insight into the changes that occur in the 3 
dimensional plane in organ culture and during wound healing to better characterise stromal 
matrix changes. 
 
By 4 weeks the coherence of collagen lamellae orientation in the OMLP-PC treated 
wounded corneas had increased and was significantly higher than that of the control 
wounded cornea (p<0.05) and showed no significant difference to the unwounded control 
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cornea (p>0.05). The distribution of orientation of all wounded corneas showed increased 
definition compared to previous weeks at this time point, and the OMLP-PC treated 
LASIK-like wounded corneas showed a more prominent peak at an approximately near 
horizontal orientation.  
 
The initial closure of epithelial wounds in the cornea close via an epithelial plug rapidly 
after the initial infliction, closing the wound completely to potential infection and debris up 
to 48-72hrs. The initial stages of the wound healing of the underlying corneal stroma 
(apoptosis and proliferation) take place relatively quickly within the first week or so (Zieske 
et al., 2001; Mohan et al., 2001; Wilson et al., 2001), however, complex stromal 
remodelling can continue for years before possibly reaching the native phenotype (Cintron 
et al., Fini, 1999; Lee et al., 1982). The OMLP-PC treated LASIK-like wounded corneas 
in this study seemed to reach an appearance (seen in H&E stained cryosections) after 4 
weeks in organ culture that more closely resembled that of the unwounded porcine corneas 
at the same point and definitely demonstrated a more competent stromal wound closure 
than that observed in the control wounded corneas. Similarly, by the 4 week time point in 
organ culture the SHG analysis of LASIK-like wounded OMLP-PC corneas showed more 
definite distribution of orientation peak and had a significantly higher orientation coherence 
than the control wounded corneas and was not significantly different to the unwounded 
corneas.  
 
Cells originating in the oral mucosa have repeatedly demonstrated their propensity for 
preferential wound healing; accelerating collagen gel contraction, whilst lowering α-sma 
activation (Shannon et al., 2006), a faster rate of proliferation, compared to dermal 
fibroblasts (Glim et al., 2014; Lee & Eun, 1999) and, most notably, a significantly increased 
ability to reorganise ECM (Stephens et al., 1995). They have been shown to express foetal 
stem-like wound healing characteristics (Sloan, 1991) in rapid remodelling of tissue 
(Stephens et al. 1996; Mak et al., 2009). Previous chapters have demonstrated that the 
application of OMLP-PCs to the wounded cornea, in comparison to the untreated cornea, 
reduce the expression of α-sma, (a marker for the transformation of corneal fibroblasts into 
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myofibroblasts) and improve transparency (Chapter 5). Whilst the results of this study by 
no means demonstrate a return to the native state of wounded stromal ECM in the 4 weeks 
of organ culture, it does demonstrate the potential of OMLP-PCs to augment corneal wound 
healing.   
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Chapter 7 
Discussion and Future Work  
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7.1. Discussion 
The biological priority of the complex cascade of corneal wound healing is to close the 
epithelial wound site to maintain the smooth refractive surface of the eye and protect the 
cornea from potential infection and invasion of foreign particulates that could compromise 
health and function. The epithelial defect caused by injury closes rapidly and efficiently, as 
outlined in chapter 1, and initiates wound healing in the stroma via cytokine release (section 
1.6). This stromal healing, whilst also efficient and complex, can have detrimental effects 
on the long term quality of vision of the patient. The cytokine release from the wounded 
epithelium triggers keratocyte apoptosis and activates neighbouring quiescent keratocytes 
that then undergo myofibroblastic transformation. (Masur et al., 1996; Mohan et al., 1997; 
Wilson et al., 2012). These myofibroblasts are responsible for the potential wound healing 
related complications that lead to reduction in visual function, via the dilution of corneal 
crystallin concentration, the laying down of excess repair extracellular matrix (including 
disorganised collagen fibrils and abnormally large proteoglycans that can over hydrate the 
cornea resulting in a loss in transparency) and exerting the contractile forces that enable 
wound closure (Wilson et al., 2012; Ljubimov & Saghizadeh, 2015; Masur et al., 1996; 
Mohan et al., 1997).  
 
This fibrotic response in the eye has been reviewed extensively by Shu & Lovicu (2017) 
and Fini (1999); it can lead, not only to a poor outcome of accidental injury and trauma, 
but also to poor surgical outcomes, namely corneal procedures, but this can also effect other 
parts of the eye; potentially blocking aqueous outflow facility after laser surgery for the 
treatment of glaucoma and causing secondary cataracts and subcapsular pathologies of the 
lens to name but a few. 
 
This study focuses in particular on the unique wound-type inflicted on the cornea by the 
popular corrective refractive procedure, laser assisted in-situ keratomileusis (LASIK). The 
procedure creates a circular penetrating epithelial wound in the mid peripheral cornea that 
then extends parallel to the epithelium through the anterior third of the corneal stroma; a 
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wound that results in the incomplete healing and closure of the stromal wound. This has 
been observed on numerous occasions post-operatively in vivo, for example, a case 
described by Crawford et al. (2003) where artifactitious separation of the flap and the 
underlying stroma was noted in a cornea 13 months after LASIK treatment and another 
case 20 months after uncomplicated LASIK where a similar separation was noted by 
Anderson et al., 2002.  
 
Peripheral flap melt and epithelial ingrowth are just some of the flap related complications 
associated with LASIK created by a microkeratome, including flap dislocation (Ivarson et 
al., 2003). This is of particular interest when discussing the potential reduction in 
biomechanical strength of the stromal wound after LASIK surgery. Whilst dislocation is 
rare, it has been reported up to 38 months post-operatively after impacts from airbags, dog 
paws, basketballs, snowballs, and fingers (Lemley et al., 2000; Melki et al., 2000; Patel et 
al., 2001; Iskander et al., 2001). Increasingly, femtosecond laser is becoming the 
preferential method of flap creation, due to its precision and superior post-operative 
outcomes, including greater biomechanical stability (although still inferior to that of the 
native unwounded cornea) and fewer post-operative complications (Kezirian & 
Stonecipher, 2004; Stonecipher et al., 2006; Alio et al., 2005). Therefore, although there 
may be a case to be made that investigating the wound healing of LASIK-like flaps created 
by a microkeratome is no longer relevant, the microkeratome is still used in practice.  
 
Additionally, the microkeratome-created LASIK flap has been posited as an interesting 
repeatable wound model of corneal wound healing. Keratocyte apoptosis occurs along the 
flap interface (Wilson et al., 2000) thus potentially stimulating a healing response. It could 
be used to provide further insight into the wound healing response in LASIK as a model to 
study the basic regulation of corneal epithelial and stromal wound repair (Ivarson et al., 
2003; Zieske, 2001). The improvement of corneal wound healing after trauma or surgery 
is a research goal and has had many permutations over the years. A selection of the wide 
range of corneal therapies and treatments, not discussed in this thesis can be seen in Table 
7.1. 
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The overall aim of this study was to determine the effect of OMLP-PCs as a cell based 
therapy on corneal wounds in an organ culture model. 
 
To achieve this aim, first an organ culture model of corneal wound healing was developed 
to attempt to evaluate and improve the physical outcomes of corneal wound healing of a 
LASIK-like flap. A porcine organ culture model that could be utilised to assess the wound 
healing of a LASIK-like corneal wounds was established (Chapter 3), and the application 
of a cell based therapy was optimised. Oral mucosal lamina propria progenitor cells 
(OMLP-PCs) were applied to the wound bed of the LASIK-like microkeratome inflicted 
wounds using an optimised 1.5x105 cells ml-1 concentration (Chapter 4) and placed in organ 
culture. These were cultured alongside similarly wounded and unwounded controls, in 
order to determine the comparative effect of OMLP-PCs on corneal wound healing, for  0, 
1, 2, 3 and 4 weeks. Once removed from culture the corneas were assessed to determine the 
Table 7.1 Corneal Therapies 
 
Pellegrini et al., 
1997; Nishida 
et al., 2004
Syed-Picard et 
al., 2015; Basu 
et al., 2014; 
Hertsenberg & 
Funderburgh, 
2016
Griffith et al., 
1999; Buznyk 
et al., 2015
Reference
Liu et al., 2005; 
Zerbe et al., 
2005; Tan et 
al., 2012
Embryonic stem cell derived keratocytes
Cell 
Therapy
Human Stromal Equivalent constructed from cell Lines
Bioengineered corneas 
Bio-
engineering
Limbal Epithelial Cell Transplantation
Corneal reconstruction with autologous oral mucosal 
Epithelium
Graft
Dental Pulp Stem Cells
Human Limbal Biopsy Derived Stromal Cells
Boston Keratoprosthesis
Implant
Procedure/Therapy 
Osteo-Odonto-Keratoprosthesis (OOKP)
Penetrating Keratoplasty
Lamellar/Deep Anterior Lamellae/endolthelial Keratoplasty
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efficacy of the OMLP-PCs on the cellular processes involved in wound healing (Chapter 
5) and the extent of wound resolution by examining the stromal matrix organisation 
(Chapter 6). 
 
The use of porcine organ culture over other animals used in previous research (such as 
ovine used by Dooley, 2012, and bovine by Kamma-Lorger, 2007) was chosen due to the 
inappropriate size of bovine eyes. Previous studies involving LASIK-like wounds in bovine 
corneas had to use custom-made devices to create the incisions (Kamma-Lorger et al., 
2009) and so wounding was not created by a microkeratome. There was also a high 
incidence of corneal injury in incoming ovine eyes (Chapter 4). 
  
The pig has been shown to be an excellent animal for comparative studies with humans due 
to their similar anatomy and physiology (Wang et al., 2000). The success of this porcine 
model can be ascertained in terms of the wound healing response in the LASIK-like 
wounded (untreated) corneas. The keratocyte apoptosis and proliferation that occur 
concurrently in corneal wound healing following the initiation of cytokine-mediated 
stromal wound healing (Masur et al 1996; Wilson et al., 2012; Gao et al., 1997; Ljubimov 
& Saghizedah, 2015; Mohan et al., 1997) were evident in this organ culture. Apoptotic cells 
in the stroma were seen at 0 time point and increased significantly at 1 week to over 20%. 
Concurrently the percentage of proliferating cells in wounded (treated) corneas followed a 
similar trend reaching a peak of 45% at 1 week (see table 7.2). This has been seen in other 
previous research, namely a similar in vivo study using rabbits by Mohan et al. (2003), 
although they found this happened in a much shorter time frame, as rabbits are known to 
have aggressive wound healing responses and are temporally distinct from other species in 
this respect (Cintron & Kubin, 1977; Thomasey et al., 2012 & 2014). The myofibroblastic 
transformation seen in the wounded control corneas (determined by the presence of α-sma) 
mirrored that seen in previous successful corneal organ culture studies (Dooley, 2012; 
Morgan, 2015) and represented the keratocyte activation and eventual transformation into 
myofibroblasts.  
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It was found in work outlined in chapter 3, that in order to obtain a consistent biomechanical 
evaluation of the flap adhesion using extensometry, a customized device would have had 
to be made from scratch. Therefore, it was decided not to pursue this line of investigation 
for this thesis. The analysis of transparency using spectrophotometry was also abandoned 
due to the irreparable damage caused to the corneas. Hence, in order to maintain the same 
corneas throughout the investigation all subsequent chapters used a Visual grading system 
to assess corneal transparency. The concentration of the solution of OMLP-PCs to be 
applied to the wound bed was determined after a 4 week organ culture using 3 separate 
OMLP-PC solution concentrations on LASIK- like wounded corneas, compared to control 
wounded (untreated) corneas. Once removed from culture the α-sma immunopositivity and 
transparency of the cells was assessed and the concentration resulting in a significantly 
more transparent cornea, when compared to the wounded controls (p<0.01), was selected; 
1.5x105 OMLP-PC ml-1.  
 
Having established a porcine organ culture model, the next step was to determine if OMLP-
PCs could augment the healing process following a LASIK-like wound. The effect of the 
application of OMLP-PCs on the LASIK-like wounded porcine corneas in this study 
reduced the percentage expression of α-sma by ~20%, when compared to the similarly 
wounded untreated control corneas (table 7.2). This was favourably comparable to the 
outcomes of previous studies by Dooley (2012) and Morgan (2014) whose results showed 
that the percentage activation for the keratocytes was significantly reduced by 
approximately 20-30% for the corneas treated with oral mucosa cells (Dooley, 2012), and 
by approximately 20% for wounded corneas, treated corneal stromal stem cells (CSSCs) 
(Morgan, 2014) compared to the control corneas at weeks 1, 2 and 3 in organ culture.  
 
Interestingly the site of the expression of α-sma in LASIK-like wounded corneas appears 
to differ between studies. In the results of this thesis α-sma positive cells were found along 
the flap bed at all time points, however Kamma-Lorger (2007) found α-sma positive cells 
only adjacent to the epithelial incisional wound in bovine eyes at all time points, in line 
with studies by Ivarsen et al. (2004) and Wilson et al. (2002). Dooley (2012) and Morgan 
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(2014), found α-sma positive cells at the flap bed, which is supported by the literature which 
states that LASIK-like wounds are known to induce apoptosis at the flap interface and so 
would likely induce wound healing (Zieske, 2001; Wilson et al., 2000). Likewise, Mohan 
et al. (2003) found α-sma positive cells along the wound bed in an in vivo study on rabbit 
eyes, but only at a later point in wound healing (4 weeks). It has been suggested that the 
onset of myofibroblastic transformation depends on the injury inflicted, the conditions of 
the injury and the species used (Kamma-Lorger et al., 2009). It may also be true that the 
site of myofibroblastic transformation in LASIK-like wounds could possibly be species 
dependent.  
 
The visually graded transparency of the OMLP-PC treated LASIK like wounded corneas 
was found to be significantly greater (p<0.01) by week 4 of the organ culture compared to 
untreated corneas (table 7.3). Although this is a similar overall outcome to previous work 
by Dooley (2012) and Morgan (2014), their results showed improved transparency at all 
time points across the wound healing in organ culture. This may be attributed to their 
attempts to return the corneas to homeostasis by de-swelling in dextran after removal from 
organ culture, a step not included in these studies due to the known adverse effects on cells 
(van der Want et al., 1983). This will be discussed later in this chapter.  
 
Collagen lamellae coherence (a measure of the number aligned in a similar direction) in 
OMLP-PC treated wounded corneas was found to be significantly higher than that of 
untreated corneas but not significantly different to unwounded corneas (table 7.3). 
Additionally, in H&E histological sections the stromal wound of OMLP-PC treated corneas 
bore a closer resemblance to unwounded corneas at week 4; the wound gap appeared to 
have closed compared to the gap still seen in untreated corneas (table 7.3). The gaping of 
LASIK treated central corneal wounds has been noted years after surgery in various in vivo 
studies (Anderson et al., 2002; Crawford et al., 2003). The initial disorganisation of the 
corneal collagen in the first weeks after wounding likely occurs due to the laying down of 
disorganised ECM, including large proteoglycans that alter the spacing of stromal collagen, 
as well as stromal swelling during organ culture (see more details of this later in this 
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discussion). The disorganised collagen is then slowly reorganised during wound healing. 
The corneas treated with OMLP-PCs appear to have been remodelled closer to the native 
stromal state. Consistent with this, previous studies by Morgan (2014). Dooley et al. (2012) 
and Meek & Leonard (1997) when examining the collagen fibril spacing and diameter using 
SAXS (small angle X-ray scattering) analysis on LASIK-like wounded ovine eyes and 
wounded rabbit eyes in vivo (respectively), found that wounded corneas demonstrated 
increased Bragg spacing (i.e. interfibrillar spacing) compared to unwounded corneas. 
Whilst both wounded corneas in Dooley et al. (2012) study demonstrated increased Bragg 
spacing, those treated with oral mucosa fibroblasts showed spacing near to homeostasis. 
These findings are consistent with the improved corneal organisation found in this thesis 
after treatment of LASIK-like wounds with OMLP-PCs. 
 
The cells used in this study were neural crest derived, multipotent progenitor cells recently 
found in the lamina propria of the oral mucosa; OMLP-PCs (Davies et al., 2010). Cells 
from the oral mucosa have been studied at length over the years due its foetal-like 
privileged wound repair (Stephens et al., 1996; Sloan, 1991). Their desirability as a 
potential cell-based therapy is heightened by their potent immunosuppressive and 
antimicrobial properties and ease of access. The foetal-like wound healing characteristics 
of oral mucosal cells have been demonstrated during this study in the LASIK-like wounded 
corneas treated with an application of OMLP-PCs. 
 
After the application of OMLP-PCs under the epithelial-stromal flap of LASIK-like 
wounded corneas the keratocyte activation and consequential transformation into the 
myofibroblast phenotype was significantly reduced during organ culture, when compared 
to the wounded control corneas. This mirrors the decreased expression of α-sma in oral 
mucosal tissue, described by Shannon et al., (2006). The proliferation of the stromal cells 
in the wounded corneas, detected by immunolabelling of proliferating cell nuclear antigen 
(PCNA), was seen to peak at an earlier time point of 1 week in the OMLP-PC treated 
corneas compared to the wounded untreated corneas peak of proliferation a week later at a 
lower percentage. This demonstrated an increased earlier proliferation of cells in the 
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OMLP-PC treated corneas, which aligns with the faster proliferation seen in oral mucosal 
tissue when compared to dermal fibroblasts (Glim et al., 2014; Lee & Eun, 1999).  
 
The analysis of the coherence of collagen lamellae in (i.e. degree of alignment) LASIK-
like wounded and unwounded corneas throughout the 4 week organ culture demonstrated 
that by 4 weeks in culture the coherence of orientation in the OMLP-PC treated corneas 
had increased from initial wounding, and was significantly higher than untreated wounded 
corneas. There was also no significant difference in coherence compared to the unwounded 
corneas. The distribution of preferred orientation angles of the same samples, indicated that 
the collagen lamellae orientation, aligned in the horizontal axis at 0 time point in all 
samples, showed a reduction in alignment over the organ culture period. At week 4, the 
OMLP-PC treated corneas showed a more defined alignment of collagen lamellae when 
compared to the untreated wounded corneas indicating an advanced stage of stromal wound 
remodelling when compared to the untreated wounded corneas. Assessment of the 
morphology of the corneas, using H&E staining, reinforced this return towards native 
structure is a result of potentially improved stromal remodelling. The OMLP-PC treated 
LASIK-like wounded corneas demonstrated a close resemblance to the unwounded corneal 
stroma, with a closed epithelial-stromal interface at 4 weeks compared to the visible gaping 
still present at the wound site in the untreated wounded corneas. This is much like the 
significant increase in ability of oral mucosa cells such as fibroblasts to reorganise ECM 
shown in the oral mucosa (Stephens et al., 1995). 
 
These foetal-like wound healing traits, observed in recent studies on the oral mucosa, 
appear to have been expressed in the wound healing of the LASIK-like wounded corneas 
treated with an application of OMLP-PCs. The reduced amount of myofibroblastic 
transformation reduces their negative impact on corneal crystallin concentration, whilst 
also reducing the laying down of excess disorganised repair ECM and the exertion of 
contractile forces which can further disrupt the corneal collagen organisation during wound 
healing. Combined with the improved remodelling of the stroma, these findings correlated 
with an increased transparency of the LASIK-like wounded corneas treated with OMLP-
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PCs, which, by week 4 in organ culture, had a significantly higher transparency than 
untreated wounded corneas when compared to untreated wounded corneas, and no 
significant difference when compared to unwounded corneas at the same time point. 
 
The results of these studies have been summarised in Table 7.2 and 7.3.      
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Table 7.2 Summary of Cellular Processes Pertinent to Wound Healing 
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There were several limitations in this study which need to be addressed. The swelling of 
the porcine corneas in organ culture was noted throughout the experiments. Corneal 
hydration homeostasis is a result of a balancing act between the natural tendency of the 
cornea to take up fluids, due to the highly hydrophilic nature of proteoglycans 
glycosaminoglycan (GAG) side chains, and the dehydrating mechanism of the stroma in 
Table 7.3 Summary of Pertinent Physical and Morphological Outcomes 
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the form of the endothelial pump (Hodson, 1997). During wound healing in organ culture 
the cornea swells, possibly due to a disruption in the endothelial barrier function (Kamma-
Lorger et al., 2007). The wound healing process itself is thought to increase the uptake of 
water as the energy requirements of the tissue itself increase (Kamma-Lorger et al., 2009) 
The production of abnormally large proteoglycans by myofibroblasts during ECM 
deposition (Funderburgh et al., 1998; Saika et al., 1998; Ishizaki et al., 1994) and higher 
cell number as a result of proliferation can contribute to corneal swelling (Mohan et al., 
2003; Wilson & Kim, 1998).  
 
Previous studies by Dooley et al., (2012) and Morgan et al., (2014) attempted to return the 
cornea to homeostasis after organ culture incubating corneas in 8% dextran at 37˚C, for 
3hrs and overnight respectively. This was successful in terms of reduction of swelling and 
potentially improved the results of corneal transparency. However, this was not carried out 
in this study as the 3hr or overnight immersion in dextran may have had negative impacts 
on the cellular processes and the LASIK-like flap morphology, thereby not generated 
results true to the time point. However, the consequent swelling of the cornea would have 
falsely altered the stromal cell number (as the number of cells in the same 100µm2 area of 
the stroma would have decreased as stromal swelling increased during the organ culture 
period) and so the actual stromal cell number may in fact be higher than that recorded. The 
collagen orientation may also have been affected by corneal swelling as the increase in  
interfibrillar spacing may have contributed to stromal disorganisation, which would have 
negatively impacted on the transparency of the corneas. The results were compared to the 
unwounded corneas, which were subjected to identical organ culture conditions and so 
would serve as a baseline comparison. The issue of excess corneal hydration will be 
addressed in future work section.  
 
Several lines of investigation for this study were discontinued relatively early on. The use 
of transmission electron microscopy (TEM) was not possible as the LASIK-like wound to 
be imaged was, by its nature, easily detached. Therefore, in order to preserve the 
morphology of the wound during processing, the size of each sample needed to be 
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unusually large for TEM. This larger size resulted in poorer quality embedding due to the 
inability of solutions to penetrate into the tissue, and the resultant inability to locate any 
wound landmarks.   
 
In extensometry tests of the samples, the results were not consistent to deliver reliable 
results. Unfortunately, epithelial-stromal flap adherence to the stromal bed could not be 
determined. Data profiles were inconsistent and showed that the time of detachment and 
force required could not be reliably ascertained from the graph alone; visual confirmation 
was required. The inconsistency of these profiles suggested that other factors such as the 
intraocular pressure (IOP) of the corneal sample would need much tighter regulation. The 
testing also completely destroyed the corneal sample and rendered any further processing 
impossible. It was decided that a custom-built shear rig or rheometer would be a more 
appropriate method, so this line of investigation was discontinued for this current study.  
 
It was anticipated that spectrophotometry of the corneal samples would provide numerical 
data relating to their transparency as a function of wavelength before and after organ 
culture. However, it destroyed the sample rendering any further processing impossible. 
Previous studies (Kamma-lorger et al., 2009) had used visual transparency grading and it 
was decided to employ this method instead as analysis of cell processes could be undertaken 
on the same corneas. This method however, did have its limitations. The visual grading (as 
described in section 2.11.2) provides a gross result in terms of perceived transparency. This 
could be improved by the use of diffuse sheet lighting when imaging to eliminate corneal 
reflections. Additionally, a more robust unbiased method of analysis of transparency by 
software such as ImageJ (National Institutes of Health, USA) would be an improvement. 
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Conclusions 
To conclude, an OMLP-PC therapeutic application to LASIK-like wounds enhanced 
stromal cell proliferation and reduced myofibroblast expression, but increased collagen 
organisation with consequent improved epithelial-stromal flap wound closure and 
increased corneal transparency
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7.2. Future Work 
1. Follow the OMLP-PC’s during wound healing in organ culture using fluorescent 
labelling/tagging to determine whether they remain in the wound integrate into the 
matrix, and then differentiate into fibroblasts or augment the wound healing process by 
the excretion of various factors into the ECM needs to be determined. If the latter, the 
known combination of optimal mediators could be determined, so that a cell–free 
therapy could be applied to the wound. 
 
2. TUNEL analysis to confirm the caspase-3 active immunolabelling detection of 
apoptosis during wound healing.  
 
3. Testing of the biomechanical strength of the wounded corneas at set time points during 
organ culture to determine the biomechanical strength of the wound healing cornea. A 
custom made rig would be necessary to ensure uniform force and detachment in a 
shearing action was possible.  
 
4. Establish a protocol to control corneal swelling during organ culture either by additions 
made to the media during incubation or by a process on removal from organ culture.  
 
5. Examine in more detail the first week of wound healing with time points set at 4hrs, 
8hrs, 12hrs, 24hrs, 48hrs and 72 hrs (etc.) to observe the changes in wound healing that 
occur during the first few hours. 
 
6. Apply the OMLP-PCs to different wound models e.g. PRK or trephine to determine 
their efficacy within different wound types, as this could be a therapy for other ocular 
wound types. 
 
7. Placing human cells in porcine organs appears to elucidate positive results, however 
species matching future in vitro and, possibly in vivo, studies could potentially improve 
results.  
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8. 3D analysis of fibril orientation to gain further insight into the changes that occur in the 
3 dimensional plane in organ culture and during wound healing to better characterise 
stromal matrix changes 
 
9. Examination of collagen ultrastructural parameters using SAXS to determine collagen 
fibril diameters and interfibrillar spacing and using WAXS to determine collagen 
intermolecular spacing and orientation. 
 
10. Create 3D models of human wound healing which could be used to test drug/therapies 
before application in culture. 
 
 
 
. 
 
 
 
 
  
181 
 
References 
Alió, J. L., Claramonte, P. J., Cáliz, A. and Ramzy, M. I. (2005) Corneal modeling of 
keratoconus by conductive keratoplasty. J Cataract Refract Surg. 31: 190–197. 
 
Al-Taan, S.L.M., 2018. Characterisations of Pre-Descemet’s (Dua’s) layer for its clinical 
application in keratoplasty (Doctoral dissertation, University of Nottingham).  
 
Ambrósio, R. Jr and Wilson, S. (2003) LASIK vs LASEK vs PRK: advantages and 
indications. Semin Ophthalmol. 18: 2-10. 
 
Anderson, N.J., Edelhauser, H.F., Sharara, N., Thompson, K.P., Rubinfeld, R.S., Devaney, 
D.M., L'hernault, N. and Grossniklaus, H.E., (2002). Histologic and ultrastructural findings 
in human corneas after successful laser in situ keratomileusis. Arch Ophthalmol, 120(3), 
pp.288-293. 
 
Andresen, J.L., Ledet, T., Hager, H., Josephsen, K. and Ehlers, N., (2000). The influence 
of corneal stromal matrix proteins on the migration of human corneal fibroblasts. Exp Eye 
Res., 71(1), pp.33-43. 
 
Azar, D. T. and Farah, S. G. (1998) Laser in situ keratomileusis versus photorefractive 
keratectomy: an update on indications and safety. Ophthalmology. 105: 1357-1358. 
 
Bansal, A. K. and Veenashree, M. P. (2001) Laser refractive surgery: technological 
advance and tissue response. Biosci Rep. 21: 491-512. 
 
Basu, S., Hertsenberg, A.J., Funderburgh, M.L., Burrow, M.K., Mann, M.M., Du, Y., 
Lathrop, K.L., Syed-Picard, F.N., Adams, S.M., Birk, D.E. and Funderburgh, J.L., (2014). 
Human limbal biopsy–derived stromal stem cells prevent corneal scarring. Sci Transl Med, 
6(266), pp.266ra172-266ra172. 
 
 
  
182 
 
Board-Davies E, Moses R, Sloan A, Stephens, P. and Davies L C. (2015), Oral Mucosal 
Lamina Propria‐Progenitor Cells Exert Antibacterial Properties via the Secretion of 
Osteoprotegerin and Haptoglobin. Stem Cell Transl Med, 4: 1283-1293.  
 
Bodner L, Dayan D, Oberman M, Hirshberg A, Tal H (1992). Healing of experimental 
wounds in sialadenectomized rat. J Clin Periodontol 19:345-347.  
 
Borcherding, M. S., Blacik, L. J., Sittig, R. A., Bizzell, J. W., Breen, M. and Weinstein, 
H. G. (1975) Proteoglycans and collagen fibre organization in human corneoscleral 
tissue. Exp Eye Res. 21: 59-70. 
 
Brown E, McKee T, DiTomaso E, Pluen A, Seed B, Boucher Y, Jain R K. (2003) Dynamic 
imaging of collagen and its modulation in tumors in vivo using second harmonic 
generation. Nat. Med. 9, 796–800  
 
Buznyk, O., Pasyechnikova, N., Islam, M.M., Iakymenko, S., Fagerholm, P. and Griffith, 
M., (2015). Bioengineered corneas grafted as alternatives to human donor corneas in three 
high‐risk patients. Clin Transl Sci, 8(5), pp.558-562. 
 
Campagnola P J, Loew L M (2003) Second-harmonic imaging microscopy for visualizing 
biomolecular arrays in cells, tissues and organisms Nat Biotechnol, 21: 1356–1360 
 
Carrington, L. M., Albon, J., Anderson, I., Kamma, C. and Boulton, M. (2006) Differential 
regulation of key stages in early corneal wound healing by TGF-beta isoforms and their 
inhibitors. Invest Ophthalmol Vis Sci. 47: 1886-1894. 
 
Carrington, L. M. and Boulton, M. (2005) Hepatocyte growth factor and keratinocyte 
growth factor regulation of epithelial and stromal corneal wound healing. J Cataract 
Refract Surg. 31: 412-423. 
 
Chakravarti, S., Magnuson, T., Lass, J. H., Jepsen, K. J., LaMantia, C. and Carroll, H. 
(1998) Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the 
absence of lumican. J Cell Biol. 141: 1277-1286. 
 
  
183 
 
Chaurasia, S.S., Kaur, H., de Medeiros, F.W., Smith, S.D. and Wilson, S.E., 2009. 
Dynamics of the expression of intermediate filaments vimentin and desmin during 
myofibroblast differentiation after corneal injury. Exp Eye Res, 89(2), pp.133-139. 
 
EChen, J., Ahmad, R., Li, W., Swain, M., & Li, Q. (2015). Biomechanics of oral mucosa. 
J R Soc Interface, 12(109), 20150325. 
 
Chuck, R.S., Quiros, P.A., Perez, A.C. and McDonnell, P.J., 2000. Corneal sensation after 
laser in situ keratomileusis1. J  Cataract Refract Surg, 26(3), pp.337-339. 
 
Cintron, C., Covington, H. I. and Kublin, C. L. (1990) Morphologic analyses of 
proteoglycans in rabbit corneal scars. Invest Ophthalmol Vis Sci. 31: 1789-1798. 
 
Cintron, C. and Kublin, C.L., 1977. Regeneration of corneal tissue. Dev Biol, 61(2), pp.346-
357. 
 
Cintron, C., Hong, B.S. and Kublin, C.L., 1981. Quantitative analysis of collagen from 
normal developing corneas and corneal scars. Curr Eye Res, 1(1), pp.1-8. 
 
Clark, R. A. (1993) Biology of dermal wound repair. Dermatol Clin. 11: 647-666. 
 
Cogan, D. G. and Kinsey, V. E. (1942) Physiologic studies on the cornea. Science. 95: 607-
608. 
 
Connon, C. J. and Meek, K. M. (2003) Organization of corneal collagen fibrils during the 
healing of trephined wounds in rabbits. Wound Repair Regen. 11: 71–78. 
 
Cox, G., Kable, E., Jones, A., Fraser, I., Manconi, F. and Gorrell, M.D., 2003. 3-
dimensional imaging of collagen using second harmonic generation. J Struct Biol, 141(1), 
pp.53-62. 
 
Cox, J. L., Farrell, R. A., Hart, R. W. and Langham, M. E. (1970) The transparency of the 
mammalian cornea. J Physiol. 210: 601-616 
 
  
184 
 
Crawford, J.B., Aldave, A.J., McLeod, S., Howes, E. and Schwartz, D., 2003. 
Histopathological analysis of the cornea after laser in situ keratomileusis. Arch Ophthalmol, 
121(6), pp.896-898. 
 
Christens-Barry, W.A., Green, W.J., Connolly, P.J., Farrell, R.A. and Mccally, R.L., 1996. 
Spatial mapping of polarized light transmission in the central rabbit cornea. Exp Eye Res 
62(6), pp.651-662. 
 
Darby I, Skalli O, Gabbiani G. (1990) Alpha‐smooth muscle actin is transiently expressed 
by myofibroblasts during experimental wound healing. Lab Invest; 63: 21–9 
 
Darzynkiewicz, Z., Galkowski, D. and Zhao, H. (2008) Analysis of apoptosis by 
cytometry using TUNEL assay. Methods. 44: 250-254. 
 
Davies L C, Locke M, Webb R D J, Roberts J T, Langley M, Thomas D W. Archer C W, 
and Stephens P (2010) A Multipotent Neural Crest-Derived Progenitor Cell Population Is 
Resident Within the Oral Mucosa Lamina Propria Stem Cell Dev 19:6, 819-830 
 
Davies L C, Lönnies H, Locke M, Sundberg B, Rosendahl K, Götherström C, Le Blanc K, 
and Stephens P (2012).Oral Mucosal Progenitor Cells Are Potently Immunosuppressive in 
a Dose-Independent Manner. Stem Cell Dev, 21:9: 1478-148 
 
Davison P F, Galbavy E J; (1986) Connective tissue remodeling in corneal and scleral 
wounds. Invest. Ophthalmol. Vis. Sci.;27(10):1478-1484. 
 
Dawson, D. G., Randleman, J. B., Grossniklaus, H. E., O’Brien, T. P., Dubovy S. R., 
Schmack, I., Stulting, R. D. and Edelhauser, H. F. (2008) Corneal ectasia after excimer 
laser keratorefractive surgery: histopathology, ultrastructure and pathophysiology. 
Ophthalmology. 115: 2181–2191. 
 
Daxer, A., Misof, K., Grabner, B., Ettl, A. and Fratzl, P. (1998) Collagen fibrils in the 
human corneal stroma: structure and aging. Invest Ophthalmol Vis Sci. 39: 644-648. 
 
 
  
185 
 
Daxer, A. and Fratzl, P. (1997) Collagen fibril orientation in the human corneal stroma and 
its implications in keratoconus. Invest Ophthalmol Vis Sci. 38: 121–129. 
 
Deering, M.F., 2005, July. A photon accurate model of the human eye. In ACM T Graphic 
(Vol. 24, No. 3, pp. 649-658). ACM. 
 
DelMonte, D.W. and Kim, T., (2011). Anatomy and physiology of the cornea. J Cataract 
Refract Surg, 37(3), pp.588-598. 
 
Doutch, J., Quantock, A. J., Smith, V. A. and Meek, K. M. (2008) Light transmission in 
the human cornea as a function of position across the ocular surface: theoretical and 
experimental aspects. Biophys J. 95: 5092-5099. 
 
Du, Y., Funderburgh, M. L., Mann, M. M., SundarRaj, N. and Funderburgh, J. L. (2005) 
Multipotent stem cells in human corneal stroma. Stem Cells. 23: 1266-1275. 
 
Dua, H. S., Faraj, L. A., Said, D. G., Gray, T. and Lowe, J. (2013) Human corneal anatomy 
redefined: a novel pre-Descemet's layer (Dua's layer). Ophthalmology. 120:1778-1785. 
 
Dua, H.S., Gomes, J.A. and Singh, A., (1994). Corneal epithelial wound healing. The Brit 
J Ophthalmol, 78(5), p.401. 
 
Dua, H.S., Miri, A., Alomar, T., Yeung, A.M. and Said, D.G., 2009. The role of limbal 
stem cells in corneal epithelial maintenance: testing the dogma. Ophthalmology, 116(5), 
pp.856-863. 
 
Elsheikh, A., Alhasso, D. and Rama P. (2008) Biomechanical properties of human and 
porcine corneas. Exp Eye Res. 86: 783-790. 
 
Enoch, S., Moseley, R., Stephens, P. and Thomas, D.W., (2008). The oral mucosa: a model 
of wound healing with reduced scarring. Oral Surg, 1(1), pp.11-21. 
 
  
186 
 
Enoch, S., Wall, I., Peake, M., Davies, L., Farrier, J., Giles, P., Baird, D., Kipling, D., Price, 
P., Moseley, R. and Thomas, D., (2009). Increased oral fibroblast lifespan is telomerase-
independent. J Dent Res, 88(10), pp.916-921. 
 
Eraslan, M. and Toker, E., 2009. Mechanisms of corneal wound healing and its modulation 
following refractive surgery. Marmara Med J, 22(2); pp.169-178 
 
Faber, C., Scherfig, E., Prause, J. U. and Sørensen, K. E. (2008) Corneal thickness in pigs 
measured by ultrasound pachymetry in vivo. Scand. J Lab Anim Sci. 35: 39-43. 
 
Fagerholm, P., Hamberg-Nyström, H. and Tengroth, B. (1994) Wound healing and myopic 
regression following photorefractive keratectomy. Acta Ophthalmol. 72: 229-234. 
 
Falabella, A. and Kirsner, R. (2005). Wound healing, Basic and Clinical Dermatology. 
Boca Raton: Talyor & Francis. 
 
Farrell, R. A. and McCally, R. L. (2000) Corneal transparency. In: Albert, D. M. and 
Jakobiec, F. A. [ed.] Principles and Practice of Ophthalmology. Philadelphia: WB 
Saunders: PA, pp. 629–643. 
 
Fini, M. E. (1999) Keratocyte and Fibroblast Phenotypes in the Repairing Cornea. Prog 
Retin Eye Res. 18: 529-551. 
 
Fini, M. E., Yue, B. Y. and Sugar, J. (1992) Collagenolytic/gelatinolytic metalloproteinases 
in normal and keratoconus corneas. Curr Eye Res. 11: 849-862. 
 
Fleisch, L. and Austin, J.C., (1978). A histologic study of the response of masticatory and 
lining mucosa to mechanical loading in the vervet monkey. J Prosthet Dent, 39(2), pp.211-
216. 
 
Foreman, D. M., Pancholi, S., Jarvis-Evans, J., McLeod, D. and Boulton, M. E. (1996) A 
simple organ culture model for assessing the effects of growth factors on corneal 
reepithelialization. Exp Eye Res. 62: 555-564. 
 
  
187 
 
Forrester, J.V., Dick, A.D., McMenamin, P. and Lee, W., 1996. The eye. Basic Sciences in 
Practice. 
 
Franěk F, Šorm F (1970) The character of homology between the N-terminal variable 
amino acid sequence of porcine and human immunoglobulin λ chains, Biochim Biophys 
Acta - Protein Structure, 221(3):593-603 
 
Freund, D. E., McCally, R. L. and Farrell, R. A. (1986) Effects of fibril orientations on light 
scattering in the cornea. J Opt Soc Am A. 3: 1970-1982. 
 
Freund, D. E., McCally, R. L. and Farrell, R. A. (1991) Light scattering tests of structure 
in normal and swollen rabbit corneas. Johns Hopkins APL Tech Dig. 12: 137–143. 
 
Funderburgh, J. L., Corpuz, L. M., Roth, M. R., Funderburgh, M. L., Tasheva, E. S. and 
Conrad, G. W. (1997) Mimecan, the 25-kDa corneal keratan sulfate proteoglycan, is a 
product of the gene producing osteoglycin. J Biol Chem. 272: 28089-28095. 
 
Funderburgh, J. L., Mann, M. M. and Funderburgh, M. L. (2003) Keratocyte phenotype 
mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis. J Biol Chem. 278: 
45629–45637. 
 
Gabbiani, G. (2003), The myofibroblast in wound healing and fibrocontractive diseases. J. 
Pathol., 200: 500-503.  
 
Gandhi, N. S. and Mancera, R. L. (2008) The structure of glycosaminoglycans and their 
interactions with proteins. Chem Biol Drug Des. 72: 455-482. 
 
Gao, J., Gelber-Schwalb, T. A., Addeo, J. V. and Stern, M. E. (1997) Apoptosis in the 
rabbit cornea after photorefractive keratectomy. Cornea. 16: 200-208. 
 
Gardner, S.J., White, N., Albon, J., Knupp, C., Kamma-Lorger, C.S. and Meek, K.M., 
2015. Measuring the refractive index of bovine corneal stromal cells using quantitative 
phase imaging. Biophys J, 109(8), pp.1592-1599 
 
  
188 
 
Georgiou, E., Theodossiou, T., Hovhannisyan, V., Politopoulos, K., Rapti, G.S. and Yova, 
D., 2000. Second and third optical harmonic generation in type I collagen, by nanosecond 
laser irradiation, over a broad spectral region. Opt Commun, 176(1-3), pp.253-260. 
 
Gipson, I.K., 1993. Corneal wound healing and fibronectin. Int Ophthalmol Clin., 33, 
pp.149-163. 
 
Girgis, R., Morris, D. S., Kotagiri, A. and Ramaesh, K. (2007) Bilateral corneal scarring 
after LASIK and PRK in a patient with propensity to keloid scar formation. Eye. 21: 96-
97. 
 
Glim J E, Everts V, Niessen F B, Ulrich M M, Beelen R H.J (2014) Extracellular matrix 
components of oral mucosa differ from skin and resemble that of foetal skin, Arch Oral 
Biol  59(10):1048-1055 
 
Griffith, M., Osborne, R., Munger, R., Xiong, X., Doillon, C.J., Laycock, N.L., Hakim, M., 
Song, Y. and Watsky, M.A., (1999). Functional human corneal equivalents constructed 
from cell lines. Science, 286(5447), pp.2169-2172. 
 
Han M, Giese G, and Bille J (2005). Second harmonic generation imaging of collagen 
fibrils in cornea and sclera, Opt Express 13, 5791-5797 
 
Hahnel, C., Somodi, S., Weiss, D.G. and Guthoff, R.F., 2000. The keratocyte network of 
human cornea: a three-dimensional study using confocal laser scanning fluorescence 
microscopy. Cornea, 19(2), pp.185-193. 
 
Hart, R. W. and Farrell, R. A. (1969) Light scattering in the cornea. J Opt Soc Am. 59:766-
774. 
 
Hashemi, H., Fotouhi, A., Yekta, A., Pakzad, R., Ostadimoghaddam, H. and Khabazkhoob, 
M., 2018. Global and regional estimates of prevalence of refractive errors: systematic 
review and meta-analysis. J Curr Ophthalmol, 30(1), pp.3-22. 
 
  
189 
 
Hayashi, S., Osawa, T. and Tohyama, K., 2002. Comparative observations on corneas, with 
special reference to Bowman's layer and Descemet's membrane in mammals and 
amphibians. J Morphol, 254(3), pp.247-258. 
 
Hayes, S., Boote, C., Lewis, J., Sheppard, J., Abahussin, M., Quantock, A. J., Purslow, C., 
Vortruba, M. and Meek, K. M. (2007a) Comparative study of fibrillar collagen arrangement 
in the corneas of primates and other mammals. Anat Rec. 290: 1542-1550. 
 
Hayes, S., White, T., Boote, C., Kamma-Lorger, C.S., Bell, J., Sorenson, T., Terrill, N., 
Shebanova, O. and Meek, K.M., (2017). The structural response of the cornea to changes 
in stromal hydration. J R Soc Interface, 14(131). 
 
Heickell, A. G., Vesaluoma, M. H., Tervo, T. M., Vannas, A. and Krootila, K. (2004) Late 
traumatic dislocation of laser in situ keratomileusis flaps. J Cataract Refract Surg. 30: 253-
256. 
 
Helena, M. C., Baerveldt, F., Kim, W. J. and Wilson, S. E. (1998) Keratocyte apoptosis 
after corneal surgery. Invest Ophthalmol Vis Sci. 39: 276-283. 
 
Hertsenberg, A.J. and Funderburgh, J.L., (2015). Generation of corneal keratocytes from 
human embryonic stem cells. In Embryonic Stem Cell Protocols (pp. 285-294). Humana 
Press, New York, NY. 
 
Hirano, K., Kobayashi, M., Kobayashi, K., Hoshino, T. and Awaya, S. (1989) Experimental 
formation of 100 nm periodic fibrils in the mouse corneal stroma and trabecular meshwork. 
Invest Ophthalmol Vis Sci. 30: 869-874. 
 
Hogan, M., Alvarado, J. and Weddell, J. (1971). Histology of the human eye. Philadelphia: 
Saunders. 
 
Huang, Y. and Meek, K.M., 1999. Swelling studies on the cornea and sclera: the effects of 
pH and ionic strength. Biophys J, 77(3), pp.1655-1665. 
 
  
190 
 
Hull, D. S., Green, K. and Laughter, L. (1984) Cornea endothelial rose Bengal 
photosensitization. Effect on permeability, sodium flux, and ultrastructure. Invest 
Ophthalmol Vis Sci. 25: 455-460. 
 
Hutson JM, Niall M, Evans D, Fowler R (1979). Effect of salivary glands on wound 
contraction in mice. Nature 279:793-795. 
 
Ihanamäki, T., Pelliniemi, L.J. and Vuorio, E., 2004. Collagens and collagen-related matrix 
components in the human and mouse eye. Prog Retin Eye Res, 23(4), pp.403-434. 
 
Irwin, C.R., Picardo, M., Ellis, I., Sloan, P., Grey, A., McGurk, M. and Schor, S.L., 1994. 
Inter-and intra-site heterogeneity in the expression of fetal-like phenotypic characteristics 
by gingival fibroblasts: potential significance for wound healing. J Cell Sci, 107(5), 
pp.1333-1346. 
 
Iskander, N. G., Peters, N. T., Anderson Penno, E. and Gimbel, H. V. (2001) Late traumatic 
flap dislocation after laser in situ keratomileusis. J Cataract Refract Surg. 27:1111-1114. 
 
Ishizaki M, Wakamatsu K, Matsunami T, Yamanaka N, Saiga T, Shimizu Y, Zhu G, Kao 
W (1994) Dynamics of the Expression of Cytoskeleton Components and Adherens 
Molecules by Fibroblastic Cells in Alkali-burned and Lacerated Corneas, Exp Eye Res, 
59(5); 537-549 
 
Ivarsen, A., Laurberg, T. and Møller-Pedersen, T. (2003) Characterisation of corneal 
fibrotic wound repair at the LASIK flap margin. Brit  J Ophthalmol. 87: 1272-1278. 
 
Jain, S. and Azar, D.T., 1994. Extracellular matrix and growth factors in corneal wound 
healing. Curr Opin Ophthalmol, 5(4), pp.3-12. 
 
Jester, J.V., 2008, April. Corneal crystallins and the development of cellular transparency. 
In Semin Cell Dev Biol (Vol. 19, No. 2, pp. 82-93). Academic Press. 
 
  
191 
 
Jester, J. V., Brown, D., Pappa, A. and Vasiliou, V. (2012) Myofibroblast differentiation 
modulates keratocyte crystallin protein expression, concentration, and cellular light 
scattering. Invest Ophthalmol Vis Sci. 53: 770-778. 
 
Jester, J. V., Budge, A., Fisher, S. and Huang, J. (2005) Corneal keratocytes: phenotypic 
and species differences in abundant protein expression and in vitro light-scattering. Invest 
Ophthalmol Vis Sci. 46: 2369–2378. 
 
Jester, J.V. and Ho-Chang, J., 2003. Modulation of cultured corneal keratocyte phenotype 
by growth factors/cytokines control in vitro contractility and extracellular matrix 
contraction. Exp Eye Res, 77(5), pp.581-592. 
 
Jester, J. V., Moller-Pedersen, T., Huang, J., Sax, C. M., Kays, W. T., Cavangh, H. D., 
Petroll, W. M. and Piatigorsky, J. J. (1999b) The cellular basis of corneal transparency: 
evidence for 'corneal crystallins'. Cell Sci. 112: 613-622. 
 
Jester, J. V., Petroll, W. M., Barry, P. A. and Cavanagh, H. D. (1995) Expression of alpha-
smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest Ophthalmol 
Vis Sci. 36: 809-819. 
 
Jester, J. V., Petroll, W. M. and Cavanagh, H. D. (1999a) Corneal stromal wound healing 
in refractive surgery: the role of myofibroblasts. Prog Retin Eye Res. 18: 311–356. 
 
Jester, J. V., Rodrigues, M. M. and Herman, I. M. (1987) Characterization of avascular 
corneal wound healing fibroblasts. New insights into the myofibroblast. Am J Pathol. 127: 
140-148. 
 
Kamma-Lorger, C. S., Boote, C., Hayes, S., Albon, J., Boulton, M. E. and Meek, K. M. 
(2009) Collagen ultrastructural changes during stromal wound healing in organ cultured 
bovine corneas. Exp Eye Res. 88: 953-959. 
 
Kao, W.W.Y., Funderburgh, J.L., Xia, Y., Liu, C.Y. and Conrad, G.W., 2006. Focus on 
molecules: lumican. Exp Eye Res, 82(1), p.3. 
 
  
192 
 
Kaufman, P. and Alm, A. (2002). Adlers physiology of the eye. 10th ed. St. Louis, Mo.: 
Mosby. 
 
Kaur, H., Chaurasia, S.S., Agrawal, V. and Wilson, S.E., 2009. Expression of PDGF 
receptor-α in corneal myofibroblasts in situ. Exp Eye Res, 89(3), pp.432-434. 
 
Kezirian, G.M. and Stonecipher, K.G., 2004. Comparison of the IntraLase femtosecond 
laser and mechanical keratomes for laser in situ keratomileusis. J Cataract Refract Surg, 
30(4), pp.804-811. 
 
Knorz, M. L., Wiesinger, B., Liermann, A., Seiberth, V. and Liesenhoff, H. (1998) Laser 
in situ keratomileusis for moderate and high myopia and myopic astigmatism. 
Ophthalmology. 105: 932–940. 
 
Koch, M., Foley, J. E., Hahn, R., Zhou, P., Burgeson, R. E., Gerecke, D. R. and Gordon, 
M. K. (2001) Alpha 1(Xx) collagen, a new member of the collagen subfamily, fibril 
associated collagens with interrupted triple helices. J Biol Chem. 276: 23120-23126. 
 
Komai, Y. and Ushiki, T. (1991) The three-dimensional organisation of collagen fibrils in 
the human cornea and sclera. Invest Ophthalmol Vis Sci. 32: 2244–2258. 
 
Krachmer, J., Mannis, M. and Holland, E. (2011). Cornea. [St. Louis, Mo.]: 
Mosby/Elsevier.  
 
Landau, D., Levy, J., Solomon, A., Lifshitz, T., Orucov, F., Strassman, E. and Frucht- Pery, 
J. (2006) Traumatic corneal flap dislocation one to six years after LASIK in nine eyes with 
a favorable outcome. J Refract Surg. 22: 884-889. 
 
Lee, R. E., Davison, P. F. and Cintron, C. (1982) The healing of linear nonperforating 
wounds in rabbit corneas of different ages. Invest Ophthalmol Vis Sci. 23: 660-665. 
 
Lee H.G, Eun H.C. (1999) Differences between fibroblasts cultured from oral mucosa and 
normal skin: implication to wound healing J Dermatol Sci, 21, pp. 176-182 
 
  
193 
 
Lemley, H.L., Chodosh, J., Wolf, T.C., Bogie, C.P. and Hawkins, T.C., 2000. Partial 
dislocation of laser in situ keratomileusis flap by air bag injury. J Refract Surg, 16(3), 
pp.373-374. 
 
Leonard, D. W. and Meek, K. M. (1997) Refractive indices of the collagen fibrils and 
extrafibrillar material of the corneal stroma. Biophys J. 72: 1382-1387. 
 
Li, W., Vergnes, J. P., Cornuet, P. K. and Hassell, J. R. (1992) cDNA clone to chick corneal 
chondroitin/dermatan sulfate proteoglycan reveals identity to decorin. Arch Biochem 
Biophys. 296: 190-197. 
 
Littlechild, S. L., Brummer, G., Zhang, Y. and Conrad, G. W. (2012) Fibrinogen, 
riboflavin, and UVA to immobilize a corneal flap--conditions for tissue adhesion. Invest 
Ophthalmol Vis Sci. 53: 4011-4020. 
 
Liu C, Paul B, Tandon R, Lee E, Fong K, Mavrikakis I, Herold J, Thorp S, Brittain P, 
Francis I, Ferrett C, Hull C, Lloyd A, Green D, Franklin V, Tighe B, Fukuda M & Hamada 
S (2005) The Osteo-Odonto-Keratoprosthesis (OOKP), Semin Ophthalmol, 20:2, 113-128 
 
Ljubimov, A.V. and Saghizadeh, M., 2015. Progress in corneal wound healing. Prog Retin 
Eye Res, 49, pp.17-45. 
 
Locke M, Davies L C, Stephens P, (2016) Oral mucosal progenitor cell clones resist in vitro 
myogenic differentiation. Arch Oral Biol 7: 100-110 
 
Lu, L., Reinach, P. S. and Kao, W. W. (2001) Corneal epithelial wound healing. Exp Biol 
Med. 226: 653-664. 
 
Mak K., Manji A., Gallant-Behm C., Wiebe C., Hart D.A., Larjav. H, et al. (2009). Scarless 
healing of oral mucosa is characterized by faster resolution of inflammation and control of 
myofibroblast action compared to skin wounds in the red Duroc pig model J Dermatol Sci, 
56, pp. 168-180 
 
  
194 
 
Mantry, S. and Shah, S., 2004. Surgical management of presbyopia. Contact Lens Anterio, 
27(4), pp.171-175. 
 
Massof, R.W. and Chang, F.W., 1972. A revision of the rat schematic eye. Vision Res 12(5), 
pp.793-796. 
 
Masur, S. K., Dewal, H. S., Dinh, T. T., Erenburg, I. and Petridou, S. (1996) Myofibroblasts 
differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci. 93: 4219 
4223. 
 
Maurice, D. M. (1957) The structure and transparency of the corneal stroma. J Physiol. 
136: 263–286. 
 
Maurice, D. M. (1984) The cornea and sclera. In: Davson, H. [ed.] The Eye. Orlando: 
Academic Press, pp. 1-158. 
 
Meek, K. M. (2009) Corneal collagen - its role in maintaining corneal shape and 
transparency. Biophys Rev. 1: 83-93. 
 
Meek, K. M., Blamires, T., Elliott, G. F., Gyi, T. J. and Nave, C. (1987) The organisation 
of collagen fibrils in the human corneal stroma: a synchrotron X-ray diffraction study. Curr 
Eye Res. 6: 841-846. 
 
Meek, K. M. and Boote, C. (2004) The organization of collagen in the corneal stroma. Exp 
Eye Res. 78: 503-512. 
 
Meek, K. M. and Boote, C. (2009) The use of X-ray scattering techniques to quantify the 
orientation and distribution of collagen in the corneal stroma. Prog Retin Eye Res. 28: 369-
392. 
 
Meek, K. M., Chapman, J. A. and Hardcastle, R. A. (1979) The staining pattern of collagen 
fibrils. Improved correlation with sequence data. J Biol Chem. 254: 10710-10714. 
 
  
195 
 
Meek, K. M., Dennis, S. and Khan, S. (2003a) Changes in the refractive index of the stroma 
and its extrafibrillar matrix when the cornea swells. Biophys J. 85: 2205-2212. 
 
Meek, K. M., Elliott, G. F., Sayers, Z., Whitburn, S. B. and Koch, M. H. (1981) 
Interpretation of the meridional X-ray diffraction pattern from collagen fibrils in corneal 
stroma. J Mol Biol. 149: 477-488. 
 
Meek, K. M. and Leonard, D. W. (1993) Ultrastructure of the corneal stroma: a comparative 
study. Biophys J. 64: 273-280. 
 
Meek, K. M., Leonard, D. W., Connon, C. J., Dennis, S. and Khan, S. (2003b) 
Transparency, swelling and scarring in the corneal stroma. Eye. 17: 927-936. 
 
Melki, S. A., Talamo, J. H., Demetriades, A. M., Jabbur, N. S., Essepian, J. P., O'Brien, 
T. P. and Azar, D. T. (2000) Late traumatic dislocation of laser in situ keratomileusis 
corneal flaps. Ophthalmology. 107: 2136-2139. 
 
Meran, S., Thomas, D., Stephens, P., Martin, J., Bowen, T., Phillips, A. and Steadman, R., 
(2007). Involvement of hyaluronan in regulation of fibroblast phenotype. J Biol 
Chem, 282(35), pp.25687-25697. 
 
Mi, S., Dooley, E. P., Albon, J., Boulton, M. E., Meek, K. M. and Kamma-Lorger, C. S. 
(2011) Adhesion of laser in situ keratomileusis-like flaps in the cornea: Effects of 
crosslinking, stromal fibroblasts, and cytokine treatment. J Cataract Refract Surg. 37:166-
172. 
 
Mohan, R.R., Hutcheon, A.E., Choi, R., Hong, J., Lee, J., Mohan, R.R., Ambrósio Jr, R.,  
Oie, Y. and Nishida, K., 2016. Corneal regenerative medicine. Regen Ther, pp.40-45. 
 
Mohan R R, Hutcheon A E.K, Choi R, Hong J, Lee J, Mohan R R, Ambrósio R, Zieske J 
D, Wilson S E, (2003) Apoptosis, necrosis, proliferation, and myofibroblast generation in 
the stroma following LASIK and PRK, Exp Eye Res 76: 71-87 
 
  
196 
 
Mohan, R. R., Liang, Q., Kim, W. J., Helena, M. C., Baerveldt, F. and Wilson, S. E. (1997) 
Apoptosis in the cornea: further characterization of Fas/Fas ligand system. Exp Eye Res. 
65: 575-589. 
 
Mohan, R. R., Mohan, R. R. and Wilson, S. E. (2001) Discoidin domain receptor (DDR) 1 
and 2: collagen-activated tyrosine kinase receptors in the cornea. Exp Eye Res. 72: 87-92. 
 
Møller-Pedersen, T., 2004. Keratocyte reflectivity and corneal haze. Exp Eye Res, 78(3), 
pp.553-560. 
 
Møller-Pedersen, T., Cavanagh, H. D., Petroll, W. M. and Jester, J. V. (2000) Stromal 
wound healing explains refractive instability and haze development after photorefractive 
keratectomy: a 1-year confocal microscopic study. Ophthalmology. 107:1235-1245. 
 
Møller-Pedersen T, Voge M, Li H F, Petroll W M, Cavanagh H D, Jester, J V. (1997) 
Quantification of Stromal Thinning, Epithelial Thickness, and Corneal Haze after 
Photorefractive Keratectomy Using In Vivo Confocal Microscopy Ophthalmology 
104(3);360-368 
 
Montés-Micó, R., Rodríguez-Galietero, A. and Alió, J.L., 2007. Femtosecond laser versus 
mechanical keratome LASIK for myopia. Ophthalmology, 114(1), pp.62-68. 
 
Moshirfar, M., Churgin, D.S. and Hsu, M., (2011). Femtosecond laser-assisted cataract 
surgery: a current review. Middle East Afr J Ophthalmol, 18(4), p.285. 
 
Moshirfar, M., Gardiner, J.P., Schliesser, J.A., Espandar, L., Feiz, V., Mifflin, M.D. and 
Chang, J.C., 2010. Laser in situ keratomileusis flap complications using mechanical 
microkeratome versus femtosecond laser: retrospective comparison. J Cataract  Refract 
Surg, 36(11), pp.1925-1933.  
 
Morgan, I.G., Ohno-Matsui, K. and Saw, S.M., 2012. Myopia. The Lancet, 379(9827), 
pp.1739-1748. 
 
  
197 
 
Morgan, S. R., Dooley, E. P., Hocking, P. M., Inglehearn, C. F., Ali, M., Sorensen, T.L., 
Meek, K. M., Boote, C. (2013) An x-ray scattering study into the structural basis of corneal 
refractive function in an avian model. Biophys J. 104: 2586-2594. 
 
Müller, L. J., Pels, L. and Vrensen, G. F. (1995) Novel aspects of the ultrastructural 
organization of human corneal keratocytes. Invest Ophthalmol Vis Sci. 36: 2557-2567. 
 
Müller, L. J., Pels, E. and Vrensen, G. F. (2001) The effects of organ-culture on the density 
of keratocytes and collagen fibers in human corneas. Cornea. 20: 86-95. 
 
Nakamura T, Inatomi T, Sotozono C, et al (2004). Transplantation of cultivated autologous 
oral mucosal epithelial cells in patients with severe ocular surface disorders. Brit J 
Ophthalmol; 88:1280-1284 
 
Netto, M.V., Mohan, R.R., Medeiros, F.W., Dupps, W.J., Sinha, S., Krueger, R.R., 
Stapleton, W.M., Rayborn, M., Suto, C. and Wilson, S.E., (2007). Femtosecond laser and 
microkeratome corneal flaps: comparison of stromal wound healing and inflammation. J 
Refract Surg, 23(7), pp.667-676. 
 
Newton, R. H. and Meek, K. M. (1998) The integration of the corneal and limbal fibrils in 
the human eye. Biophys J. 75: 2508-2512. 
 
Nishida, K., Yamato, M., Hayashida, Y., Watanabe, K., Yamamoto, K., Adachi, E., Nagai, 
S., Kikuchi, A., Maeda, N., Watanabe, H. and Okano, T., (2004). Corneal reconstruction 
with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N  
Engl J Med, 351(12), pp.1187-1196. 
 
Nishida, T., Ueda, A., Fukuda, M., Mishima, H., Yasumoto, K. and Otori, T. (1988) 
Interactions of extracellular collagen and corneal fibroblasts: morphologic and biochemical 
changes of rabbit corneal cells cultured in a collagen matrix. In Vitro Cell Dev Biol. 24: 
1009-1014. 
 
  
198 
 
Ohki T, Yamato M, Murakami D, et al (2006). Treatment of oesophageal ulcerations using 
endoscopic transplantation of tissue-engineered autologous oral mucosal epithelial cell 
sheets in a canine model Gut; 55:1704-1710.  
 
Pallikaris, I. G., Kymionis, G. D. and Astyrakakis, N. I. (2001) Corneal ectasia induced by 
laser in situ keratomileusis. J Cataract Refract Surg. 27: 1796-1802. 
 
Pallikaris, I. G., Papatzanaki, M. E., Stathi, E. Z., Frenschock, O. and Georgiadis, A. (1990) 
Laser in situ keratomileusis. Lasers Surg Med. 10: 463-468. 
 
Pallikaris, I.G., Papatzanaki, M.E., Siganos, D.S. and Tsilimbaris, M.K., (1991). A corneal 
flap technique for laser in situ keratomileusis: human studies. Arch Ophthalmol, 109(12), 
pp.1699-1702. 
 
Pallikaris, I. G. and Siganos, D. S. (1994) Excimer laser in situ keratomileusis and 
photorefractive keratectomy for correction of high myopia. J Refract Corneal Surg. 10: 
498–510. 
 
Patel, C.K., Hanson, R., McDonald, B. and Cox, N., (2001). Late dislocation of a LASIK 
flap caused by a fingernail. Arch Ophthalmol, 119(3), pp.447-449. 
 
Patel, S.V., McLaren, J.W., Hodge, D.O. and Bourne, W.M., 2001. Normal human 
keratocyte density and corneal thickness measurement by using confocal microscopy in 
vivo. Invest Ophthalmol Vis Sci, 42(2), pp.333-339. 
 
Pellegrini, G., Traverso, C.E., Franzi, A.T., Zingirian, M., Cancedda, R. and De Luca, M., 
(1997). Long-term restoration of damaged corneal surfaces with autologous cultivated 
corneal epithelium. The Lancet, 349(9057), pp.990-993. 
 
Pei, Y., Reins, R. Y. and McDermott, A. M. (2006) Aldehyde dehydrogenase (ALDH) 3A1 
expression by the human keratocyte and its repair phenotypes. Exp Eye Res. 83:1063-1073. 
 
  
199 
 
Pérez-Santonja, J. J., Linna, T. U., Tervo, K. M., Sakla, H. F., Alió y Sanz, J. L., Tervo, T. 
M. (1998) Corneal wound healing after laser in situ keratomileusis in rabbits. J Refract 
Surg. 14: 602-609 
 
Perez-Santonja, J.J., Sakla, H.F. and Alió, J.L., 1998. Contrast sensitivity after laser in situ 
keratomileusis. J Cataract Refract Surg, 24(2), pp.183-189. 
 
Petersen, H. and Seiler, T., (1999). Intraoperative and postoperative complications after 
laser in situ keratomileusis (LASIK). Der Ophthalmologe, 96(4), pp.240-247. 
 
Petroll, W.M., Cavanagh, H.D. and Jester, J.V., (1993). Three‐dimensional imaging of 
corneal cells using in vivo confocal microscopy. J Microsc, 170(3), pp.213-219  
 
Petroll, W.M., Cavanagh, H.D. and Jester, J.V., (2004). Dynamic three‐dimensional 
visualization of collagen matrix remodeling and cytoskeletal organization in living corneal 
fibroblasts. Scanning, 26(1), pp.1-10 
 
Piatigorsky, J. (2000) Review: A case for corneal crystallins. J Ocul Pharmacol Ther. 16: 
173-180. 
 
Poole, C.A., Brookes, N.H. and Clover, G.M., (1993). Keratocyte networks visualised in 
the living cornea using vital dyes. J Cell Sci, 106(2), pp.685-691. 
 
Radner, W., Zehetmayer, M., Aufreiter, R. and Mallinger, R. (1998) Interlacing and cross-
angle distribution of collagen lamellae in the human cornea. Cornea. 17: 537-543 
 
Raiskup, F., Hoyer, A. and Spoerl, E. (2009) Permanent corneal haze after riboflavin- 
UVA-induced cross-linking in keratoconus. J Refract Surg. 25: S824-828. 
 
Randleman, J. B., Woodward, M., Lynn, M. J. and Stulting, R. D. (2008) Risk assessment 
for ectasia after corneal refractive surgery. Ophthalmology. 115: 37–50. 
 
Rawe, I.M., Meek, K.M., Leonard, D.W., Takahashi, T. and Cintron, C., (1994). Structure 
of corneal scar tissue: an X-ray diffraction study. Biophys J, 67(4), pp.1743-1748. 
  
200 
 
Read, S.A., Collins, M.J. and Carney, L.G., 2007. A review of astigmatism and its possible 
genesis. Clin Exp Optom, 90(1), pp.5-19. 
 
Robert, L., Legeais, J. M., Robert, A. M. and Renard, G. (2001) Corneal collagens. Pathol 
Biol. 49: 353-363. 
 
Rosen, E.S., 2000. LASIK mania. J Cataract Refract Surg, 26(3), p.303. 
 
Saika, S., Shiraishi, A., Liu, C. Y., Funderburgh, J. L., Kao, C. W., Converse, R. L. and 
Kao, W. W. (2000) Role of lumican in the corneal epithelium during wound healing. J 
Biol Chem. 275: 2607-2612. 
 
Sanchez, I., Martin, R., Ussa, F. and Fernandez-Bueno, I., (2011). The parameters of the 
porcine eyeball. Graefe's Arch Clin Exp Ophthalmol, 249(4), pp.475-482. 
 
Saude, T. (1993) Occular anatomy and physiology. Oxford: Blackwell Scientific 
Publications. 
 
Schmack, I., Dawson, D. G., McCarey, B. E., Waring, G. O. 3rd, Grossniklaus, H. E. and 
Edelhauser, H. F. (2005) Cohesive tensile strength of human LASIK wounds with 
histologic, ultrastructural, and clinical correlations. J Refract Surg. 21: 433-445. 
 
Shannon D.B., McKeown S.T., Lundy F.T., Irwin C.R. (2006) Phenotypic differences 
between oral and skin fibroblasts in wound contraction and growth factor expression 
Wound Repair Regen, 14, pp. 172-178 
 
Shaw, L. M. and Olsen, B. R. (1991) FACIT collagens: diverse molecular bridges in 
extracellular matrices. Trends Biochem Sci. 16: 191-194. 
 
Singerman, L. J. and Coscas, G. (1998) Current techniques in ophthalmic laser surgery. 
Boston: Butterworth-Heinemann. 
 
Sloan P (1991). Current concepts of the role of fibroblasts and extracellular matrix in 
wound healing and their relevance to oral implantology J Dent, 19, pp. 107-109 
  
201 
 
Smolin, G., Foster, C.S., Azar, D.T. and Dohlman, C.H. eds., (2005). Smolin and Thoft's 
the cornea: scientific foundations and clinical practice. Lippincott Williams & Wilkins. 
 
Steele, C. (1999) Corneal wound healing: a review. Optometry Today. 24: 28-34. 
 
Stephens P (1995) An In-Vitro Comparison of the Contractile Ability of Oral and Dermal 
Fibroblasts J Dental Res 74(3), p.862 
 
Stephens, P., Davies, K.J., Al-Khateeb, T., Shepherd, J.P. and Thomas, D.W., (1996). A 
comparison of the ability of intra-oral and extra-oral fibroblasts to stimulate extracellular 
matrix reorganization in a model of wound contraction. J Dent Res, 75(6), pp.1358-1364. 
 
Stephens, P., Davies, K.J., Occleston, N., Pleass, R.D., Kon, C., Daniels, J., Khaw, P.T. 
and Thomas, D.W., (2001). Skin and oral fibroblasts exhibit phenotypic differences in 
extracellular matrix reorganization and matrix metalloproteinase activity. Brit J 
Dermatol, 144(2), pp.229-237. 
 
Stephens, P., Hiscox, S., Cook, H., Jiang, W.G., Zhiquiang, W. and Thomas, D.W., (2001). 
Phenotypic variation in the production of bioactive hepatocyte growth factor/scatter factor 
by oral mucosal and skin fibroblasts. Wound Repair Regen, 9(1), pp.34-43. 
 
Stephens, P. and Davies, L.C., 2015. Oral Mucosal Progenitor Cells. In Stem Cell Biology 
and Tissue Engineering in Dental Sciences (pp. 297-306). Academic Press. 
 
Stiemke, M.M., Edelhauser, H.F. and Geroski, D.H., (1991). The developing corneal 
endothelium: correlation of morphology, hydration and Na/K ATPase pump site 
density. Curr Eye Res, 10(2), pp.145-156. 
 
Strupler, M., Pena, A.M., Hernest, M., Tharaux, P.L., Martin, J.L., Beaurepaire, E. and 
Schanne-Klein, M.C., (2007). Second harmonic imaging and scoring of collagen in fibrotic 
tissues. Opt Express, 15(7), pp.4054-4065. 
 
Summerlin W T, Miller G E, Harris J E, Good R A (1973) The Organ-Cultured Cornea: An 
in vitro Study. Invest. Ophthalmol. Vis. Sci.;12(3):176-180 
  
202 
 
Syed-Picard, F.N., Du, Y., Lathrop, K.L., Mann, M.M., Funderburgh, M.L. and 
Funderburgh, J.L., (2015). Dental pulp stem cells: a new cellular resource for corneal 
stromal regeneration. Stem Cell Transl Med, 4(3), pp.276-285. 
 
Szpaderska A.M., Zuckerman J.D, DiPietro L.A (2003) Differential injury responses in oral 
mucosal and cutaneous wounds J Dent Res, 82, pp. 621-626 
 
Taliana, L., Evans, M.D., Dimitrijevich, S.D. and Steele, J.G., (2000). Vitronectin or 
Fibronectin Is Required for Corneal Fibroblast–Seeded Collagen Gel Contraction. Invest 
Ophthalmol Vis Sci, 41(1), pp.103-109. 
 
Tan, D.T., Dart, J.K., Holland, E.J. and Kinoshita, S., (2012). Corneal transplantation. The 
Lancet, 379(9827), pp.1749-1761. 
 
Taneri, S., Zieske, J.D. and Azar, D.T., (2004). Evolution, techniques, clinical outcomes, 
and pathophysiology of LASEK: review of the literature. Surv Ophthalmol, 49(6), pp.576-
602. 
 
Thomas B, McIntosh D, Fildes T, Smith L, Hargrave F, Islam M, Thompson T, Layfield 
R, Scott D, Shaw B, Burrell C L, Gonzalez S, Taylor S (2017) Second-harmonic generation 
imaging of collagen in ancient bone. Bone Reports 7: 137-144 
 
Thomasy, S.M., Raghunathan, V.K., Winkler, M., Reilly, C.M., Sadeli, A.R., Russell, P., 
Jester, J.V. and Murphy, C.J., (2014). Elastic modulus and collagen organization of the 
rabbit cornea: epithelium to endothelium. Acta biomater, 10(2), pp.785-791. 
 
Toda, I., Asano-Kato, N., Komai-Hori, Y. and Tsubota, K., (2001). Dry eye after laser in 
situ keratomileusis. Am J Ophthalmol, 132(1), pp.1-7. 
 
Torricelli A .M, Wilson, S E. (2014) Cellular and extracellular matrix modulation of 
corneal stromal opacity, Exp Eye Res, 129: 151-160 
 
  
203 
 
Tsai C, Hata K, Torii S et al. (1995) Contraction potency of hypertrophic scar‐derived 
fibroblasts in a connective tissue model: in vitro analysis of wound contraction. Ann Plast 
Surg; 35: 638–46 
 
Upadhyay, S., 2015. Myopia, Hyperopia and Astigmatism: A Complete Review with View 
of Differentiation. Int J Sci Res. 
 
van der Want, H.J., Pels, E., Schuchard, Y., Olesen, B. and Sperling, S., (1983). Electron 
microscopy of cultured human corneas: osmotic hydration and the use of a dextran fraction 
(dextran T 500) in organ culture. Arch Ophthalmol, 101(12), pp.1920-1926 
 
Van Horn, D. L., Doughman, D. J., Harris, J. E., Miller, G. E., Lindstrom, R. and Good, R. 
A. (1975) Ultrastructure of human organ-cultured cornea. II. Stroma and epithelium. Arch 
Ophthalmol. 93: 275-277. 
 
Vargas-Fragoso, V. and Alió, J.L., 2017. Corneal compensation of presbyopia: 
PresbyLASIK: an updated review. Eye and Vision, 4(1), p.11. 
 
Warner, N., 2016. Update on myopia. Current Opin Ophthalmol, 27(5), pp.402-406. 
 
Wang, J.F., Olson, M.E., Reno, C.R., Kulyk, W., Wright, J.B. and Hart, D.A., (2000). 
Molecular and cell biology of skin wound healing in a pig model. Connect Tissue Res, 
41(3), pp.195-211 
 
Widera, D., Zander, C., Heidbreder, M., Kasperek, Y., Noll, T., Seitz, O., Saldamli, B., 
Sudhoff, H., Sader, R., Kaltschmidt, C. and Kaltschmidt, B., (2009). Adult palatum as a 
novel source of neural crest‐related stem cells. Stem Cells, 27(8), pp.1899-1910. 
 
William Mohler, Andrew C. Millard, Paul J. Campagnola, (2003) Second harmonic 
generation imaging of endogenous structural proteins, Methods, 29(1):97-101 
 
Wilson, S. E. (2002) Analysis of the keratocyte apoptosis, keratocyte proliferation, and 
myofibroblast transformation responses after photorefractive keratectomy and laser in situ 
keratomileusis. Trans Am Ophthalmol Soc. 100: 411-433. 
  
204 
 
Wilson, S. E., He, Y. G., Weng, J., Li, Q., McDowall, A. W., Vital, M. and Chwang, E. L. 
(1996) Epithelial injury induces keratocyte apoptosis: hypothesized role for the interleukin-
1 system in the modulation of corneal tissue organization and wound healing. Exp Eye Res. 
62: 325-327. 
 
Wilson, S. E. and Hong, J. W. (2000) Bowman's layer structure and function: critical or 
dispensable to corneal function? A hypothesis. Cornea. 19: 417-420. 
 
Wilson, S. E., Liu, J. J. and Mohan, R. R. (1999) Stromal-epithelial interactions in the 
cornea. Prog Retin Eye Res. 18: 293-309. 
 
Wilson, S. E., Mohan, R. R., Mohan, R. R., Ambrósio, R. Jr, Hong, J. and Lee, J. (2001) 
The corneal wound healing response: cytokine-mediated interaction of the epithelium, 
stroma, and inflammatory cells. Prog Retin Eye Res. 20: 625-637. 
 
Wong, J.W., Gallant‐Behm, C., Wiebe, C., Mak, K., Hart, D.A., Larjava, H. and Häkkinen, 
L., 2009. Wound healing in oral mucosa results in reduced scar formation as compared with 
skin: evidence from the red Duroc pig model and humans. Wound Repair Regen, 17(5), 
pp.717-729. 
 
Woodhead-Galloway, J., 1980. Structure of the collagen fibril: some variations on a theme 
of tetragonally packed dimers. Proc R Soc Lond B Biol Sci, pp.275-297. 
 
Yin, G.H.W., McAlinden, C., Pieri, E., Giulardi, C., Holweck, G. and Hoffart, L., 2016. 
Surgical treatment of presbyopia with central presbyopic keratomileusis: One-year results. 
J Cataract Refract Surg, 42(10), pp.1415-1423. 
 
Zerbe, B.L., Belin, M.W., Ciolino, J.B. and Boston Type 1 Keratoprosthesis Study Group, 
2006. Results from the multicenter Boston type 1 keratoprosthesis study. Ophthalmology, 
113(10), pp.1779-1784. 
 
Zieske, J D (2001) Extracellular matrix and wound healing Curr. Op. in Ophthalmology.; 
12(4):237-241 
 
  
205 
 
Zieske, J. D., Guimarães, S. R. and Hutcheon, A. E. (2001) Kinetics of keratocyte 
proliferation in response to epithelial debridement. Exp Eye Res. 72: 33-39. 
 
Zieske, J.D. and Wilson, S.E., 2003. Apoptosis, necrosis, proliferation, and myofibroblast 
generation in the stroma following LASIK and PRK. Exp Eye Res, 76(1), pp.71-87. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
206 
 
Appendix 
Preparation of Phosphate Buffer Solution (PBS)  
Materials 
7.4pH Phosphate Buffer Saline Tablets (1282-1680, Fisher Scientific, UK) 
dH2O (as required) 
1L dewar 
 
Solution Preparation 
1. Dissolve one tablet per 100ml of dH2O in a 1L dewar. 
 
 
Preparation of Stock Antibiotic solution  
Materials 
500 mg Streptomycin Sulphate (S1400000, Sigma, UK) 
500 mg Kanamycin Sulphate from Streptomyces Kanamycetious (K4000, Sigma, UK 
300 mg Penicillin G (P3032, Sigma, UK) 
730 mg L-Glutamine (G8540, Sigma, UK) 
50 ml ddH2O   
 
Solution Preparation  
1. Weigh out and dissolve all powders into the ddH20 
2. Filter into 10 ml aliquots using a 0.2 μm filter in sterile conditions.   
 
 
Preparation of 1% Agar/1% Gelatine Solution  
Materials 
Agar Powder (A1296, Sigma, UK) 
Gelatine Powder (G2500, Sigma, UK) 
ddH2O 
300ml Dewar 
60 ml Sterile Pots. 
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Solution Preparation 
1.Weigh out 2g of agar and 2g of gelatine powder 
2.Place in a 300ml Dewar 
3.Add 200ml ddH2O 
4.Stir continuously until completely dissolved.  
5.Place in individual pots, leave to set overnight and then store in fridge. 
 
 
Preparation of Dulbecco’s Modified Eagles Medium (DMEM)  
Materials 
500ml bottle DMEM - High glucose, Pyruvate, no glutamine 500mL (21969035, 
Thermofisher, UK)  
70% IMS Spray 
Fungizone® antimycotic solution (11520496, Thermofisher, UK) 
Stock antibiotic solution (see separate SOP) 
Syringe 
0.2µl Filters 
 
Solution Preparation 
1.The 500ml bottle of DMEM media must be prepared inside the class II culture cabinet. 
Spray the outside of unopened/factory sealed DMEM bottle with 70% IMS to sterilise. 
Introduce into the cabinet.  
2.Spray the outside of previously prepared antibiotic stock solution (5ml) and Fungizone® 
antimycotic solution (5ml) and introduce to the class II cabinet. 
3.Filter the antibiotic solution and Fungizone® into the DMEM solution using a syringe 
with a 0.2µm filter attached.  
4.This can be prepared in advance and stored in the fridge until day of use.  
 
 
Preparation of 7.4% Sodium Bicarbonate (NaHCO3) Solution  
Materials 
NaHCO3 Powder (S5761, Sigma, UK) 
300ml Dewar 
ddH2O 
 
Solution Preparation 
1. Weigh out 22.2g of NaHCO3  
2.Place the NaHCO3 into a 300ml dewar. 
3. Add 300mls of ddH2O and stir continuously until dissolved.  
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4. Can be stored at room temperature.  
 
 
Preparation of 1% Agar/1% Gelatine Support Matrix  
Materials 
70% IMS 
1%Agar/1%Gelatine (see previous SOP) 
500ml DMEM (11520496, Thermofisher, UK) 
7.4% NaHCO3 Solution (see previous SOP) 
Antibiotic stock solution (see previous SOP) 
Fungizone® Antimycotic solution (11520496, Thermofisher, UK)  
Stripettes 
2ml syringes 
Sterile pots 
0.2µm syringe filters 
 
Solution Preparation 
1.The preparation of this support matrix is to take place in the sterile conditions of a class 
II cabinet.  
2.To turn the 1%agar/1%gelatine mixture into a solution, heat in a microwave on low 
power for 20 seconds at a time until melted. Then spray the surface with 70% IMS and 
introduce into the class II cabinet. 
3.Spray the surface of 500ml DMEM bottle, 7.4% NaHCO3 flask, antibiotic stock 
solution, Fungizone®, 10 ml stripette, 2ml syringes, sterile pots and 0.2µm filters with 
70% IMS and introduce them into the class II cabinet. 
4.Using the syringes with the filters attached, filter the following solutions and quantities 
into the agar/gelatine solution; 
20ml DMEM media 
10ml 7.4% NaHCO3 
2ml Stock Antibiotic solution 
2ml Fungizone® solution 
5.Decant the final solution into sterile pots, label appropriately and seal.  
6.Store the solution in the fridge until needed.  
 
 
 
 
 
  
209 
 
Preparation of 0.2M Sodium Cacodylate buffer  
Materials 
Sodium Cacodylate 
Calcium Chloride Dihydrate 
dH20 
1M Hycrochloric Acid (HCL) 
 
Solution Preparation 
1.Transfer open pan balance to fume hood and, wearing gloves, weigh 4.28g sodium 
cacodylate powder into a beaker.  
2.Clear up any spillage of powder immediately with damp tissue. 
3.Add (Calcium Chloride Dihydrate) CaCl2.2H2O for 3mM  
4.Add 50ml distilled water. 
5.Transfer to pH meter and correct pH to 7.2 with 1M HCl 
6.Make up to 100ml with dH20. 
 
 
Preparation of 2.5% glutaraldehyde/0.1M sodium cacodylate  
Materials 
0.2M sodium cacodylate buffer  
stock 25% glutaraldehyde  
dH20 
 
Solution Preparation 
1.Add 5ml stock 25% glutaraldehyde to 25ml Sodium Cacodylate  
2.Add 20ml dH20 
 
 
*TUNEL solutions (all solutions and chemicals, unless otherwise stated, are from the 
Click-iTTM Plus TUNEL Assay (C10617, Invitrogen, UK)  
 
Preparation of Click-iTTM TUNEL Reaction Buffer  
Materials 
Click-iTTM TUNEL Reaction Buffer 
Deionised Water  
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Solution Preparation 
1.Transfer 500µl of Click-iTTM TUNEL Reaction Buffer into 4.5ml of deionised water 
2.Rinse the original vial with some of the Click-iTTM TUNEL Reaction Buffer solution 
to ensure all of the 10X concentration 
3.Dilute 1:10 with deionised water for storage at 2-8˚C 
 
 
Preparation of 1X Click-iTTM Plus TUNEL Supermix  
Materials 
Click-iTTM TUNEL Reaction Buffer 
Copper Protectant 
AlexafluorTM 488 Picolyl Azide 
 
Solution Preparation 
1.To 2630µl Click-iTTM TUNEL Reaction Buffer add 67µl Copper Protectant and 3.7 µl 
Alexa FluorTM picolyl azide 
2.Store at -20 ˚C 
 
 
Preparation of 100X stock Click-iTTM TUNEL Reaction Buffer Additive  
Materials 
Click-iTTM TUNEL Reaction Buffer Additive 
Deionised water 
 
Solution Preparation 
1.Add 2ml of deionised water into vial containing Click-iTTM TUNEL Reaction Buffer 
Additive (400mg) 
2.Mix until fully dissolved 
3.Aliquot and store at -20 ˚C 
  
 
Preparation of 1X Proteinase K Solution  
Materials 
Proteinase K 
PBS (see previous SOP) 
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Solution Preparation 
1.Dilute Proteinase K 1:25 in PBS 
2.Aliquot and store at -20 ˚C 
 
 
Preparation of Terminal deoxynucleotidyl transferase (TdT) reaction mixture  
Materials 
TdT Reaction Buffer 
EdUTP 
TdT Enzyme  
 
Solution Preparation 
1.For 10 sections, to 470µl of TdT Reaction Buffer add 10 µl of EdUTP and 20 µl of TdT 
Enzyme 
2.Do not store as a prepared solution 
,  
 
Preparation of Click-iTTM Plus TUNEL Reaction Cocktail  
Materials 
1X Click-iTTM Plus TUNEL Supermix 
10X Click-iTTM TUNEL Reaction Buffer  
 
Solution Preparation 
1.For 10 sections, to 450µl of 1X Click-iTTM Plus TUNEL Supermix add 50µl of 
10XClick-iTTM TUNEL Reaction Buffer  
2.Use within 15minutes of preparation. 
3.Do not store prepared solution
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